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Abstract 
 
In response to DNA damage during S phase, cells slow DNA replication.  This 
slowing is orchestrated by the intra-S checkpoint and involves inhibition of origin 
firing and reduction of replication fork speed.  Slowing of replication allows for 
tolerance of DNA damage and suppresses genomic instability.  Although the 
mechanisms of origin inhibition by the intra-S checkpoint are understood, major 
questions remain about how the checkpoint regulates replication forks: Does the 
checkpoint regulate the rate of fork progression?  Does the checkpoint affect all 
forks, or only those encountering damage?  Does the checkpoint facilitate the 
replication of polymerase-blocking lesions?  To address these questions, we 
have analyzed the checkpoint in the fission yeast Schizosaccharomyces pombe 
using a single-molecule DNA combing assay, which allows us to unambiguously 
separate the contribution of origin and fork regulation towards replication slowing, 
and allows us to investigate the behavior of individual forks.  Moreover, we have 
interrogated the role of forks interacting with individual sites of damage by using 
three damaging agents—MMS, 4NQO and bleomycin—that cause similar levels 
of replication slowing with very different frequency of DNA lesions.  We find that 
the checkpoint slows replication by inhibiting origin firing, but not by decreasing 
fork rates.  However, the checkpoint appears to facilitate replication of damaged 
templates, allowing forks to more quickly pass lesions.  Finally, using a novel 
analytic approach, we rigorously identify fork stalling events in our combing data 
  
ix 
and show that they play a previously unappreciated role in shaping replication 
kinetics in response to DNA damage. 
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Preface 
Chapter I is compiled from two published reviews which were written by Nick 
Rhind and me and are published in the journals Biochemical Society 
Transactions and Genes. 
 
A part of Chapter II is compiled from the methods paper, which was written by 
Nick Rhind and me. Shankar Das is also a contributing author in this methods 
paper for his efforts in initial trouble-shooting of the technique. The methods 
paper has been accepted at Cold Spring Harbor Protocols. Chapter II also 
contains a part of the manuscript written by Nick Rhind and me. This manuscript 
is currently under review at PLOS Genetics. 
 
Chapter III is mainly from the manuscript written by Nick Rhind and me and is 
currently under review at PLOS Genetics. 
 
Chapter IV is a part of a larger study carried out by Stefano Santaguida in 
Angelika Amon’s lab at MIT. The cells were prepared by Stefano Santaguida. 
Sample processing, combing and analysis were performed by me. All the figures 
of Chapter IV were prepared by me. This work is published as a part of a larger 
study (Santaguida et al., 2017) in Developmental Cell. 
 
  
1 
 
Chapter I 
Introduction: 
Checkpoint Regulation of Forks in Response to 
DNA Damage 
 
 
 
 
Chapter I is compiled from two published reviews which were written by Nick 
Rhind and me (Iyer and Rhind, 2013; Iyer and Rhind, 2017). Extra sections have 
been added to make it suitable for this thesis. 
 
 
 
 
 
 
 
 
  
  
2 
Why study fork regulation in response to DNA damage? 
Cells slow replication in response to DNA damage during S phase. This slowing 
of replication in response to DNA damage has been documented for more than 
half a century (Ord and Stocken, 1956; Ord and Stocken, 1958; Lajtha et al., 
1958; Painter, 1967). The initial hints of checkpoint regulation of replication 
slowing came from Ataxia Telangiectasia (AT) patients, characterized by 
hypersensitivity to ionizing radiation (IR). Cells from AT patients fail to slow 
replication in response to IR, a characteristic termed ‘radio-resistant DNA 
synthesis’ (Painter and Young, 1980; Painter, 1981; Houldsworth and Lavin, 
1980; Young and Painter, 1989). AT patients suffer from severe developmental 
defects and are highly predisposed to developing cancer (Gatti et al., 2001; 
Friedberg et al., 1995).  
The symptoms of AT patients highlight the importance of checkpoint 
regulated slowing of replication in response to damage. Later studies 
in Saccharomyces cerevisiae and Schizosaccharomyces pombe showed that 
slowing of S phase is an evolutionarily conserved mechanism in response to 
DNA damage (Lindsay et al., 1998; Rhind and Russell, 1998; Paulovich and 
Hartwell, 1995). This bulk slowing of replication is achieved through a 
combination of inhibition of origin firing and regulation of fork progression 
(Kaufmann and Cleaver, 1981; Kaufmann et al., 1980; Merrick et al., 2004; Falck 
et al., 2002; Santocanale and Diffley, 1998; Chastain et al., 2006; Seiler et al., 
2007; Kumar and Huberman, 2009).  
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Several studies have hinted that regulation of forks is perhaps the most 
crucial function of the intra-S checkpoint and yet there seems to be no clear 
answer to the exact role of the checkpoint in regulating forks encountering DNA 
damage (Paciotti et al., 2001; Tercero et al., 2003; Tercero and Diffley, 2001; 
Jossen and Bermejo, 2013; Cortez, 2015). A separation-of-function checkpoint 
mutant in which origin regulation is disrupted, is not sensitive to DNA damaging 
drugs, unlike a checkpoint null allele, suggesting that fork regulation is the more 
crucial role of the checkpoint (Tercero et al., 2003; Paciotti et al., 2001). Although 
origin regulation by the checkpoint has been worked out in great details, 
regulation of forks by the checkpoint has remained largely elusive (Santocanale 
and Diffley, 1998; Shirahige et al., 1998; Kaufmann et al., 1980; Merrick et al., 
2004; Falck et al., 2001; Falck et al., 2002; Chastain et al., 2006; Seiler et al., 
2007; Kumar and Huberman, 2009; Luciani et al., 2004). A long-standing 
question in the field is whether fork progression is regulated by the checkpoint 
and if so, how?  
To understand the regulation of forks by the checkpoint, we decided to use 
DNA combing, a single-molecule based technique for visualizing replication fork 
dynamics, to unequivocally monitor the regulation of individual forks in response 
to different kinds of lesions. This dissertation describes the development of 
sequential analog labeling in fission yeast to study the regulation of forks at 
single-molecule level by DNA combing (Chapter II) (Iyer et al., in press). Further, 
using a novel analytic approach we have identified fork stalling events in our 
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combing datasets (Chapter II). Using three different damaging drugs - 4NQO, 
MMS and bleomycin - we have studied the behavior of individual forks in 
response to different kinds of lesions during S phase (Chapter III).  Finally we 
have also studied the consequences of aberrations in chromosome number on 
replication kinetics by combing (Chapter IV).  
In this introductory chapter, I will discuss the mechanism of activation of the 
intra-S checkpoint, regulation of origins and forks by the checkpoint in response 
to DNA damage, and finally discuss the methodologies used over the years to 
study replication kinetics and end with the advantages of using a single-molecule 
approach to study the regulation of replication kinetics by the checkpoint. 
 
1. The Intra-S Checkpoint – why, what and how? 
1.1 Need for an S phase Checkpoint 
 “The dream of every cell is to become two cells” is the basic tenet of cell cycle, 
as stated by Francois Jacob in 1965 (Monod, 1971). In order to achieve this 
dream, cells need to faithfully duplicate their genetic material without aberrations.  
Genetic material is constantly subject to insults by both intrinsic and extrinsic 
factors such as free radicals and UV light (Zhou and Elledge, 2000; Hoeijmakers, 
2009; Lindahl and Barnes, 2000). DNA damage checkpoints safeguard the 
genome against these insults and ensure its faithful transmission across 
generations. Once activated, these checkpoints block cell cycle progression and 
ensure that the DNA is fully repaired before allowing progression to the next 
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phase of the cell cycle (Hartwell and Weinert, 1989). However, even though the 
cell has checkpoints and repair pathways dedicated to DNA damage repair in 
G1, it is impossible to guarantee that cells will enter S phase with a perfect 
template. Further, damage could occur during S phase itself. Therefore, the cell 
must be prepared to encounter damaged DNA during S phase (Bartek et al., 
2004; Ciccia and Elledge, 2010; Livneh et al., 2016).  
 
1.2 Sources of Damage 
1.2.1 Intrinsic Sources of Damage 
Intrinsic sources of damage include reactive oxygen species (ROS) generated as 
a by-product of cellular metabolism, which can cause oxidative damage to DNA 
(Cooke et al., 2003). Other toxic metabolites include reactive aldehydes 
generated via alcohol metabolism, which can crosslink DNA (Burcham, 1999; 
Brooks and Theruvathu, 2005). Apart from toxic by-products of metabolism, 
ribonucleotides can pose a threat, too (Dalgaard, 2012). Despite the specificity of 
DNA polymerases for deoxyribonucleotides over ribonucleotides, recent studies 
have shown that more than 10,000 ribonucleotides may be incorporated into 
the Saccharomyces cerevisiae genome during replication and can cause 
genomic stress if not actively removed. In unperturbed cells, ribonucleotides are 
removed from the genome using a combination of ribonuclease H (RNaseH) 
activity and post-replication repair pathways (Nick McElhinny et al., 2010; 
Lazzaro et al., 2012). Replication stress can also be caused by intrinsically 
difficult to replicate sequences in the genome, such as G-quadruplexes and 
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repeats, which can lead to replication fork slippage and chromosomal breaks 
(Pearson et al., 2005; Valton and Prioleau, 2016; Kim and Mirkin, 2013). Another 
natural impediment to the replication fork is the transcriptional machinery. 
Collision between the replication and the transcription machinery leads to fork 
stalling, R-loop formation, and topological stress, which may trigger DNA damage 
and recombination (Bermejo et al., 2012b; Helmrich et al., 2013). Cells have 
active mechanisms to constrain the deleterious effects of all these aberrations, 
so as to curtail their impact on the genome. 
 
1.2.2 Extrinsic Sources of Damage 
Extrinsic factors that damage DNA include ultra-violet light (UV) and IR, and 
chemicals such as methyl-methane sulfonate (MMS), mitomycin C, cisplatin, 
psoralen, camptothecin (CPT), and etoposide, to list a few of the well-known 
DNA damaging agents. These damaging agents cause different kinds of lesions, 
from simple alkylation of bases by MMS, to the more complex pyrimidine dimers 
by UV, topoisomerase-DNA covalent complexes by CPT, and inter-strand and 
intra-strand crosslinks by cisplatin and psoralen (Wyatt and Pittman, 2006; Cadet 
et al., 2005; Liu et al., 2000a; Deans and West, 2011). Cells have evolved 
various pathways to specifically detect and repair different kinds of lesions. The 
repair pathways include base excision repair (BER), which targets modified 
bases, nucleotide excision repair (NER), which targets more complex 
modifications such as pyrimidine dimers. Inter-strand crosslinks are repaired 
using inter-strand crosslink repair pathway, which involves a combination of 
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repair pathways consisting of NER, homologous recombination (HR), translesion 
synthesis (TLS), and Fanconi anemia (FA) repair pathways. Finally, double 
strand breaks (DSB) are repaired by non-homologous end-joining (NHEJ) and 
HR pathways (Hoeijmakers, 2009; Ciccia and Elledge, 2010; Wyatt and Pittman, 
2006; Deans and West, 2011; Lindahl and Wood, 1999; Sancar et al., 2004; 
Marteijn et al., 2014; Jackson, 2002; Mehta and Haber, 2014). 
 
1.3 The Main Players of Intra-S Checkpoint  
Despite having specific repair pathways dedicated to each kind of DNA lesion, 
the cell relies on a single checkpoint to mediate the DNA damage response 
during S phase. The cell has two main checkpoint kinases, Ataxia Telangiectasia 
Mutated (ATM) and ATM and Rad3-related (ATR), both of which are critical for 
maintaining genomic integrity. Of the two, ATR is the more crucial mediator of 
intra-S checkpoint responses since it is activated in response to diverse lesions. 
ATM (Tel1 in budding and fission yeast) mainly responds to double strand 
breaks, while ATR (Mec1 in budding yeast, Rad3 in fission yeast) is activated in 
response to a variety of genotoxins such as UV, MMS, hydroxyurea (HU), 
aphidicolin, and psoralen. ATR also functions in every unperturbed S phase, 
where it regulates origin firing (Shechter et al., 2004b; Syljuåsen et al., 2005; 
Petermann et al., 2010; Sørensen et al., 2003; Sørensen et al., 2004; 
Marheineke and Hyrien, 2004). Since several different pathways activate ATR in 
response to diverse lesions, it has been suggested that the checkpoint is 
activated by a common repair intermediate (Cimprich and Cortez, 2008; 
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Cimprich, 2007; Paulsen and Cimprich, 2007; Cortez, 2005; Flynn and Zou, 
2011; Maréchal and Zou, 2013; Shechter et al., 2004a). 
 
1.4 Detection of Lesion During S phase 
The first step key to all repair pathways is the detection of the lesion itself. 
Detection of a lesion can be a challenge in the vast pool of undamaged template 
(Livneh et al., 2016; Sancar et al., 2004). Furthermore, individual damaged bases 
must be detected in the context of DNA complexed with protein and condensed 
into chromatin (Peterson and Côté, 2004). Depending on the severity of lesions, 
certain aberrations may be detected only during the act of replication itself. The 
replication fork is a sensitive detector of lesions, since it has to interact with every 
base in the genome during replication. Several studies have shown that lesions 
caused by UV and MMS activate the checkpoint only during S phase (Tercero 
and Diffley, 2001; Tercero et al., 2003; Lupardus et al., 2002; Stokes et al., 2002; 
Callegari et al., 2010; Takeda and Dutta, 2005). Studies in S. cerevisiae have 
shown that, if replication initiation is blocked using conditional alleles of initiation 
factors such as Cdc6, or Cdc45, or Cdc7, then cells undergo nuclear division 
without replicating DNA or activating the checkpoint even when treated with 
0.033% MMS, demonstrating that this level of damage is not recognized outside 
of S phase (Tercero et al., 2003). However, during S phase, as little as 0.005% 
MMS is sufficient to activate the checkpoint, suggesting that the replication fork is 
a highly sensitive and efficient activator of the checkpoint (Tercero et al., 2003). 
Similarly, in Xenopus extracts, prevention of replication by addition of geminin 
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blocks checkpoint activation in response to UV and MMS induced lesions 
(Lupardus et al., 2002; Stokes et al., 2002). In human cells too, ATR activation in 
response to UV requires replication (Ward et al., 2004). 
UV- and MMS-induced lesions at high concentrations can activate the DNA 
damage checkpoint outside S phase. Such activation relies on repair pathways 
such as BER in the case of MMS-induced lesions and NER in the case of UV-
induced lesions to generate intermediate structures capable of activating the 
checkpoint (Pellicioli et al., 1999; Sidorova and Breeden, 1997; Sun et al., 1996; 
Marini et al., 2006; Giannattasio et al., 2010; Hanasoge and Ljungman, 2007). 
Thus, the checkpoint can be activated by stalled replication forks as well as 
intermediate structures generated by repair pathways in response to diverse 
lesions caused by different agents such as UV, MMS, and aphidicolin (Cimprich, 
2007). 
2. Intra-S Checkpoint Activation 
2.1 The Structure Necessary for Checkpoint Activation 
The fact that ATR is activated in response to different kinds of genotoxins 
suggests that the activation might occur not through recognition of damage itself 
but a common intermediate generated in response to any lesion that perturbs 
replication. Several studies indicate that the common intermediate necessary for 
checkpoint activation is replication protein A (RPA)–single-stranded DNA 
(ssDNA) complex (Longhese et al., 1996; Garvik et al., 1995; Kim and Brill, 2001; 
Zou and Elledge, 2003; Byun et al., 2005; Paulsen and Cimprich, 2007; Cortez, 
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2005). Replicative polymerases tend to stall in response to lesions while the 
helicase continues to unwind the DNA ahead of the lesion. Such uncoupling of 
the helicase and the polymerase leads to generation of ssDNA, which gets 
coated with the ssDNA binding protein RPA (Zou and Elledge, 2003; Byun et al., 
2005; Paulsen and Cimprich, 2007; Cortez, 2005). This common intermediate 
comprised of stalled replicative polymerase allows for a simple mode of 
checkpoint activation by diverse lesions (Paulsen and Cimprich, 2007; Cortez, 
2005). In the cases of double-strand breaks and inter-strand crosslinks—which 
do not directly produce ssDNA—lesion processing creates ssDNA, as described 
below. 
2.2 The Factors Necessary for Checkpoint Activation 
Several studies have shown that RPA coated ssDNA is essential for activation of 
the S-phase checkpoint kinase, ATR (Longhese et al., 1996; Zou and Elledge, 
2003; Byun et al., 2005; Costanzo et al., 2003; Ball et al., 2007). ATR is a highly-
conserved checkpoint kinase, which responds to various kinds of lesions that 
block DNA replication (Melo and Toczyski, 2002; Zeman and Cimprich, 2014). 
RPA bound ssDNA interacts with ATR-interacting protein (ATRIP) (Ddc2 in 
budding yeast, Rad26 in fission yeast), which binds ATR, leading to its 
recruitment to sites of DNA damage (Table 1) (Zou and Elledge, 2003; Ball et al., 
2007; Paciotti et al., 2000; Rouse and Jackson, 2002).  
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Table 1: List of key proteins involved in intra-S checkpoint activation 
conserved across species 
  
S. cerevisiae S. pombe Mammals
Checkpoint kinase Mec1 Rad3 ATR
Ddc2 Rad26 ATRIP
Rad24 Rad17 Rad17
Sensors Ddc1 Rad9 Rad9
Mec3 Hus1 Hus1
Rad17 Rad1 Rad1
Dpb11 Cut5 TopBP1
Adaptors Mrc1 Mrc1 Claspin
Tof1 Swi1 Tim
Csm3 Swi3 Tipin
Effector kinase Rad53 Cds1 Chk1
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The stalled fork junction composed of ssDNA-RPA complex and dsDNA further 
recruits Rad17-RFC complex, which loads a trimeric ring-shaped complex Rad9-
Rad1-Hus1 (9-1-1) at sites of damage, although it is unclear if Rad17-RFC 
recognizes the 3'ds/ssDNA junction, perhaps after polymerase release or a 
5'ds/ssDNA junction, which would be created by repriming ahead of a stalled 
polymerase on either the leading or lagging strand (Figure 1.1) (MacDougall et 
al., 2007; Zou et al., 2003). 9-1-1 complex in turn recruits DNA topoisomerase II 
binding protein 1 (TopBP1) (Dpb11 in budding yeast, Cut5 in fission yeast), 
which further stimulates ATR activity (Zou et al., 2003; Bonilla et al., 2008; 
Kumagai et al., 2006; Navadgi-Patil and Burgers, 2009; Majka et al., 2006; 
Bermudez et al., 2003; Parrilla-Castellar and Karnitz, 2003; Ellison and Stillman, 
2003; Mordes et al., 2008; Delacroix et al., 2007). Rad17-RCF and 9-1-1, 
together with regulators Claspin (Mrc1 in budding and fission yeast) and 
Tim/Tipin (Tof1/Csm3 in budding yeast, Swi1/Swi3 in fission yeast), are essential 
for activation of checkpoint kinase 1 (Chk1), which is the main target of ATR and 
the effector kinase in the checkpoint pathway in metazoan (Figure 1.1) (Foss, 
2001; Chou and Elledge, 2006; Noguchi et al., 2003; Noguchi et al., 2004; Bartek 
and Lukas, 2003; Osborn and Elledge, 2003; Yoo et al., 2004; Liu et al., 2006; 
Yoshizawa-Sugata and Masai, 2007; Unsal-Kaçmaz et al., 2007). 
 
 
  
  
13 
Figure 1.1 Intra-S checkpoint activation 
 
Figure 1.1 Intra-S checkpoint activation. Fig1.1 depicts how a stalled fork 
generates RPA-ssDNA, which subsequently recruits ATR-ATRIP, Rad17/9-1-1, 
TopBP1 leading to ATR activation. Rad17/9-1-1 complex further recruits 
adaptors like Claspin which leads to transduction of the signal to the effector 
kinase Chk1. Chk1 and ATR phosphorylate a wide range of substrates affecting 
several aspects of cellular physiology in response to damage such as 
transcription, replication kinetics, modulation of nuclear membrane processes 
and alteration of chromatin structure. 
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2.3 Downstream Effectors of Checkpoint Activation 
ATR and ATM activate two effector kinases, Chk1 and Chk2, in response to 
damage to relay the checkpoint signal across the cell. In mammals, Chk1 and 
Chk2 play overlapping roles. Although Chk1 is primarily activated by ATR in 
response to various kinds of lesions and Chk2 by ATM in response to DSBs, 
there is substantial cross-talk between the two pathways making it difficult to 
unambiguously assign Chk1 and Chk2 to a single checkpoint pathway (Zhao and 
Piwnica-Worms, 2001; Rhind, 2009; Shiotani and Zou, 2009; Bartek and Lukas, 
2001; Bartek et al., 2004; Bartek et al., 2001; Shiloh, 2001; Bartek and Lukas, 
2003; Zhang and Hunter, 2014). The roles played by Chk1 and Chk2 also vary 
substantially across species (Rhind and Russell, 2000b). In budding and fission 
yeasts, Rad53 and Cds1 are homologs of mammalian Chk2, respectively. 
However, they are functionally equivalent to mammalian Chk1. In budding yeast 
Rad53 is required for the intra-S checkpoint as well as G2/M checkpoint 
responses, while Cds1 in fission yeast acts only during S phase (Melo and 
Toczyski, 2002; Sanchez et al., 1999; Lindsay et al., 1998; Rhind and Russell, 
1998; Boddy and Russell, 1999). 
Inter-strand crosslinks also activate ATR, even though they do not generate 
RPA-ssDNA in the canonical way by uncoupling helicase and the polymerase. To 
activate ATR, inter-strand crosslinks rely on the FA pathway. Processing of the 
inter-strand crosslink by the FA pathway leads to generation of ssDNA-RPA, 
which in turn activates ATR. Inhibition of the FA pathway using chemical inhibitor 
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DDN or by immunodepletion of FANCD2, greatly diminishes Chk1 activation in 
response to inter-strand crosslinks (Pichierri and Rosselli, 2004; Ben-Yehoyada 
et al., 2009). 
 
2.4 Strength of Checkpoint Activation 
Replication initiation involves melting of DNA, which produces RPA-coated 
ssDNA, the structure necessary for checkpoint activation. Therefore, one 
complication of checkpoint activation via RPA-ssDNA complex is that it is a 
common intermediate generated even during an unperturbed S phase. Several 
studies indicate that the checkpoint functions in every S phase even in the 
absence of damage. The importance of this function is suggested by the fact that 
inhibition of Chk1 during unperturbed S phase leads to unrestrained origin firing, 
which is detrimental to genomic stability (Shechter et al., 2004b; Syljuåsen et al., 
2005; Petermann et al., 2010; Sørensen et al., 2003; Sørensen et al., 2004; 
Marheineke and Hyrien, 2004). The effect of the checkpoint during unperturbed 
replication can also be seen in Xenopus extracts, where the rate of replication 
decreases with increasing concentration of template in a checkpoint-dependent 
manner (Shechter et al., 2004b; Walter and Newport, 1997). Therefore, it 
appears that the ssDNA-RPA structures of many unperturbed replication forks 
are capable of collectively activating the checkpoint, even in the absence of 
damage. 
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Even though the checkpoint is activated in every S phase, there is a 
quantitative difference between level of activation during an unperturbed S phase 
and level required to be induced by DNA damage to activate a full-strength 
checkpoint response. The level of Chk1 activation is tightly correlated with the 
amount of ssDNA generated. In the presence of fork stalling lesions the helicase 
becomes uncoupled from the polymerase leading to generation of longer 
stretches of ssDNA than present in an unperturbed fork (Byun et al., 2005). The 
excess ssDNA-RPA complex formed in response to DNA damage leads to robust 
activation of the checkpoint. Titration experiments with plasmids of varying sizes 
in Xenopus extracts show that the amount of ssDNA generated determines the 
strength of Chk1 activation (Byun et al., 2005). Along similar lines, the number of 
active forks determine the activation of Rad53 in response to DNA damage in S. 
cerevisiae (Shimada et al., 2002). 
Although double strand breaks primarily activate ATM, resection of their 
ends leads to ssDNA generation leading to subsequent activation of ATR 
(Shiotani and Zou, 2009; Jazayeri et al., 2006; Myers and Cortez, 2006; Adams 
et al., 2006; Mantiero et al., 2007; Rhind, 2009). The strength of checkpoint 
activation and subsequent cell cycle delay in response to DSB is regulated by 
both the number of DSBs generated and the amount of ssDNA generated at 
each DSB (Mantiero et al., 2007; Lee et al., 1998; Nakada et al., 2004). Thus, 
checkpoint activation can be quantitatively modulated by the amount of ssDNA 
generated in response to different kinds of lesions. 
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2.5 Downstream Targets 
Unlike ATR, which mainly phosphorylates substrates on chromatin, the S-phase 
effector kinases transduce the signal to many targets across the cell (Bermejo et 
al., 2011; Bermejo et al., 2012a; Smolka et al., 2007; Randell et al., 2010; Chen 
et al., 2010; Rodriguez and Tsukiyama, 2013; Willis et al., 2016). Activation of 
Chk1 in metazoans and Rad53 and Cds1 in yeast in response to replication 
stress leads to regulation of replication kinetics via inhibition of origin firing and 
regulation of replication forks, and to transcriptional reprogramming. 
 
3. Regulation of Replication Kinetics by the Checkpoint 
3.1 Origin Regulation 
3.1.1 Inhibition of Origin Firing 
Replication of the genome occurs in a temporally ordered manner with different 
parts of the genome replicating at specific times in S phase (Rhind and Gilbert, 
2013). In the presence of damage, the early origins fire regardless of the 
presence of lesions, since the forks established by early origins are the ones, 
which sense the lesions and activate the checkpoint. Once the checkpoint is 
activated, it suppresses firing of late origins (Santocanale and Diffley, 1998; 
Shirahige et al., 1998; Kaufmann et al., 1980; Merrick et al., 2004; Falck et al., 
2001; Falck et al., 2002; Chastain et al., 2006; Seiler et al., 2007; Kumar and 
Huberman, 2009; Luciani et al., 2004). In S. cerevisiae, Rad53 phosphorylates 
the origin activation factors Sld3 and Dbf4 in response to replication stress to 
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prevent subsequent origin firing (Lopez-Mosqueda et al., 2010; Zegerman and 
Diffley, 2010). Sld3 is a replication-fork assembly factor required during early 
steps of replication initiation; Dbf4 is the regulatory subunit of Dbf4-dependent 
kinase (DDK), which is required for origin firing and fork progression (Kamimura 
et al., 2001; Kanemaki and Labib, 2006; Jackson et al., 1993). In mammals, 
Chk1 targets multiple substrates to block origin firing. In response to IR, Chk1 
phosphorylates Cdc25A, targeting it for ubiquitin-mediated degradation. Cdc25A 
is a phosphatase necessary for Cdk2-CyclinE activity, which is required for 
binding of Cdc45 to the pre-replicative complex (pre-RC) and initiating replication 
(Sørensen et al., 2003; Falck et al., 2001). Chk1 also phosphorylates Treslin, the 
metazoan homolog of Sld3, to prevent loading of Cdc45 onto chromatin (Guo et 
al., 2015). Further studies in Xenopus and mammalian cells suggest that Chk1 
also targets DDK in response to UVC and etoposide treatments (Costanzo et al., 
2003; Heffernan et al., 2007; Matsuoka et al., 2007). Inhibition of origin firing 
prevents new forks from encountering damage and stalling. Although reduction in 
origin firing leads to slowing of replication, it does not significantly contribute to 
maintenance of cell viability, at least not in S. cerevisiae (Tercero et al., 2003). 
 
3.1.2 Activation of Dormant Origins 
Although checkpoint activation inhibits origin firing globally, several reports 
suggest that it might allow dormant origins to fire locally in response to replication 
stress (Yekezare et al., 2013; McIntosh and Blow, 2012). Cells license origins 
during G1 phase of the cell cycle and activate them throughout S phase (Blow 
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and Dutta, 2005; Diffley, 2011; Masai et al., 2010; Tanaka and Araki, 2011). In an 
unperturbed S phase, a cell fires only about 10% of its licensed origins. Most of 
the remaining origins are licensed but not fired and hence referred to as dormant 
origins. During unperturbed replication, dormant origins are passively replicated. 
However, in the event of replication stress, forks from early origins stall and the 
dormant origins remain un-replicated. Under such conditions, the dormant origins 
fire and help complete replication in the vicinity of stalled forks and thereby 
mitigate the consequences of fork stalling. Reduction of dormant origin firing via 
depletion of mini-chromosome maintenance (MCM) complex makes the cell 
hypersensitive to replication perturbation, highlighting the importance of dormant 
origins (Ge and Blow, 2010; Ge et al., 2007; Woodward et al., 2006; Anglana et 
al., 2003). At this point, it is unclear how the checkpoint could suppress origin 
firing globally but permit activation of dormant origins in response to replication 
stress. A possible explanation is that the checkpoint reduces origin firing globally, 
but that even so dormant origin firing increases due to the reduction in passive 
replication or that the dormant origins fire before the checkpoint is fully activated 
and thus escape inhibition (Yekezare et al., 2013; McIntosh and Blow, 2012). 
 
3.2 Fork regulation 
3.2.1 Importance of fork regulation 
Several studies suggest that the regulation of replication forks in response to 
replication stress is the crucial function of the intra-S checkpoint. The first hint of 
the importance of fork regulation came from the discovery of a separation of 
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function mutant in budding yeast called mec1-100 (Paciotti et al., 2001). mec1-
100 cells cannot suppress origin firing in response to stress, but are not 
hypersensitive to MMS, unlike mec1Δ cells (Tercero et al., 2003; Paciotti et al., 
2001). Presumably fork regulation is intact in mec1-100, hinting that fork 
regulation is more critical for cell viability in response to MMS than origin firing 
inhibition. Consistent with this conclusion, Tercero et al. have shown that forks 
progress slowly but stably in mec1-100 to complete replication in response to 
MMS (Tercero et al., 2003). In contrast, in mec1Δ and rad53Δ cells treated with 
HU or MMS, forks collapse irreversibly leading to large stretches of un-replicated 
DNA (Tercero and Diffley, 2001; Lopes et al., 2001). Experiments in which 
Rad53 expression is suppressed during HU treatment but induced after release 
from HU arrest show that the checkpoint is necessary at the time of fork stalling 
to maintain the replication fork in a restart competent manner. Expression of 
Rad53 after release from HU arrest is not sufficient to maintain viability (Tercero 
et al., 2003). Along similar lines in mammals, ATR-/- and CHK1-/- are embryonic 
lethal in mice and inactivation of ATR during replication stress greatly hampers 
fork progression and cell viability (Couch et al., 2013; Brown and Baltimore, 
2000; Liu et al., 2000b). Collectively, these studies suggest that the checkpoint is 
essential for preventing fork collapse in response to replication stress. The 
mechanism by which the checkpoint accomplishes fork stabilization and 
maintains cell viability is not understood. 
 
3.2.2 Regulation of Fork Speed 
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A consistent observation is that forks slow in response to DNA damage (Tercero 
and Diffley, 2001; Szyjka et al., 2008; Unsal-Kaçmaz et al., 2007; Seiler et al., 
2007; Conti et al., 2007).  Whether slowing of forks in the presence of damage is 
checkpoint-dependent or simply due to the physical presence of lesions is not 
clear (Tercero and Diffley, 2001; Szyjka et al., 2008; Unsal-Kaçmaz et al., 2007; 
Seiler et al., 2007; Conti et al., 2007).  Initial work in budding yeast showed that 
replication forks in checkpoint mutant and wild-type cells were slowed to the 
same extent in the presence of damage, suggesting that slowing is checkpoint-
independent (Tercero and Diffley, 2001).  However, subsequent work showed 
that checkpoint activation inhibited replication of damaged DNA, suggesting an 
active role in the slowing of replication forks (Szyjka et al., 2008).  Furthermore, 
work in mammalian cells showed a role for checkpoint signaling in DNA-damage-
dependent slowing of replication forks (Unsal-Kaçmaz et al., 2007; Seiler et al., 
2007; Conti et al., 2007).  Thus, so far it is unclear whether the checkpoint 
regulates the progression of forks through the damaged template or not. 
 
3.2.3 Regulation of Number of Forks 
In response to replication stress, suppression of late firing origins limits the 
generation of an excess number of stalled forks. Unrestrained firing of origins in 
the presence of replication stress might overwhelm the capacity of the checkpoint 
to attenuate the consequences of stalled forks. Supporting this idea, Toledo et al. 
observed that in the absence of ATR activity, excess firing of origins in response 
to HU depletes the nuclear pool of RPA leading to DSB generation (Toledo et al., 
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2013). Therefore, the critical role of the checkpoint may not be to regulate the 
fork per se but to curtail origin firing in response to replication stress so as to 
avoid generation of an excess number of stalled forks. However, it is yet to be 
determined whether replication forks from ATR inhibited cells supplemented with 
excess RPA are capable of stably progressing and completing replication when 
released from HU arrest. Furthermore, HU treatment in the absence of a 
checkpoint leads to excessive unwinding and generation of longer stretches of 
ssDNA as compared to cells in which the checkpoint activity is intact (Sogo et al., 
2002). Therefore, RPA may have a more critical role under excessive unwinding, 
as seen in checkpoint mutants, than in wild-type cells. 
 
3.2.4 Maintenance of Replisome Stability 
The most controversial role of the checkpoint at stalled forks is the maintenance 
of replisome stability (Jossen and Bermejo, 2013; Cortez, 2015). Replisome 
stability refers to the physical association of the replisome factors with the stalled 
replication fork (Figure 1.2.a). Several chromatin immuno-precipitation (ChIP) 
studies done in budding yeast have suggested that, in response to HU, 
polymerases and helicases tend to dissociate from the stalled fork in the absence 
of an active checkpoint (Cobb et al., 2003; Cobb et al., 2005; Cotta-Ramusino et 
al., 2005; Lucca et al., 2004; Naylor et al., 2009). Similarly, studies 
in Xenopus and mammalian cells have shown that several components of the 
replisome are lost from forks stalled in response to prolonged treatment with 
aphidicolin in the absence of ATR (Trenz et al., 2006; Ragland et al., 2013; 
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Hashimoto et al., 2011). However, contrary to these studies, De Piccoli et al. 
have shown—using genome-wide ChIP-seq—that the replisome components 
remain stably associated with forks stalled in HU even in the absence of Rad53 
or Mec1 in budding yeast (De Piccoli et al., 2012). Perhaps the discrepancy 
between these reports can be explained by the differences between their ChIP 
assays. The former focused on early origins with ChIP PCR probes designed at 
close proximity to the early origins as opposed to genome-wide ChIP-seq by the 
latter, which gives a more comprehensive picture. The latter work shows that, in 
the absence of checkpoint, forks from early origins continue to replicate longer 
and hence stall replisome components further downstream than they would in 
wild-type cells. Thus, by ChIP-PCR with probes designed at close proximity to 
the early origins, the replisome components appear to be intact in wild-type and 
depleted in the checkpoint mutant (De Piccoli et al., 2012). However, at this 
point, it remains a matter of debate whether the checkpoint affects the physical 
association of the replisome components or only regulates their functionality in 
response to replication stress (Cortez, 2015). 
Most studies trying to understand the role of checkpoint in maintaining 
replisome stability have focused on forks stalled for a prolonged duration (20 to 
60 min) in response to HU arrest. Stalling forks in the order of tens of minutes in 
response to HU might be biologically very different than fork pausing briefly in 
response to MMS-induced lesions. It is not clear whether stability of the 
replisome components is affected if the fork stalls are short-lived as compared to 
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that in a HU arrest. Therefore, the mechanism by which Rad53 allows the forks 
to progress slowly but stably and complete replication of the whole genome in 
response to MMS remains unclear. 
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Figure 1.2 Regulation of forks in response to damage 
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Figure 1.2 Regulation of forks in response to damage. (a) Replisome stability 
pertains to stable association of replisome components; (b) Fork reversal in 
response to damage, wherein the leading strand anneals with the lagging strand 
to form a four-way structure. Fork reversal is opposed by nucleases such as 
Exo1, Dna2; (c) Downstream repriming. Leading strand can bypass damage by 
repriming downstream of the stalled fork; (d) Translesion polymerase based 
synthesis. A stalled fork can bypass damage by recruiting translesion 
ploymerase in an error prone manner. Recruitment of translesion polymerase 
requires mono-ubiquitination of PCNA; (e) Template switching. A stalled fork can 
bypass damage by using the lagging strand as a template instead of the 
damaged parental strand. Template switching requires poly-ubiquitination of 
PCNA. 
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3.2.5 Fork Reversal 
Regardless of whether the checkpoint affects replisome stability or not, it 
prevents accumulation of pathological structures at stalled replication 
forks. rad53 mutants accumulate structures similar to those obtained by 
destabilizing replisome components as monitored by 2D gels (Lopes et al., 
2001). Similarly, electron microscopy (EM) studies have shown that HU 
treatment of rad53Δ cells leads to excessive unwinding and generation of longer 
stretches of ssDNA as compared to wild-type cells (Sogo et al., 2002). 
Furthermore, rad53Δ cells accumulate reversed forks wherein the leading strand 
is unwound and anneals with the lagging strand to form a four-way structure 
(Figure 1.2.b) (Sogo et al., 2002; Cotta-Ramusino et al., 2005). Whether 
reversed forks are a pathological structure or productive repair intermediates is 
uncertain. In yeast, fork reversal is mainly observed in the absence of checkpoint 
and therefore appears to be pathological. However, in metazoans, fork reversal 
appears to be a part of DNA damage tolerance mechanism (Neelsen and Lopes, 
2015). Chaudhuri et al. have shown that in mammalian cells, Xenopus extracts, 
and yeast cells, low doses of CPT treatment lead to fork reversal. In mammals, 
reversal of forks is mediated by poly (ADP-ribose) polymerase 1 (PARP1) (Ray 
Chaudhuri et al., 2012). Depletion of PARP1 prevents fork reversal and leads to 
double strand break formation (Ray Chaudhuri et al., 2012). Furthermore, Rad51 
dependent fork reversal is seen in human cells in response to a variety of 
genotoxins (Zellweger et al., 2015). Thus, in mammals, fork reversal appears to 
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play a protective role. However, in the absence of checkpoint, nucleases such as 
Mus81 and Slx4 can improperly process reversed forks leading to genomic 
instability (Couch et al., 2013; Neelsen et al., 2013; Froget et al., 2008). Thus, 
fork reversal itself may not be pathological, but its regulation by the checkpoint 
may prevent deleterious outcomes. In vitro biochemical studies have identified 
several helicases and translocases such as Rad54, WRN, BLM, HLTF, FANCM, 
FBH1, SMARCAL1, and ZRANB3 capable of regressing forks (Bugreev et al., 
2011; Bétous et al., 2012; Bétous et al., 2013; Yusufzai and Kadonaga, 2008; 
Yusufzai and Kadonaga, 2010; Gari et al., 2008; Ciccia et al., 2012; Blastyák et 
al., 2007; Blastyák et al., 2010; Kile et al., 2015; Fugger et al., 2015; Machwe et 
al., 2006; Machwe et al., 2011). However, of all these factors, only Rad51 and 
FBH1 have been shown to be required for fork regression in vivo (Zellweger et 
al., 2015; Fugger et al., 2015). Furthermore, how helicases and translocases 
may be regulated by the checkpoint at stalled forks is not known. 
 
3.2.6 Regulation of Nucleases 
There is mounting evidence that the checkpoint plays a role in protecting forks 
from aberrant activity of nucleases. Support for this idea comes from Segurado 
and Diffley, who show that deletion of EXO1 rescues rad53Δ sensitivity to the 
genotoxins UV, MMS, and IR, although not HU (Segurado and Diffley, 2008). 
Phospho-proteomic screens have also identified Exo1 as a target of Rad53 and 
this phosphorylation has been shown to negatively regulate Exo1’s activity 
(Smolka et al., 2007; Morin et al., 2008). Furthermore, EM studies in budding 
  
29 
yeast have shown that Exo1 creates ssDNA intermediates of reversed forks and 
drives fork collapse in the absence of Rad53 (Cotta-Ramusino et al., 2005). 
However, deletion of EXO1 alone is not sufficient for fork stabilization. Forks are 
unable to restart when released from HU arrest even in 
a rad53Δexo1Δ background, as is the case for rad53Δ cells (Segurado and 
Diffley, 2008). Thus, Rad53 has Exo1-independent functions at maintaining fork 
integrity. 
In fission yeast, Cds1 phosphorylates and activates Dna2, a 
helicase/nuclease, which prevents accumulation of reversed forks (Hu et al., 
2012). In human cells, DNA2 is involved in the processing and restart of reversed 
forks (Thangavel et al., 2015; Duxin et al., 2012). These observations further 
support the notion that the checkpoint modulates fork reversal by activating or 
inhibiting nucleases. 
 
3.2.7 Restart of Stalled Forks 
The ultimate question of how the checkpoint restores progression of stalled forks 
is just being uncovered. As mentioned above, stalled forks can undergo fork 
reversal even in the presence of checkpoint. In human cells, reversed forks are 
restarted in a RECQ1 and DNA2 dependent manner (Thangavel et al., 2015; 
Berti et al., 2013). Mus81-Eme1, a structure specific endonuclease, is normally 
active only during mitosis due to the requirement of phosphorylation by CDK1 
and Polo-like kinase 1 (Plk1) for activation (Matos et al., 2011; Matos et al., 2013; 
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Szakal and Branzei, 2013). However, several recent studies suggest that Mus81 
could also play a role in fork restart mechanisms during S phase by creating 
double strand breaks and promoting recombination (Dehé et al., 2013; Pepe and 
West, 2014b; Whitby et al., 2003; Pepe and West, 2014a; Amangyeld et al., 
2014; Shimura et al., 2008; Regairaz et al., 2011; Fugger et al., 2013; Hanada et 
al., 2007). In human cells, fork cleavage and restart of stalled forks in S phase is 
governed by Mus81-Eme2, while the G2/M functions of Mus81 are guided by 
Mus81-Eme1 complex (Pepe and West, 2014b; Pepe and West, 2014a; 
Amangyeld et al., 2014). SMARCAL1 may also be an important candidate, as it 
possesses both fork reversal as well as fork restoration activities, and is 
regulated by ATR (Couch et al., 2013; Bétous et al., 2012; Bétous et al., 2013). 
However, its exact function at stalled forks in vivo is yet to be determined. 
In the case of stalled forks that have not reversed, restart or restoration of 
fork progression occurs mainly in three ways: by repriming (Figure 1.2.c), by 
translesion-polymerase-based synthesis (TLS) (Figure 1.2.d), or by template 
switching (Figure 1.2.e) (Branzei and Szakal, 2016; Branzei and Foiani, 2007; 
Branzei and Foiani, 2009; Ulrich and Walden, 2010; García-Rodríguez et al., 
2016; Sale, 2012; Ulrich, 2009). Lesions on the lagging strand can be easily 
bypassed due to the discontinuous nature of lagging-strand synthesis. However, 
lesions on the leading strand must be actively bypassed using various 
mechanisms in order to continue DNA synthesis. The first evidence that lesion 
bypass via repriming downstream could be employed in the case of leading 
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strand comes from studies done in bacteria. Bacterial replisomes are capable of 
repriming and re-initiating replication in response to UV-induced lesions (Figure 
1.2.c) (Heller and Marians, 2006; Yeeles and Marians, 2011). Recent discovery 
of similar activity by PrimPol in human cells shows that repriming downstream 
may be an evolutionarily widespread approach. PrimPol, which has primase as 
well as translesion polymerase activity, allows repriming of stalled forks in 
response to UV as well as dNTP depletion (Bianchi et al., 2013; Mourón et al., 
2013; Helleday, 2013). Furthermore, EM studies suggest that repriming activities 
on leading strand in response to UV occurs in budding yeast, too, although it 
must be via a distinct mechanism, because PrimPol is not conserved in yeast 
(Lopes et al., 2006; Rudd et al., 2014). 
The TLS and template switching mechanisms of fork restart are regulated by 
ubiquitination of the proliferating cell nuclear antigen (PCNA) (Hoege et al., 2002; 
Frampton et al., 2006; Lee and Myung, 2008). ssDNA generated in response to 
replication stress recruits Rad18, which, along with Rad6, monoubiquitinates 
PCNA at K164 (Hoege et al., 2002; Davies et al., 2008). Monubiquitination of 
PCNA allows recruitment of translesion polymerases, which have low fidelity, 
allowing the fork to replicate across damaged bases (Figure 1.2.d) (Kannouche 
et al., 2004; Watanabe et al., 2004; Stelter and Ulrich, 2003). Although 
translesion polymerases permit replication across damaged template, the bypass 
occurs in an error prone manner. PCNA can also be polyubiquitinated at K164 by 
Rad5 along with Mms-Ubc13 (Hoege et al., 2002; Ulrich and Jentsch, 2000; 
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Parker and Ulrich, 2009). Polyubiquitination of PCNA promotes template 
switching (Figure 1.2.e) (Zhang and Lawrence, 2005; Hishida et al., 2009; 
Branzei et al., 2004; Chiu et al., 2006). Template switching involves usage of the 
undamaged sister chromatid for bypass of lesions and usually occurs in an error 
free manner. Inhibition of polyubiquitination increases TLS-based mutations 
suggesting competition between TLS and template switching pathways (Chiu et 
al., 2006). SUMOylation at K164 of PCNA also affects template switching 
(Papouli et al., 2005; Pfander et al., 2005; Branzei et al., 2008). The exact role of 
polyubiquitination of PCNA and how it leads to recruitment of the recombination 
factors necessary for template switching are not known (Branzei and Szakal, 
2016; Ulrich and Walden, 2010; Lee and Myung, 2008; Moldovan et al., 2007). 
Regulation and crosstalk between various modifications on PCNA and the role of 
checkpoint in mediating lesion bypass are also poorly understood. Furthermore, 
PCNA functions as a tri-mer at the replication fork. Therefore, at a single stalled 
fork, individual copies of PCNA may harbor different modifications and the tri-mer 
collectively may regulate the mechanism of lesion bypass (Branzei and Szakal, 
2016; Ulrich and Walden, 2010; Sale, 2012; Moldovan et al., 2007). 
 
4. Tools to look at replication kinetics 
4.1 Bulk methods used to study replication kinetics in response to damage 
Some of the earliest methods looking at slowing of replication in response to 
irradiation involved measuring 32P, 14C or 3H incorporation rates into DNA (Ord 
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and Stocken, 1956; Ord and Stocken, 1958; Lajtha et al., 1958; Painter, 1967). 
At the time, the program of replication was not known and thus the net effect on 
replication rate via scintillation counting was the only way to study the effect of 
damage on DNA replication rate.  
 
4.1.1 Flow Cytometry – a rapid approach to look at slowing of replication 
A more rapid method to look at net slowing of replication in a large population of 
cell was made feasible with the development of flow cytometry to analyze DNA 
content and thereby define the distribution of cells across different phases of cell 
cycle (Holm and Cram, 1973; Imray and Kidson, 1983). Eventually slowing of 
DNA replication was characterized by flow cytometry in mammalian cells, 
budding and fission yeasts (Lavin et al., 1989; Lindsay et al., 1998; Rhind and 
Russell, 1998; Paulovich and Hartwell, 1995}. 
By 1960’s the mechanism of eukaryotic replication was beginning to be 
understood. Some of the key discoveries on the mechanism of replication, which 
were critical for understanding the regulation of replication kinetics was that the 
mammalian DNA was organized in the form of “long fibers” and the fibers 
replicated in “fork-like growing points” (Cairns, 1966; Huberman and Riggs, 1966; 
Sasaki and Norman, 1966). Furthermore these “fork-like growing points” 
originated at several sections on the fiber and the pairs of them tended to move 
in opposite directions (Huberman and Riggs, 1968). Thus with the discovery of 
the mechanism of replication it became important to understand how origins and 
forks are regulated in response to damage.  
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4.1.2 Density gradient centrifugation distinguishes between effects on 
initiation v. elongation rates 
Initial studies aimed at understanding the regulation of origins and forks involved 
labeling cells with 3H-thymidine and separating the newly replicated fragments of 
DNA by alkaline sucrose density gradient centrifugation. Several studies initially 
found that irradiation only led to repression of initiation of replication (Walters and 
Hildebrand, 1975; Painter and Young, 1975; Makino and Okada, 1975; Painter 
and Young, 1976; Dahle et al., 1979). However later studies using higher doses 
of irradiation found that initiation of replication as well as chain elongation (fork 
speed), both were affected. In conclusion, initiation of replication was highly 
sensitive to inhibition even at low doses, while fork rates were affected only at 
high doses of damage (Watanabe, 1974; Makino and Okada, 1974; Cleaver et 
al., 1983; Painter and Young, 1980; Painter, 1981; Young and Painter, 1989).  
 
4.1.3 2D-gels – studying the effect of damage one origin at a time 
Once again advances in the understanding of replication program generated 
further questions about the regulation of replication in response to damage. 
Specifically it was realized that replication of the genome occurs in a temporal 
manner (Hatton et al., 1988; McCarroll and Fangman, 1988; Fangman et al., 
1983; Fangman and Brewer, 1992; Reynolds et al., 1989). Studies were carried 
out to understand how the intra-S checkpoint regulates the temporal program of 
origin firing. 2D-gels were employed to study specific loci in the genome to 
understand the impact of damage-induced checkpoint activity on origin firing 
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(Larner et al., 1994). By late 1990’s several origins of replication were mapped in 
S. cerevisiae along with their replication timings. This knowledge allowed a 
systematic comparison of the checkpoint effects on early v. late-firing origins. It 
was discovered that the checkpoint preferentially inhibited the late-firing origins in 
response to DNA damage (Santocanale and Diffley, 1998; Shirahige et al., 
1998). 
 
4.2 Why use single-molecule approach to study replication kinetics? 
Caveats of bulk methods 
Labeling cells with 3H and separating newly synthesized DNA by density gradient 
centrifugation allows one to compare the effect of damage on initiation v. 
elongation rates. A reduction in origin firing rate is inferred from the absence of 
small fragments in the irradiated sample (Walters and Hildebrand, 1975; Painter 
and Young, 1975; Makino and Okada, 1975; Painter and Young, 1976; Dahle et 
al., 1979; Painter and Young, 1980). However absence of small fragments could 
be due to two reasons – reduction in origin firing rate or reduction in cells 
entering S phase. Using synchronized cultures a later study found that loss of 
small fragments was a combination of cells arresting in G1 phase as well as 
inhibition of origin firing in cells already in S phase (Lee et al., 1997). Thus 
density gradient results in isolation cannot give the complete picture. 
2D-gels can be employed to distinguish between the effects on origins and 
forks in response to damage, however the analysis is limited to one origin at a 
time and is suitable for only defined and highly efficient origins. Studies over the 
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last decade have highlighted that although distinct domains of the genome 
replicate at defined times during S phase, the replication of each domain itself is 
achieved using a different cohort of origins in each cell (Lebofsky et al., 2006; 
Cayrou et al., 2011; Hamlin et al., 2008; Bechhoefer and Rhind, 2012; Farkash-
Amar et al., 2008; Ryba et al., 2010; Yaffe et al., 2010; Xu et al., 2012; Dileep et 
al., 2015). This cell-to-cell variability in the usage of origin is due to the presence 
of inefficient origins, which fail to fire in every cell cycle (Patel et al., 2006; 
Czajkowsky et al., 2008; Hawkins et al., 2013). Particularly higher organisms 
tend to have many inefficient origins making 2D-gels an intractable approach to 
study the effects of DNA damage on origin regulation (Lebofsky et al., 2006; 
Cayrou et al., 2011; Hamlin et al., 2008; Bechhoefer and Rhind, 2012; Farkash-
Amar et al., 2008; Ryba et al., 2010; Yaffe et al., 2010; Xu et al., 2012; Hamlin et 
al., 2008; Rhind and Gilbert, 2013; Dileep et al., 2015). 
 
4.3 Single-molecule approaches 
4.3.1 DNA fiber autoradiography 
DNA fiber autoradiography was the first single-molecule method, applied to DNA 
replication, which allowed several seminal discoveries to be made. Replicating 
cells were first labeled with 3H-thymidine, and then chased with 3H-thymidine of 
higher activity or with cold thymidine. After labeling, cells were lysed and DNA 
fibers were spread on a surface and autoradiographed. The replicated DNA is 
observed as silver grains on an autoradiogram. Since the cells are first labeled 
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with 3H-thymidine, followed by cold or 3H-thymidine of a different activity, the 
direction of replication could be ascertained (Hand, 1975; Liapunova, 1994). This 
technique led to the discovery of the bi-directional movement of forks in 
Escherichia coli (Cairns, 1963; Masters and Broda, 1971; Prescott and Kuempel, 
1972). Later this technique was employed by Huberman and Riggs to discover 
that in mammalian cells the DNA fiber replicates by initiating replication at 
several loci called origins and the forks from each origin move in a bi-directionally 
opposite manner (Huberman and Riggs, 1968). Further since the length of the 
tracks could be estimated and divided by the length of the labeling period, the 
approach allowed for a quantitative estimation of parameters such as fork rate as 
well as distances between origins. DNA fiber autoradiography studies by 
Watanbe in 1974 provided the first direct proof that chain elongation (fork rate) is 
affected at high doses of irradiation (Watanabe, 1974). 
Despite the wealth of knowledge gained from DNA fiber autoradiography the 
technique had several limitations (Liapunova, 1994). The resolution was limited 
by the size and continuity of the silver grains. Moreover only the replicated 
regions could be visualized by autoradiography while the un-replicated regions 
had to be guessed. The size of the replicated regions could be vastly 
overestimated due to merging of tracks or bundling of fibers. Further the 
stretching of the DNA fibers was very unpredictable. Therefore a quantitative 
estimation of replicated regions was difficult. It was also difficult to isolate long 
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fibers reproducibly. Finally the exposure times were often in the order of several 
months making the whole process very time consuming. 
 
4.3.2 DNA Combing 
Several issues with fiber autoradiography were overcome with the development 
of fluorescence fiber techniques. Briefly cells are lysed on glass slides and the 
DNA fibers are stretched by the flow of the buffer across a tilted slide. Fibers are 
visualized by hybridizing fluorescently labeled probes complementary to specific 
regions in the genome (Parra and Windle, 1993). Fluorescence fiber studies of 
replication were first enabled with the development of antibodies specific to 
thymidine analogs such as 5-bromo-2’-deoxyuridine (BrdU) (Gratzner, 1982). 
Development of specific antibodies towards two different thymidine analogs, 5-
chloro-2’-deoxyuridine and 5-iodo-2’-deoxyuridine made it possible to study the 
temporal dynamics of replication (Aten et al., 1992). However a major drawback 
was still the lack of reproducibility of stretched fibers. These difficulties were 
overcome with the invention of dynamic molecular combing (Bensimon et al., 
1994; Allemand et al., 1997; Michalet et al., 1997).  
In combing, a silanized coverslip is dipped into a DNA solution and slowly 
withdrawn at constant rate to get reproducibly high density of uniformly stretched 
(1 µm ≈ 2 kb), linear, single molecules of DNA. The high density of molecules 
permits statistical sampling of parameters. The technique has been employed to 
study replication kinetics, map genes, detect micro-deletions or amplifications, as 
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well as rearrangements such as inversions, and translocations (Herrick et al., 
2000; Lebofsky and Bensimon, 2003; Herrick and Bensimon, 1999a; Herrick and 
Bensimon, 1999b; Herrick and Bensimon, 2009).  
Studying perturbations of replication kinetics by DNA combing has several 
advantages (Herrick and Bensimon, 1999a). Combing allows for detection of 
individual origins and forks on a global scale (Jackson and Pombo, 1998; Iyer et 
al., in press; Gallo et al., 2016a; Gallo et al., 2016b; Bianco et al., 2012). Briefly 
cells are labeled in vivo with thymidine analogs and DNA is isolated, combed and 
immuno-stained with antibodies against the thymidine analogs. Sequential 
labeling with two different analogs allows for determination of the direction and 
speed of replication of labeled tracks on a fiber(Jackson and Pombo, 1998; Iyer 
et al., in press). Further, combing can be supplemented with FISH to study 
specific regions of interest. Because combing reveals the behavior of individual 
replication origins and forks, it allows for unambiguous study of the effect of 
checkpoint on origin firing and fork rates.  In particular, it allows one to measure 
the heterogeneity of fork rates and determine if all forks respond the same way to 
lesions.  The importance of measuring the heterogeneity of fork rates can be 
illustrated in a case where some forks pass lesions without slowing, but others 
stop at the lesion and do not resume replication for the duration of the 
experiment, a condition we refer to as fork stalling (Chapter II and III).   
Finally using combing we can distinguish whether the regulation of forks is a 
global or local effect. A fundamental question about the regulation of fork 
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progression in response to DNA damage is whether it is a global or local effect 
(Iyer and Rhind, 2013).  The effect of checkpoint on origins is inherently a global 
response because origins distant to sites of damage are blocked from firing.  
However slowing of forks could be a local or a global effect.  If all forks are 
slowed by checkpoint activation, irrespective of whether they encounter damage 
or not, then slowing is a global effect.  On the other hand, if forks are slowed only 
when they encounter a lesion, then it is a local effect (Iyer and Rhind, 2013). 
Analysis of individual forks by combing should allow us to decipher whether fork 
regulation by checkpoint is global or local. 
 
Conclusion 
In conclusion, studying regulation of forks is critical to understand how the intra-S 
checkpoint contributes to maintenance of genomic stability. Important insight into 
the role of fork regulation comes from EM studies, which have helped us uncover 
the structural alterations observed at stalled forks, and from in vitro biochemical 
studies with fork components and artificial templates, which have allowed us to 
decipher their catalytic functions. However, how the fate of a stalled fork is 
determined by the interplay of various factors in vivo is unclear. Specifically how 
the checkpoint regulates the various factors to mediate stable progression of 
forks through a damaged template is unknown. Thus, to understand the 
regulation of individual forks on a global scale by the checkpoint at single-
molecule level we have used DNA combing (Chapter II and III). Specifically we 
have studied the behavior of forks in response to three different DNA damaging 
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drugs and the role of checkpoint in regulating the fork responses as discussed in 
greater detail in Chapter III.  
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Chapter II  
Materials and Methods: 
Analysis of DNA Replication in Fission Yeast by 
Combing 
 
 
 
 
A part of Chapter II is compiled from the methods paper, which was written by 
Nick Rhind and me. Shankar Das is also a contributing author in this methods 
paper for his efforts in initial trouble-shooting of the technique. The methods 
paper has been accepted at Cold Spring Harbor Protocols (Iyer et al., in press). 
Chapter II also contains a part of the manuscript written by Nick Rhind and me. 
This manuscript is currently under review at PLOS Genetics (Iyer and Rhind). 
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Introduction 
DNA replication studies based on population experiments give an average 
estimate of replication kinetics from many cells. This average replication profile 
masks the stochastic nature of origin firing in eukaryotes, which is revealed by 
using single-molecule techniques, such as DNA combing. The analysis of 
replication kinetics by DNA combing involves isolating DNA from cells that have 
been pulse-labeled with thymidine analogs and stretching it on a silanized 
coverslip. The analog-labeled patches on the stretched DNA fibers can then be 
detected using fluorescent antibodies against the analog. Each fiber represents a 
part of the genome from a single cell; therefore, it is possible to study the 
variation in behavior of individual origins and forks from one cell to another. 
Furthermore, each DNA fiber is uniformly stretched, making it possible to 
measure distances accurately at kilobase resolution. It is also possible to stretch 
a high density of fibers on coverslips allowing for statistical sampling of 
replication parameters.  
In order to study the effect of DNA damage on replication kinetics at single 
molecule level, we implemented a sequential analog labeling approach in fission 
yeast. Sequential analog labeling is necessary to ascertain the directionality of 
replication and thus distinguish between origins and forks. This chapter describes 
in detail the protocol developed for sequential analog labeling in fission yeast 
during S phase. Further it describes an in-depth analysis of every permutation of 
replication pattern observed in a tri-color combing dataset. Finally using a novel 
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analytic approach we have developed a probabilistic approach to rigorously 
determine the rate of fork stalling in a tri-color combing dataset. 
 
1. General methods 
All experiments were done in fission yeast. Uptake of the thymidine-analog label 
requires yeast cells integrated with human equilibrative nucleoside transporter 1 
(hENT1) and herpes simplex virus thymidine kinase (tk) (Hodson et al., 2003; 
Sivakumar et al., 2004). hENT1 is a nucleoside transporter that allows uptake of 
exogenous nucleosides into cell and tk phosphorylates them so that it can be 
incorporated into DNA (Griffiths et al., 1997; Lengronne et al., 2001; McNeil and 
Friesen, 1981; Vernis et al., 2003). The following strain used in this study was 
created by standard methods and grown in YES at 25°C (Forsburg and Rhind, 
2006): yFS940 (h+ leu-32 ura4-D18 his7-366 cdc10-M17 leu1::pFS181 (leu1 
adh1:hENT1) pJL218 (his7 adh1:tk)). 
 
2. S phase progression assay by flow cytometry 
2.1 Time course 
Cells were synchronized in G1 phase using cdc10-M17 temperature sensitive 
allele combined with centrifugal elutriation, which selects cells that have been 
arrested in G1 for as little time as possible (Willis and Rhind, 2011).  Cells were 
grown to mid log phase at 25°C and arrested at 35°C for 2 hours followed by 
centrifugal-elutriation-based size selection at 35°C to collect cells that had most 
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recently arrested in G1.  The cells were then immediately released into S phase 
by shifting them to 25°C. 
 
 2.2 Flow Cytometry 
S-phase progression was followed by flow cytometry using a nuclei isolation 
protocol, as previously described (Willis and Rhind, 2011) with the following 
minor modifications.   
• 0.6 O.D. of cells were pelleted every 20 minutes for 2 hours after release 
into S phase.  
•  Pelleted cells were fixed by resuspension in 70% ethanol and stored 
overnight at 4°C.   
• Fixed cells were washed once with 0.6M KCl and spheroplasted at 37°C 
for 1 hour in 0.6 M KCl with 1 mg/ml Lysing enzyme (Sigma # L1412) and 
0.5 mg/ml Zymolyase 20T (Sunrise Science Products # N0766391).   
• Cells were then washed with 0.1 M KCl containing 0.1% Triton X-100 
followed by 20 mM Tris-HCl, 5 mM EDTA, pH 8.0.   
• The cells were then resuspended in 20 mM Tris-HCl, 5 mM EDTA, pH 8.0 
containing 250 µg/ml RNaseA and incubated at 37°C overnight.   
• Cells were pelleted, chilled and sonicated for 7 seconds with a Sonifier 
(Branson Sonifier 450) equipped with a micro tip at power 5 and constant 
duty cycle to release nuclei.   
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• Nuclei were mixed with equal amount of 1x PBS containing 2 µM Sytox 
Green and analyzed by flow cytometry (Figure 2.1A).  S-phase 
progression values were obtained from the histograms as previously 
described (Figure 2.1B) (Willis and Rhind, 2011).  
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Figure 2.1 S phase progression by FACS in wild-type 
 
Figure 2.1 S phase progression by FACS in wild-type. A) yFS940 cells were 
synchronized in G1 phase using cdc10-M17 temperature sensitive allele followed 
by elutriation. Elutriated G1 cells were released into permissive temperature. 
Progression of S phase was monitored by collecting samples for FACS. B) S 
phase progression values were obtained from histograms of DNA content as 
described in Willis and Rhind, 2011.  Error bars represent standard deviation. 
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3. DNA Combing 
3.1 Cell labeling  
Cells were pulse labeled with 2 µM or 5 µM CldU for 5 minutes and chased with 
20 µM IdU for 10 minutes at 45, 50 or 55 minutes into S phase time course, 
which corresponds to mid S phase. Analog labeling was stopped by adding 
sodium azide to a final concentration of 0.1% and cooling the cells on ice.  10 
O.D. of cells were pelleted for combing, frozen in liquid N2 and stored at -80°C.  
 
The effect of analog addition on replication kinetics 
Addition of analog early in S phase causes slowing of bulk replication, probably 
due to checkpoint-dependent origin inhibition (Figure 2.2A). Therefore, we have 
labeled cells in a manner so as to incur minimal effect on S phase progression 
due to analog addition (Figure 2.2B).  By adding analogs at different time points 
across S phase and examining the effect on S phase progression by FACS, we 
chose to add analog at 50 minutes after release and harvest cells for combing by 
65 minutes after release for wild-type (Figure 2.2B). 
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Figure 2.2 Effect of analog addition on replication kinetics 
Figure 2.2 Effect of analog addition on replication kinetics.  A) Wild-type 
cells were synchronized and released into S phase with analog added at different 
concentrations—0.1 µM, 0.5 µM, 1 µM, 2 µM CldU—and chased with 20 µM IdU 
at 35 minutes after release or without any analog.  B) The S-phase progression 
of cultures with and without analog addition used for combing experiments.  2 µM 
or 5 µM CldU analog was added at 50 minutes after release for 5 minutes and 
chased with 20 µM IdU for 10 minutes and the cells were harvested for combing 
at 65 minutes after release so as to have minimal effects of analog addition on 
replication kinetics. 
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3.2 Plug preparation and digestion 
 
• The pellet was washed twice with 1ml spheroplasting buffer (20mM Citrate 
phosphate pH 5.6, 50mM EDTA pH 8.0, 1M Sorbitol) in a 2ml round-
bottomed microcentrifuge tube. To wash, the cells were re-suspended 
gently with a pipette, and centrifuged at 5000g for 1min, at room 
temperature.  
• The pellet was then re-suspended in 150 µL of DNA combing enzyme mix 
(spheroplasting buffer with 0.4 mg/ml Zymolyase 20T, 0.5mg/ml Lysing 
enzyme (Sigma # L1412), 0.5% β-mercaptoethanol) and incubated at 
37°C for 5 minutes.  
• The re-suspended cells were mixed with 150 µL of 1.5% low-melting 
agarose (1.5% in spheroplasting buffer, dissolved by boiling at 95°C and 
cooled to 42°C) using a cut-off 200 µL tip. The cells were mixed well with 
agarose and 150 µL was dispensed into each well of plug mold (two wells 
per sample) and left to solidify for 20 – 30 minutes at 4°C.  
• Plugs from each sample (two) were placed in a single round-bottomed 
tube with 1 ml of DNA combing plug solution (spheroplasting buffer with 
10mg/ml Zymolyase 20T, 12mg/ml Lysing enzyme, 1% β-
mercaptoethanol). The plugs were digested with DNA combing plug 
solution for at least 6 hours or up to 9 hours.  
3.3 Proteinase K treatment 
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The plugs were transferred to a new round-bottomed tube and digested with 1ml 
Proteinase K buffer (50mM EDTA pH 8.0, 1% SDS, 0.5mg/ml Proteinase K 
enzyme (10mM Tris pH 8.0, 1mM CaCl2, 30% glycerol, 20mg/ml Proteinase K)) 
in a 50°C water bath overnight. The Proteinase K buffer was replaced roughly 
every 12 hours. The Proteinase K digestion was done for a total of 60 hours with 
5 changes of freshly made buffer.  
 
3.4 TE washes 
After Proteinase K treatment the plugs were transferred to a 15ml conical bottom 
tube and washed twice for 2 hours each with 10ml TE buffer (10mM Tris, 1mM 
EDTA) + 1ml of 0.5M EDTA pH 8.0 at room temperature with gentle rocking.  The 
plugs were then washed twice for 2 hours each with 10ml TE buffer at room 
temperature with gentle rocking. The plugs were stored at 4°C in TE until 
needed. 
 
3.5 Melting plugs 
• One-half or one plug was placed in a 2 mL round bottomed 
microcentrifuge tube. To the plug 500 µL TE/YOYO (0.4 µM YOYO-1 
Iodide (ThermoFisher # Y3601) in TE), 480 µL 0.5 M MES pH 5.35* and 
up to 1.4 mL H2O was added.  
(*The pH of MES is extremely critical for combing. It determines the density of 
DNA that will stick to coverslips and their degree of stretching. Titrate the pH of 
MES using λ DNA. Prepare several combing solutions of λ DNA with MES buffer 
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of varying pH. Add 200 ng λ DNA to 500 µL TE/YOYO and 480 µL 0.5M MES of 
pH varying between 5.2 and 6.5 in a final volume of 1.4 mL. Comb the λ DNA 
and check for density of fibers and their stretching as described below. With 200 
ng of DNA, the coverslip should be densely covered with fibers. Use very small 
increments of pH for standardization (e.g., 0.05). Once the pH is standardized, 
use the optimum pH for melting sample plugs. Combing can vary substantially 
between pH 5.30 and pH 5.35; a more basic pH gives fewer, but longer fibers on 
the coverslip and a more acidic pH allows more DNA of shorter length to stick on 
the coverslip but allows more stretching. Higher pH of MES (6.25 or 6.35) was 
used for combing instead of pH 5.4 to isolate longer fibers (Kaykov and Nurse, 
2015).) 
• The plug was incubated for 20 minutes at 65°C. If the plug had not fully 
melted then the incubation was extended by another 10 minutes. 
• The plug was transferred to 42°C and incubated for 30 minutes.  
• 40 µL β-agarase mix (4 µL 10× NEB buffer, 4 µL β-agarase, 32 µL sterile 
H2O) was added to the tube**. The plug was digested overnight at 42°C.  
(**Do not mix after adding β-agarase. Gently swirl with a tip if needed. After 
digestion the samples should appear very clear. Usually, a small amount of 
wispy, thread-like agarose remnant is seen but there should be very few, if any, 
agarose clumps. If clumps are present, remelt the plug at 65°C and digest again 
with β-agarase mix. Improper cell wall digestion will make the plugs appear very 
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cloudy and the β-agarase digestion will not occur optimally leading to poor DNA 
recovery.) 
• The melted plug was centrifuged at 800g for 5 min at room temperature. 
The tubes were handled with extreme care to avoid any damage to DNA 
fibers.  
• The supernatant was transferred directly into the Teflon reservoir of a 
DNA Combing instrument or, if the sample is to be stored for latter 
processing, into a new round-bottomed tube using a cut off 1 mL tip***.  
(***This supernatant is the DNA combing solution and there should be hardly any 
pellet. Use extreme care while transferring the supernatant to avoid DNA fiber 
breakage. The combing solution can be stored at 4°C.  However, with time the 
DNA fibers break; therefore, avoid storing for >1 mo.)  
3.6 Preparation of silanized coverslips 
Coverslips were cleaned in a plasma cleaner such as a Harrick basic plasma 
cleaner. Liquid-based cleaning protocols can be used if a plasma cleaner is not 
available (Demczuk and Norio, 2009; Marheineke et al., 2009).  
 
3.6.1 Plasma cleaning of coverslips  
• Ceramic coverslip holders were washed with water and then with ethanol 
and allowed to dry.  
• The coverslips (22 x 22 mm, No. 1) were placed in ceramic holders 
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without touching the flat surfaces of the coverslips. The coverslips were 
cleaned according to the instructions of the plasma cleaner manufacturer. 
The coverslips were quickly transferred to the desiccator for silanization.  
(After plasma cleaning, proceed immediately to silanization. Exposure of the 
coverslip to oxygen will lead to poor silanization.) 
3.6.2 Silanization and storage of coverslips  
• A 25 mL beaker was placed in the center of the desiccator chamber. (Use 
a fresh beaker each time.) 
• 1 mL octenyltrichlorosilane mixture of isomers 96% (Sigma 539279) was 
added to the beaker.(Open the silane bottle, quickly take 1 mL and 
immediately close the bottle to minimize silane oxidization.)   
• The air was evacuated from the desiccator by connecting it to a vacuum 
pump. The silane will boil after vacuum is established. The desiccator was 
evacuated for 2 min.   
• The desiccator was sealed and silane coating was allowed to occur 
overnight.   
• The seal was broken and the beaker containing remaining silane was 
removed. The desiccator was resealed using vacuum. 
• The coverslips were stored under vacuum until needed but used within 1 
week.   
3.7 DNA Combing 
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This protocol is based upon the DNA Combing System instrument from Genomic 
Vision, although other surface- coating systems should work (Marheineke et al., 
2009; Kaykov et al., 2016). Over 50 coverslips can be combed using the combing 
solution from one-half of a plug.  
• The DNA combing solution was transferred very carefully (to avoid DNA 
breakage) into a Teflon reservoir.  To avoid breakage of DNA, after 
spinning the melted plug, the supernatant can be transferred using a cut 
off 1 mL tip directly into the Teflon reservoir, instead of transferring it into a 
new tube and then into the reservoir.   
• A silanized coverslip was attached to the instrument holder and dipped 
into the reservoir for 5 min.   
• The coverslip was withdrawn at a constant speed of 500 µM/sec to allow 
DNA molecules to  stretch.   
• The density of fibers and stretching on the coverslips was checked by 
epifluorescence using a GFP filter set and a 100× objective to visualize 
YOYO-1 stained DNA fibers. Coverslips with well- stretched fibers of 
appropriate density were selected for further analysis. Usually 5–10 
coverslips will be suitable for further analysis.  The coverslips can be 
easily viewed with an inverted microscope. An upright microscope can 
also be used, but a coverslip holder is required to hold the coverslip DNA-
side down while it is being viewed. Such a holder can be made by cutting 
a square hole in a thin piece of stiff plastic.   
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• The immersion oil was aspirated away from the coverslip. A drop of super 
glue was placed on a slide and the coverslip was placed oil-side down on 
the glue and the slide was labeled using pencil. 
• The slide was incubated for 2 h at 65°C or overnight. Baking robustly 
attaches DNA strands to the cover slip.   
3.8 Immuno-staining of stretched DNA fibers 
• The slides were cooled at room temperature for 5 min. The slides were 
placed in a Coplin jar. The slides were denatured with freshly prepared 0.5 
N NaOH or 2.5 N HCl for 30 min; acid or alkali was added and the jar was 
placed on a rocking platform.   
The choice of denaturing agent, either HCl or NaOH, depends on the batch of 
coverslips. Test the coverslip batch for optimal staining using spare labeled DNA 
before proceeding with test samples. Typically, CldU is best visualized using HCl 
denaturation. However, IdU staining does not work well with HCl denaturation. 
IdU is best visualized using NaOH denaturation, while CldU staining is moderate. 
At low concentrations, CldU staining is quite punctate, which can complicate 
analysis. At high CldU concentrations, NaOH gives good results.   
 
• The slides were transferred to a fresh Coplin jar and washed with 0.1× 
PBS three times for 5 min each on a rocking platform.   
• The slides were placed in a humid chamber (box containing wet paper 
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towels).   
• The coverslips were blocked with 1% BSA (1% BSA fraction V in 0.1x 
PBS with 0.05% Tween-20) by adding 50 µL of solution per coverslip. A 
second coverslip was placed on top of each to spread out the solution and 
to prevent evaporation. Incubate the box for 25 min at 37°C. Fresh top 
coverslips were applied as described in this step for all subsequent 
antibody incubations.   
• The top coverslip was removed by dipping the slide horizontally in a wide 
chamber containing 0.1× PBST (0.1x PBS with 0.05% Tween-20). The 
slides were washed with 0.1× PBST twice for 2 min each.  The top 
coverslips were removed as described in this step for all subsequent 
washes. In most cases the top coverslip will float off easily; however, it 
may be necessary to gently ease it off using a micropipette tip.   
• 50 µL CldU (rat) and IdU (mouse) primary antibodies were added to each 
coverslip (prepare all Ab dilutions in blocking agent; see Table 2 for 
dilutions). The coverslips were incubated for 1 h at 37°C.   
• The slides were washed with 0.1× PBST twice for 3 min each.   
• Anti-rat 594 or Cy5 and anti-mouse 488 or Cy 3.5 antibodies were added 
to each coverslip. The coverslips were incubated for 30 min at 37°C.  
• The slides were washed with 0.1× PBST twice for 3 min each.   
• Rabbit anti-ssDNA primary antibody was added to each coverslip. The 
coverslips were incubated for 1 h at 37°C.   
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• The slides were washed with 0.1× PBST twice for 3 min each.   
• Anti-rabbit 350 or BV480 was added to each coverslip. The coverslips 
were incubated for 30 min at 37°C.   
• The slides were washed with 0.1× PBST twice for 3 min each.   
• Excess 0.1× PBST was drained off. 18 µL of anti-fade mounting medium 
was added per coverslip. A coverslip was placed on top of each and 
sealed with nail polish. The nail polish was allowed to dry before 
visualization.  If using ProLong Gold Antifade, allow the slides to cure for 
24 h at room temperature before sealing with nail polish.   
• The slides were kept at −20°C for long-term storage.   
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Table2.1: Antibody dilutions (all dilutions were prepared in blocking agent) 
 Antibody Detection Dilution 
1 Mouse anti-BrdU (BD Biosciences 347580) 
 
IdU and BrdU 1:20 
2 Rabbit anti-ssDNA (IBL 18731) ssDNA 1:50 
3 Rat anti-BrdU (Abcam ab 6326) 
 
CldU and BrdU 1:50 
4 Alexa fluor 488 goat anti-mouse IgG (H+L), 
highly cross-adsorbed (Invitrogen A-11029) 
Mouse BrdU Ab 1:100 
5 Alexa fluor 350 goat anti-rabbit IgG (H+L), 
highly cross-adsorbed (Invitrogen A-21068) 
Rabbit ssDNA Ab 1:100 
6 Alexa fluor 594 goat anti-rat IgG (H+L) 
(Invitrogen A-11007) 
 
Rat BrdU Ab 1:100 
7 Goat anti-mouse IgG H&L Cy3.5 
preadsorbed (Abcam ab6946) 
 
Mouse BrdU Ab 1:50 
8 BV480 Goat anti-rabbit IgG polyclonal (BD 
Biosciences 564879) 
 
Rabbit ssDNA Ab 1:10 
9 Goat anti-rat IgG H&L Cy5 preadsorbed 
(Abcam ab6565) 
 
Rat BrdU Ab 1:50 
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3.9 Imaging 
Fibers stained with secondary antibodies Alexa Fluor 488, 350, and 594 were 
visualized using a Zeiss Axioskop 2 Plus epifluorescence microscope with 100X 
Plan-NEOFLUAR oil objective and standard DAPI (Ex:360/40 DC:400 
Em:460/50), GFP(Ex:470/40 DC:495 Em:525/50), and Texas red (Ex:560/60 
DC:600 Em:615) filter sets and imaged using SPOT monochrome cooled-CCD 
camera.  Fibers stained with secondary antibodies Cy3.5, BV480 and Cy5 were 
imaged using the FiberVision® scanner in collaboration with Genomic Vision, 
France.  
 
3.10 Data collection 
Fibers were measured in pixels using Image J (Schneider et al., 2012).  Pixels 
were converted to kb using λ DNA as a standard.  Only fibers longer than 120 kb 
were analyzed.  For images acquired in collaboration with Genomic Vision, the 
fibers were manually measured using FiberStudio® software. About 25 Mb of 
DNA was collected for each dataset. For each fiber, the length of each green, red 
and unlabeled track was manually measured. Analysis of this data was 
automated using MATLAB scripts.  
 
4. Data Analysis 
We pulsed cells in S phase with 5-chloro-2’-deoxyuridine (CldU) for 5 minutes 
and chased it with 5-iodo-2’-deoxyuridine (IdU) for 10 minutes, isolated and 
combed DNA, and visualized the CldU and IdU analogs with red and green 
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antibodies, respectively. Figure 2.3 shows a sample fiber from the dataset. The 
fiber contains a rightward moving fork (red-green [RG]), an origin that fired during 
IdU labeling (green [G]), and three origins that fired during CldU labeling (green-
red-green [GRG]).  Further replication patterns observed in our combing dataset 
are shown with an interpretation of each pattern.  The patterns observed were 
most simply interpreted as a leftward fork (green-red [GR]), a rightward fork 
(RG), origins that fired during CldU (GRG) or IdU (G), and terminations during 
IdU (red-green-red [RGR]) or CldU (red [R]).  However, a more sophisticated 
analysis allowing the possibility of fork stalling reveals that many of these 
patterns—in particular termination during CldU (R)—are ambiguous, as 
described below (Figure 2.6).  For each experiment we collected about 25 Mb of 
DNA, which is about twice the size of the fission yeast genome, ensuring 
representation of most genomic loci in our analysis.  From the combing data we 
estimated four parameters: origin firing rate, fork density, fork rate and fork 
stalling frequency 
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Figure 2.3 Visualization of replication fork progression 
Figure 2.3 Visualization of replication fork progression. Wild-type cells 
(yFS940) were G1 synchronized and pulse labeled at 50 minutes after release 
into S phase with CldU (visualized using red antibody) for 5 minutes, and chased 
with IdU (visualized using green antibody) for 10 minutes.  Shown are a sample 
fiber from the wild-type dataset and the various replication patterns observed in 
the dataset with their simplest interpretations.  See Figure 2.6 for other possible 
interpretations of ambiguous patterns. 
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4.1 Fork rate measurement 
Green tracks (containing IdU, the second analog added) continuing from red 
tracks (containing CldU, the first analog added) were used to determine fork rate.  
The length of the green track was measured from green-red (GR), red-green 
(RG) and green-red-green (GRG) events and divided by the length of the chase 
time (10 minutes).  For each dataset the fork rate distribution was plotted as a 
histogram and was fit to a Gaussian curve (Figure 2.4).  The mean fork rate was 
obtained from the fit. 
We also considered that there could be a lag between the addition of analog 
and its incorporation into the DNA, which might lead to an underestimation of the 
actual fork rate.  To estimate the lag we labeled the cells as previously described 
with 2µM CldU for 5 minutes and chased it with 20µM IdU but collected samples 
after different lengths of IdU incubation: 3, 4, 5, 6, 7, 8, 10, 14 and 16 minutes.  
However we did not find any lag in analog incorporation by plotting the lengths of 
IdU labeled forks across different lengths of time after IdU addition (Figure 2.5). 
Fork rate was also analyzed by excluding forks occurring at the ends of the 
fiber, as broken forks may lead to an under-estimation of the actual fork rate.  
However, excluding the forks occurring at the ends of the fiber does not 
significantly affect fork rate estimations, consistent with the observation that only 
6% of the forks in our dataset occur at the end of a fiber. 
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Figure 2.4 Fork rate distribution in wild-type sample 
 
 
Figure 2.4 Fork rate distribution in wild-type sample. Fork rate distribution 
from wild-type sample from three different time-courses (blue, red, green). Each 
distribution was fit to a Gaussian curve. Mean fork rate and standard deviation 
was obtained from the fit.  
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Figure 2.5 Estimation of lag in analog incorporation 
  
Figure 2.5 Estimation of lag in analog incorporation.  Cells were pulse 
labeled with 2 µM CldU for 5 minutes and chased with 20 µM IdU for varying 
lengths of time: 3, 4, 5, 6, 7, 8, 10, 14, 16 minutes.  At least 100 forks were 
collected for each time point except for 3 and 4 minutes of IdU labeling for which 
only 11 and 44 forks were measured, respectively, due to lack IdU labeled forks 
at such short lengths of labeling period. 
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4.2 Origin firing rate measurement 
To estimate the rate of origin firing, the total number of origin firing events in each 
fiber was divided by the length of the unreplicated DNA of that fiber and by the 
total length of the analog pulses (15 minutes).  The total number of origins firing 
in the fiber is the sum of origins that fire during the first and the second analog.  
Origins that fire during the first analog are identified as GRG events.  Origins that 
fire during the second analog are identified as isolated green events.  However, 
origins that fire in the first analog will appear as GRG only if both its forks 
progress into the second analog labeling.  In the event of a unidirectional fork 
stall during the first analog pulse, origins that fire will appear as GR or RG.  An 
origin may also appear as an isolated red event if both its forks stall during the 
first analog pulse.  Therefore, the origin firing rates were corrected by accounting 
for the probability of forks stalling during the first analog pulse which would have 
disrupted GRG events, based on the measured fork stall rate (see below for stall 
rate calculation). 
 
4.3 Fork density measurement 
Origin firing rate captures the origins that fire during the course of the analog 
pulses.  However, the rate of origin firing prior to labeling influences the density 
of forks during the pulses and provides a parallel measure of origin activity.  
Therefore, we measured fork density to assess origin firing rate during the period 
prior to our S-phase labeling pulses.  Fork density, the total number of forks in 
each fiber was divided by the length of the unreplicated DNA of that fiber, and 
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was calculated independently for the two labeling pulses.  The basic strategy for 
measuring the fork density during either analog pulse is straight-forward.  For the 
first pulse, it is done by counting the following events in each fiber and dividing by 
the length of the unreplicated DNA of that fiber: the number of origins firing 
(GRG) and terminations (R and RGR) during the first pulse multiplied by two, 
since each origin or termination comprises two forks, and the unidirectional forks 
(GR and RG) counted once.  Likewise, for the second analog pulse it is done by 
counting the following events in each fiber and dividing by the length of the 
unreplicated DNA of that fiber: the number of origin firing during the second pulse 
(G), forks from origins firing in the first pulse (GRG) and terminations during the 
second pulse (RGR) multiplied by two, and the unidirectional forks (GR and RG) 
counted once.  We also calculated the total fork density for each fiber, which is 
done by counting following events in each fiber and dividing by the length of the 
unreplicated DNA of that fiber: number of origins firing during each analog (GRG 
and G) and terminations (R and RGR) multiplied by two, and the unidirectional 
forks (GR and RG) counted once.  However, these calculations are confounded 
by forks that stall during the first pulse, leading to the misclassification of events 
(Figure 2.6).  To account for such stalling events, we took a probabilistic 
approach, in which the measured stall rate is used to more accurately estimate 
fork density, as described below. 
 
4.4 Fork stall rate measurement 
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Difficulty in identifying fork stalling events in combing data arises from the fact 
that stalls during the first pulse can result in ambiguous analog incorporation 
patterns (Figure 2.6A) (Técher et al., 2013).  For instance, an isolated first analog 
event is open to any of the following three interpretations: an unidirectional 
elongating fork that stalled, or an origin firing event for which both forks stalled, or 
a termination event (Figure 2.6A). Therefore, we cannot use first-pulse events 
alone as rigorous evidence for stalled forks. However, using double-labeled 
combing data we can unambiguously identify fork stalling. In particular, two 
apparently unidirectional forks moving in the same direction on a fiber must have 
had the fork in between them stall (Figure 2.6B).  Such unambiguous stall events 
leave signature red-unlabeled-green (RUG) or green-unlabeled-red (GUR) 
patterns (Figure 2.6B & 2.7).  On the other hand the signature for two unstalled 
forks is green-unlabeled-green (GUG) (Figure 2.7). Thus, a red-unlabeled-green 
(RUG) or green-unlabeled-red (GUR) pattern is diagnostic of a fork stall.  Since 
the fibers in our datasets average over 400 kb, we observed many neighboring 
forks, allowing us to robustly measure fork stalling. We can estimate the fork stall 
rate only during the first analog pulse.  Stalls occurring during the second analog 
pulse simply reduce the length of the second analog incorporation track and thus 
get interpreted as a reduction in fork rate. 
  
  
69 
 Figure 2.6 Identification of stalled forks using the context of neighboring 
forks 
 
Figure 2.6 Identification of stalled forks using the context of neighboring 
forks (A) Ambiguity in interpreting isolated first analog events. Possible 
interpretations of isolated first analog event based on the neighboring event are 
listed.  (B) The signature we have used to identify definite stalled forks: RUG 
(red-unlabeled-green) and GUR (green-unlabeled-red).  Two forks moving in the 
same direction indicate that the fork moving in between them in the opposite 
direction must have stalled.  
  
Definite stalled fork
 A
GUR
RUG
stalled elongating fork
origin with both forks stalled
termination
GUR                
 B
Origin
RUG
CldU - first analog 
IdU - second analog 
R - red
G - green
U - unlabelled
Possible interpretations for isolated first analog event
Identification of unambiguous stalled events in our dataset using signature RUG and GUR pattern
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Calculation of stall rate from unambiguous events 
To estimate the apparent stall rate in the dataset we counted every RUG and 
GUR event and divided it by the sum of GUR, RUG and GUG events (Figure 
2.7).  The GUR and RUG events are included in the denominator because every 
stall event represents a loss of one fork.  For example, consider an origin (GRG) 
on a fiber.  If one of its fork is stalled then it will appear as GR or RG and we 
would calculate the stall rate as 50% since one fork is stalled but ideally there 
should be two (one fork which we can visualize and one which is stalled). 
 
Calculation of stall rate from all events (unambiguous as well as 
ambiguous events) 
Although the unambiguous events allow us to determine the stall rate with 
certainty, not every isolated first analog event is flanked by second analog events 
to help us determine whether it is stalled or not.  For example consider Figure 
2.8, which shows two forks moving away from one another (RUR pattern).  It can 
be interpreted as forks moving away from a single origin or as two origins with 
stalled forks on their inner side.  
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Figure 2.7 Calculation of apparent stall rate (for unambiguous events only). 
 
Figure 2.7 Calculation of apparent stall rate (for unambiguous events only). 
Apparent stall rate was estimated by dividing the number of RUG and GUR 
events by summation of GUG, RUG, and GUR events. 
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Figure 2.8 Ambiguous events in the dataset 
 
Figure 2.8 Ambiguous events in the dataset. Ambiguous events such as RUR 
(red-unlabeled-red) and their possible interpretations. 
  
Interpretation1:  
forks moving away 
from a single origin 
Interpretation2:  
two origins with stalled 
forks on the inner side 
Origin1      Origin2
RUR
Ambiguous replication patterns
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To estimate the stall rate across the ambiguous events we used a 
probabilistic approach.  We considered all combinations in which ambiguous 
events could occur (e.g. UR, RU, RUR, GRU, URG, GRUR, RURG, URUR, 
RURU, RURUR etc.) (Figure 2.9). Figure 2.9 shows a schematic representation 
of all the permutations in which a red track can occur and their possible 
interpretations. 
 
Figure 2.9 Permutations in which a red track can occur. 
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GURG
Permutation 1: red track is an origin with a stalled fork
URG ?
Permutation 2: red track could be an origin with a stalled 
leftward fork or just an elongating rightward fork
RURG
??
Permutation 3:elongating forks from an origin in the center 
or two origins whose inner forks have stalled
GRUG
Permutation 4: red track is an origin with 
a stalled rightward fork
GRU?
Permutation 5: red track could be an origin with a stalled 
rightward fork or just an elongating leftward fork
GRUR
? ?
Permutation 6: elongating forks from an origin in the center 
or two origins whose inner forks have stalled
GURU ?
Permutation 7: red track could be an elongating fork with 
a stalled leftward fork or an origin with two stalls
URUG?
Permutation 8:red track could be an elongating fork with 
a stalled rightward fork or an origin with two stalls
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??RURU
Permutation 9: red track could be a termination event or an 
origin with two stalls or an elongating fork with stall on either side
?? URUR
Permutation 10: red track could be a termination event or an 
origin with two stalls or an elongating fork with stall on either side
??
RURUR
Permutation 11: red track could be a termination event or an 
origin with two stalls or an elongating fork with stall on either side
? RURUG
Permutation 12: red track could be an elongating fork with
a stalled rightward fork or could be an origin with two stalls
?GURUR
Permutation 13: red track could be an elongating fork with 
a stalled leftward fork or could be an origin with two stalls
GURUG
Permutation 14: red track is an origin with both its forks stalled
??
URU
Permutation 15: red track could be a termination event or an origin 
with two stalls or an elongating fork with stall on either side 
GRG
Permutation 16: red track is an origin with two forks
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Figure 2.9 Permutations in which a red track can occur. A schematic 
representation of all the permutations in which a red track can occur and their 
possible interpretations. The red track of interest is italicized in each case. 
  
R - red
G - green
U - unlabeled
? - ambiguous red track
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The ambiguous events were assigned a probability of being either stalled or 
not, using the apparent stall rate as the probability of a fork stalling (Table 2.2).  
For example, consider red-unlabeled-red (RUR) event represented in Figure 2.8, 
if the leftward moving fork is interpreted as an origin with stalled rightward fork 
then it automatically implies that the rightward moving fork on the fiber is also an 
origin with stalled leftward moving fork.  Therefore the probability of both the 
events being considered as origins with a stalled fork, is the product of two stall 
events occurring at the same time i.e. square of the apparent stall rate.  If the 
apparent stall rate is 10%, then RUR events are assigned a 1% probability of as 
having two stalled forks.  The probabilistic interpretation of the ambiguous events 
also changes the absolute number of forks in the dataset.  For example 
according to interpretation 1 in Figure 2.8 there is only one origin with two 
elongating forks on the fiber. However according to interpretation 2 there are two 
origins with a total of 4 expected and 2 apparent forks.  To estimate the stalls per 
kb for each fiber the unambiguous stall events (RUG and GUR) in each fiber 
were combined with the fraction of the ambiguous events that were predicted to 
be stalled and this total was divided by the length of the un-replicated DNA.  To 
estimate the stall rate per fiber the unambiguous stall events (RUG and GUR) in 
each fiber were combined with the fraction of the ambiguous events that were 
predicted to be stalled and this total was divided by the total number of ongoing 
forks in the first analog, which was calculated as the sum of GR, RG, and R 
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events (counted once or twice based on whether they were interpreted as 
elongating forks or as an origin with a stalled fork) plus two forks for each GRG. 
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Table 2.2 Probability of stalling assigned to each permutation listed in 
Figure 2.9 
 
Permutation Probability 
of the red 
track 
having a 
stalled fork 
Probability 
of the red 
track 
being an 
origin with 
two stalled 
forks 
Total 
number of 
stalled 
forks 
Total 
number of 
unstalled 
forks 
Total number 
of ongoing 
forks 
1 1 - 
 
n(GURG) n(GURG) 2*n(GURG) 
2 st - n(URG)*st n(URG)*(1-
st) 
n(URG)*(1-st) 
+ 
2*st*n(URG) 
3 st2 - n(RURG)*
st2 
n(RURG)*(1
-st2) 
n(RURG)*(1-
st2) + 
2*st2*n(RUR
G) 
4 1 - n(GRUG) n(GRUG) 2*n(GRUG) 
5 st - n(GRU)*st n(GRU)*(1-
st) 
n(GRU)*(1-st) 
+ 
2*st*n(GRU) 
6 st2 - n(GRUR)*
st2 
n(GRUR)*(1
-st2) 
n(GRUR)*(1-
st2) + 
2*st2*n(GRU
R) 
7 1-st st n(GURU)*
(1-st) +  
2*n(GUR
U)*st 
- n(GURU)*(1-
st) + 
2*n(GURU)*st 
 
8 1-st st n(URUG)*
(1-st) + 
 
- n(URUG)*(1-
st) + 
2*n(URUG)*st 
R - red
G - green
U - unlabeled
st - apparent stall rate
n - number of events in the entire dataset
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2*n(URU
G)*st 
9 st + st2 - 
2*st3 
st3 n(RURU)*
(st + st2 - 
2*st3) + 
 
2*n(RURU
)*st3 
2*n(RURU)*
(1 - st - st2 + 
st3) 
n(RURU)*(st 
+ st2 - 2*st3) +  
2*n(RURU)* 
st3 + 
2*n(RURU)*(
1 - st - st2 + 
st3) 
10 st + st2 - 
2*st3 
st3 n(URUR)*
(st + st2 - 
2*st3) + 
 
2*n(URUR
)*st3 
2*n(URUR)*
(1 - st - st2 + 
st3) 
n(URUR)*(st 
+ st2 - 2*st3) +  
2*n(URUR)* 
st3 + 
2*n(URUR)*(
1 - st - st2 + 
st3) 
 
11 2*(st2 - st4) st4 2*n(RURU
R)*(st2 - 
st4) +  
2*n(RURU
R)*st4 
2*n(RURUR
)*(1 - 2*st2 + 
st4) 
2*n(RURUR)*
(st2 - st4) +  
2*n(RURUR)*
st4 + 
2*n(RURUR)*
(1 - 2*st2 + 
st4) 
12 1-st2 st2 n(RURUG
)*(1-st2) +  
2*n(RURU
G)*st2 
- n(RURUG)*(1
-st2) 
+2*n(RURUG
)*st2 
13 1-st2 st2 n(GURUR
)*(1-st2) +  
2*n(GUR
UR)*st2 
- n(GURUR)*(1
-st2) + 
2*n(GURUR)*
st2 
14 - 1 2*n(GUR
UG) 
- 2*n(GURUG) 
15 2*(st - st2) st2 2*n(URU)*
(st - st2) + 
 
2*n(URU)*
st2 
2*n(URU)*(
1 - 2*st + 
st2) 
2*n(URU)*(st 
- st2) + 
2*n(URU)*st2 
+  
2*n(URU)*(1 - 
2*st + st2) 
16 - - - 2*n(GRG) 2*n(GRG) 
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stall rate    =
total number of stalled forks per fiber
total number of ongoing forks per fiber
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Conclusion 
Bulk assays of replication kinetics, such as the quantitation of radioactive 
thymidine incorporation or flow cytometry, provide only an average profile of 
replication kinetics, convolving the effects of origin firing and fork progression and 
obscuring any heterogeneity in fork slowing.  The effects of DNA damage on 
specific origins and on forks replicating specific loci can be analyzed by gel- or 
sequence-based methods (Santocanale and Diffley, 1998; Shirahige et al., 1998; 
Tercero and Diffley, 2001; Kumar and Huberman, 2009; Szyjka et al., 2008), but 
these techniques still only reveal the average response to DNA damage.  Such 
approaches lack the single-molecule resolution necessary to identify 
heterogeneity in response to damage and to distinguish, for instance, if all forks 
pause briefly at all lesions or if only a fraction of forks stall, but for a longer time.   
Therefore, to investigate the effect of polymerase blocking lesions on 
individual origins and forks on a global scale, we have implemented a double-
analog labeled, single-molecule DNA combing assay in fission yeast. Sequential 
analog labeling allows us to distinguish between origins and forks and thus study 
their regulation in response to damage. Further, we have developed an in-depth 
analysis of every permutation of labeled track found in a tri-color combing dataset 
to rigorously study the effect of damage on origins v forks. Finally, using the 
context of neighboring events we have identified fork stalling events in tri-color 
combing dataset. Detection of fork stalling events is complicated due to lack of 
consensus on how to identify them in the DNA fiber datasets (Técher et al., 
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2013).  Generally, signal from the first (red) analog alone on a fiber (a unlabeled-
red-unlabeled [URU] event) is presumed to be either an elongating fork that 
stalled or an origin that fired in the first pulse followed by stalling of both its forks 
(Figure 2.6A) (Técher et al., 2013; Scorah and McGowan, 2009; Wilsker et al., 
2008; Merrick et al., 2004; Conti et al., 2010).  Alternatively the events from the 
first analog alone can be interpreted as terminations (Figure 2.6A) (Técher et al., 
2013; Anglana et al., 2003; Courbet et al., 2008; Letessier et al., 2011).  
However, both interpretations rely on heuristic arguments and are unable to 
quantitate ambiguous signals, such as URU.  Therefore we developed a new, 
rigorous way of quantitating stalled forks in double-labeled data.  We have used 
the context in which the first analog event occurs to define it as a stalled fork or 
not.  As discussed in greater detail in the data analysis section we have used 
RUG and GUR patterns as a diagnostic for fork stall event occurring during the 
first analog (Figure 2.6B and 2.7).  We then used a probabilistic approach to 
quantitate the frequency of stall events in the ambiguous patterns in order to 
determine the net fork stall rate for the entire dataset (Figure 2.8 and 2.9, Table 
2.2).  It should be noted that we can detect a stall only if it occurs during the first 
(red) analog pulse and persists throughout the second (green) analog pulse. 
Thus using the approach we have developed we can study the behavior of 
individual forks and understand their regulation by checkpoint in response to 
damage (Chapter III). We can ascertain whether regulation of forks is global or 
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local, that is do all forks show uniform or heterogeneous behavior in response to 
damage (Chapter III)(Iyer and Rhind, 2013). 
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Chapter III  
 
Replication fork slowing and stalling are distinct, 
checkpoint-independent consequences of 
replicating damaged DNA 
 
 
 
 
 
 
Chapter III is mainly from the manuscript written by Nick Rhind and me and is 
currently under review at PLOS Genetics (Iyer and Rhind, submitted). 
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Introduction 
In response to DNA damage during the G1 or G2 phase of the cell cycle, DNA 
damage checkpoints block cell cycle progression, giving cells time to repair 
damage before proceeding to the next phase of the cell cycle (Hartwell and 
Weinert, 1989; Rhind and Russell, 2012).  The response to DNA damage during 
S phase is more complicated, because repair has to be coordinated with ongoing 
DNA replication (Bartek et al., 2004).  DNA damage during S phase activates the 
intra-S DNA damage checkpoint, which does not completely block S-phase 
progression, but rather slows DNA replication, presumably allowing for 
replication-coupled repair (Rhind and Russell, 2000a).  Lack of the intra-S DNA 
damage checkpoint predisposes cells to genomic instability (Zhou and Elledge, 
2000).  Nonetheless, the mechanisms by which replication is slowed, and the 
roles of checkpoint-dependent and -independent regulation in the S-phase DNA 
damage response, are not well understood. 
The slowing of S phase in response to damage involves both inhibition of 
origin firing and reduction in fork rate (Kaufmann et al., 1980; Merrick et al., 2004; 
Falck et al., 2002; Santocanale and Diffley, 1998; Chastain et al., 2006; Seiler et 
al., 2007; Kumar and Huberman, 2009).  The effect of the checkpoint on origin 
firing has been characterized in budding yeast and mammalian cells.  The 
checkpoint prevents activation of late origins by targeting initiation factors 
required for origin firing.  In mammals, checkpoint kinase 1 (Chk1) inhibits origin 
firing by targeting the replication kinases, cyclin-dependent kinase (CDK) and 
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Dbf4-dependent kinase (DDK) (Zhao and Piwnica-Worms, 2001; Falck et al., 
2001; Sørensen et al., 2003).  In budding yeast, Rad53 targets Sld3, an origin 
initiation factor, and Dbf4, the regulatory subunit of DDK (Zegerman and Diffley, 
2010; Lopez-Mosqueda et al., 2010). 
Although checkpoint inhibition of origin firing is conserved from yeast to 
mammals, the contribution of origin regulation to damage tolerance is not clear.  
For instance, budding yeast mutants such as mec1-100, SLD3-m25 and dbf4-
m25, which cannot block origin firing in response to damage, are not sensitive to 
damaging agents such as methyl methanesulfonate (MMS) (Zegerman and 
Diffley, 2010; Lopez-Mosqueda et al., 2010; Tercero et al., 2003; Paciotti et al., 
2001) suggesting that checkpoint regulation of origin firing is not as critical as the 
checkpoint’s contribution to damage tolerance via fork regulation. 
The effect of checkpoint activation on replication forks is less well 
understood.  Because many DNA damage lesions block the replicative 
polymerases, in order for forks to pass leading-strand lesions, they must have 
some way to reestablish leading-strand synthesis downstream of the lesion.  
Recruitment of trans-lesion polymerases, template switching and leading-strand 
repriming have all been proposed to be involved in the fork by-pass of lesions, 
but which is actually used in vivo and how the checkpoint may affect that choice, 
is unclear (Branzei and Foiani, 2009; Branzei and Foiani, 2005; Ulrich, 2012; 
Daigaku et al., 2010; Sale, 2012; Lee and Myung, 2008). 
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DNA damage leads to slowing of fork progression. However, whether 
slowing of forks is checkpoint dependent or independent is controversial (Tercero 
and Diffley, 2001; Szyjka et al., 2008; Unsal-Kaçmaz et al., 2007). Bulk assays 
(2D-gels) provide only an average snapshot of fork behavior. To understand the 
regulation of individual forks on a global scale we have used single-molecule 
DNA combing assay. Sequential analog labeling allows us to distinguish between 
origins and forks and thus allows us to get a detailed snapshot of behavior of 
individual forks in response to damage. 
Here, we have assayed checkpoint-dependent slowing of S phase in fission 
yeast in response to three DNA damaging drugs that activate the checkpoint at 
significantly different densities of lesions: methyl methanesulfonate (MMS), which 
mainly methylates purines and creates a relatively small adduct, 4-nitroquinoline 
1-oxide (4NQO), which adds a quinoline group to purines resulting in a bulkier 
adduct (Sikora et al., 2010; Galiègue-Zouitina et al., 1985; Galiègue-Zouitina et 
al., 1986) and bleomycin, which mainly creates single strand and double strand 
DNA breaks (Chen and Stubbe, 2005).  MMS and 4NQO create polymerase-
stalling lesions and have been shown to activate the intra-S checkpoint 
(Friedberg et al., 1995; Larson et al., 1985; Minca and Kowalski, 2011; Lopez-
Mosqueda et al., 2010; Willis and Rhind, 2009; Lindsay et al., 1998).  The 
standard dose of 3.5 mM (0.03%) MMS causes about one lesion every 1 kb 
whereas a physiologically similar dose of 1 µM 4NQO causes one lesion about 
every 25 kb and 16.5 µM of bleomycin causes about 5 double-strand breaks per 
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haploid yeast genome (Lundin et al., 2005; Snyderwine and Bohr, 1992; Ma et 
al., 2008; Asaithamby and Chen, 2009).  Although these are only rough 
approximations of lesion density, they show that forks will encounter many more 
MMS lesions than 4NQO lesions or bleomycin-induced double-strand breaks.  
This wide disparity in lesion density allows us to address differences in global 
and local effects of the checkpoint.  In case of 4NQO, since the lesions are rare, 
we expect few forks to encounter lesions.  Therefore, if all forks slow in response 
to 4NQO then we can conclude that fork regulation by checkpoint is global in 
nature. On the contrary, if fork regulation is a local effect then only the very few 
forks that actually encounter lesion will slow.  Similarly since the double-strand 
breaks caused by bleomycin are infrequent we expect very few forks to be 
affected by the breaks unless the checkpoint actively regulates all forks.  In case 
of MMS, since the lesions are frequent we expect all forks to encounter lesions, 
and thus to slow regardless of whether slowing is a local or global effect.  By 
comparing the effects of these three drugs, we can differentiate between global 
and local effects on fork regulation by the checkpoint.  We find that fork slowing 
is a local, checkpoint-independent effect, but that persistent fork stalling plays a 
more significant role in replication kinetics than previously appreciated. 
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Results 
MMS, bleomycin and 4NQO-induced DNA damage show a similar effect on 
the overall replication rate 
To determine the effect of MMS, bleomycin, and 4NQO—three compounds that 
activate the checkpoint at very different densities of lesions—on the replication 
rate at a population level, we analyzed cells response to them by flow cytometry.  
G1 synchronized cells were released into S phase with or without DNA damage, 
using the commonly used dose of 3.5 mM (0.03%) MMS or a dose of 1 µM 
4NQO or 16.5 µM bleomycin chosen to produce a similar slowing of bulk 
replication (Figure 3.16).  These doses of MMS, 4NQO and bleomycin cause 
lesions about once every 1 kb, 25 kb, and 3000 kb respectively (Lundin et al., 
2005; Snyderwine and Bohr, 1992; Ma et al., 2008; Asaithamby and Chen, 
2009).  By flow cytometry, control cells completed replication by 80 minutes, 
while in the presence of either drug cells slowed replication, reaching only about 
60% replicated by the end of the time course (Figures 3.1A and 3.2A).   
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Figure 3.1 Slowing of S phase progression in response to damage by 
FACS.
 
Figure 3.1 Slowing of S phase progression in response to damage by 
FACS. Wild-type (yFS940) (A) and cds1∆ (yFS941) (B) cells were synchronized 
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in G1 phase using cdc10-M17 temperature sensitive allele followed by elutriation. 
Elutriated G1 cells were released into permissive temperature untreated or 
treated with 3.5 mM MMS or 1 µM 4NQO or 16.5 µM Bleomycin. S phase 
progression was followed by taking samples for FACS. 
  
93 
Figure 3.2 MMS-, 4NQO and bleomycin-induced DNA damage show a 
similar effect on the overall replication rate 
 
Figure 3.2 MMS-, 4NQO and bleomycin-induced DNA damage show a 
similar effect on the overall replication rate (A) Wild-type cells (yFS940) show 
similar slowing of replication in response to 3.5 mM (0.03%) MMS, 1 µM 4NQO, 
and 16.5 µM bleomycin by flow cytometry.  (B) Slowing in response to damage is 
largely checkpoint dependent by bulk assay.  Wild-type (yFS940, A) and cds1Δ 
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(yFS941, B) cells were synchronized in G1 and released into S phase in the 
presence or absence of 3.5 mM MMS, or 1µM 4NQO, or 16.5 µM bleomycin.  S-
phase progression values were obtained from histograms of Figure 3.1.  The 
error bars represent standard deviation. 
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Thus, despite the disparity in the number of lesions created by MMS, 4NQO and 
bleomycin, all three drugs led to a similar extent of replication slowing at the 
doses used.  In all cases, the slowing in response to DNA damage was largely 
checkpoint-dependent.  In the absence of the Cds1 checkpoint kinase, cells 
completed replication by 100 minutes even in the presence of damage, as 
reported previously (Figure 3.1B and 3.2B) (Lindsay et al., 1998; Rhind and 
Russell, 1998).  Although the three drugs appeared to have similar extent of 
slowing in wild-type, their effects in cds1Δ cells differed, with cds1Δ cells showing 
more checkpoint-independent slowing in MMS than in 4NQO or bleomycin 
(Figure 3.2B).  We therefore examined if there is a difference in the mechanism 
by which DNA replication is slowed in response to MMS, 4NQO and bleomycin. 
 
Inhibition of origin firing is immediate in response to 4NQO and Bleomycin, 
but delayed in the case of MMS 
As shown in Figure 3.2A we see similar levels of bulk slowing for all three 
damage treatments at 60 minutes in S phase (Figure 3.2A and 3.3A). We first 
analyzed the effect of DNA damage on origin firing.  To measure the rate of 
origin firing, we directly measured the number of new origins fired during the 
CldU pulse (green-red-green (GRG) patches) or IdU pulse (isolated green 
patches).  The overall origin firing rate was calculated as the total number of 
origin firing events in each fiber normalized to total length of un-replicated DNA of 
that fiber and to the length of the analog pulse (Figure 3.3B).  Additionally, the 
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origin firing rate during first analog and second analog was determined 
separately (Figure 3.4A, B, C).  In untreated controls, the rate of origin firing in 
the first analog was 2.3±0.7 origins per Mb per minute, similar to previous 
estimates of origin firing rates (Table 3.1) (Goldar et al., 2009). 
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Table 3.1 Summary of all the combing datasets with the total and analog 
specific origin firing rate and fork density for each sample. 
 
 
  
Origin firing rate per Mb per min Fork density per Mb 
Strain no. Expt Dataset No. Drug Total CldU IdU Total CldU IdU
yFS940 WT WT1-N Untreated 0.84 1.75 0.38 28.53 20.87 24.78
yFS940 WT WT1-N 4NQO 0.35 0.88 0.08 13.82 12.19 9.66
yFS940 WT WT2-M Untreated 0.81 1.92 0.26 28.43 23.19 24.75
yFS940 WT WT2-M MMS 0.72 1.96 0.09 24.96 23.12 15.79
yFS940 WT WT3-M Untreated 1.33 3.18 0.41 44.26 36.13 41.12
yFS940 WT WT3-M MMS 0.86 2.28 0.16 30.25 27.13 24.83
yFS940 WT WT4-M Untreated 1.28 2.25 0.80 43.88 27.80 40.54
yFS940 WT WT4-M MMS 1.06 2.23 0.47 36.53 27.05 31.15
yFS940 WT WT5-M Untreated 1.18 2.52 0.51 39.36 29.14 36.35
yFS940 WT WT5-M MMS 1.09 2.63 0.32 39.63 33.24 30.29
yFS940 WT WT6-M Untreated 1.06 2.21 0.49 39.07 29.35 34.96
yFS940 WT WT6-M MMS 0.78 1.82 0.25 31.86 26.82 22.57
yFS940 WT WT7-N Untreated 0.97 1.58 0.66 38.59 25.39 32.37
yFS940 WT WT7-N 4NQO 0.50 0.99 0.25 19.52 14.49 15.95
yFS940 WT WT8-B Untreated 1.15 1.65 0.90 42.48 24.50 36.88
yFS940 WT WT8-B Bleomycin 0.77 1.56 0.38 29.07 21.53 23.24
yFS940 WT WT9-B Untreated 1.53 3.51 0.54 62.58 51.84 52.06
yFS940 WT WT9-B Bleomycin 0.95 2.02 0.42 36.37 28.07 28.26
yFS941 cds1 cds1-1-N Untreated 1.24 3.28 0.22 41.25 36.81 37.00
yFS941 cds1 cds1-1-N 4NQO 1.03 2.63 0.23 35.58 30.90 29.42
yFS941 cds1 cds1-2-M Untreated 1.43 3.35 0.47 47.49 38.02 44.57
yFS941 cds1 cds1-2-M MMS 1.66 3.33 0.83 57.13 40.57 49.54
yFS941 cds1 cds1-3-M Untreated 1.54 3.29 0.66 49.10 35.86 46.45
yFS941 cds1 cds1-3-M MMS 1.81 3.94 0.75 60.98 45.91 55.83
yFS941 cds1 cds1-4-M Untreated 1.53 3.06 0.76 51.89 36.76 47.72
yFS941 cds1 cds1-4-M MMS 1.59 3.50 0.64 54.82 41.94 49.99
yFS941 cds1 cds1-5-N Untreated 1.62 3.00 0.93 63.93 45.24 52.43
yFS941 cds1 cds1-5-N 4NQO 1.77 2.20 1.56 61.33 30.22 55.85
yFS941 cds1 cds1-6-B Untreated 1.83 4.61 0.44 69.17 60.34 56.25
yFS941 cds1 cds1-6-B Bleomycin 1.53 3.50 0.55 58.95 47.98 41.93
yFS941 cds1 cds1-7-B Untreated 1.75 3.67 0.79 68.94 53.20 51.88
yFS941 cds1 cds1-7-B Bleomycin 1.36 2.70 0.69 53.40 39.55 41.09
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Figure 3.3 4NQO, MMS and bleomycin slow S phase by reducing origin 
firing rate. 
 
Figure 3.3 4NQO, MMS and bleomycin slow S phase by reducing origin 
firing rate. Wild-type cells (yFS940) were synchronized in G1 and released into 
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S phase untreated, or treated with 3.5 mM MMS, or 1µM 4NQO, or 16.5 µM 
bleomycin.  Cells were labeled at mid-S phase with CldU followed by IdU for 
DNA combing.  All parameters are represented as a ratio of treated v. untreated 
sample.  (A) 4NQO, bleomycin and MMS slow S phase to similar extent by flow 
cytometry. Total replication by FACS was calculated at 60 minutes after release, 
which is close to the mid-point of analog labeling.  (B) and (C) 4NQO, bleomycin 
and MMS show differing levels of reduction in origin firing rate and fork density. 
For calculations of origin firing rate and fork density refer to Chapter II.  For each 
sample of each experiment, about 25Mb of DNA was collected.  All error bars 
represent SD.   
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  In the presence of 4NQO, the origin firing rate in wild-type cells decreased 
to 47% of the untreated control (p=5.17x10-12, t tests were used for all statistical 
tests) (Figure 3.3B and Table 3.1).  Since, the origin firing rate only measures the 
origins that fired during the analog pulses, we also measured the density of 
active forks in the datasets in order to estimate the effect on origin firing prior to 
the analog pulses (see Chapter II for details).  Fork density in 4NQO-treated cells 
was 64% of the untreated control (p=1.28x10-6) during the first analog pulse and 
44% (p=3.08x10-13) in the second, consistent with the trend seen in origin firing 
rates (Figure 3.4A). Thus, the response to 4NQO included an immediate 
reduction in origin firing rate. We see a similar trend for bleomycin treated 
sample. The origin firing rate decreases to 58% (p=7.45x10-5) and the fork 
density decreases to 61% (p=1.33x10-5) (Figure 3.3B and 3.3C).  Analog specific 
estimation shows that bleomycin treatment leads to reduction in the origin firing 
rate in the first analog as well as second analog to 69% (3.91x10-4) and shows a 
corresponding decrease in fork density during the first (77%, p=7.65x10-4) and 
the second analog (55%, p=8.54x10-7) (Figure 3.4B). 
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Figure 3.4 Inhibition of origin firing is immediate in response to 4NQO and 
Bleomycin, but delayed in the case of MMS 
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Figure 3.4 Inhibition of origin firing is immediate in response to 4NQO and 
Bleomycin, but delayed in the case of MMS (A), (B), (C) Analog specific 
estimations of origin firing rate and fork density for 4NQO, bleomycin and MMS 
respectively.  4NQO and bleomycin treatment leads to immediate reduction in 
origin firing rate in the first analog while in MMS the reduction is apparent only 
during the second analog.  For calculations of origin firing rate and fork density 
refer to Chapter II.  For each sample of each experiment, about 25Mb of DNA 
was collected.  All error bars represent SD.   
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In case of MMS, the overall origin firing rate was reduced to 72% 
(p=1.18x10-6) (Figure 3.3B).  Analyzing origin firing during the first and second 
pulse separately, we saw no statistically significant reduction in the first analog 
(90%, p=0.0748) followed by a stronger reduction to 56% (p=7.15x10-11) in the 
second analog (Figure 3.4C).  Therefore, the effect of MMS on origin firing rate is 
delayed.  This conclusion was supported by two observations.  Firstly, the 
average fork density across both analogs in MMS showed a modest reduction to 
78% (p=2.59x10-5) as compared to 53% (p=5.7x10-12) in 4NQO (Figure 3.3C).  
Second, the analog-specific fork density estimations for MMS followed a similar 
trend as the origin firing rate showing a greater reduction during the second 
analog (0.93 v. 0.62, Figure 3.4C).  Hence, the effect of MMS-induced damage 
on origin firing is only manifest late in S-phase, after significant bulk slowing has 
already occurred, whereas 4NQO- and bleomycin-induced damage inhibit origin 
firing immediately in early S phase. 
 
Fork rate declines in response to MMS but not 4NQO or bleomycin 
Since 4NQO and MMS both create polymerase-blocking lesions (Friedberg et al., 
1995; Larson et al., 1985; Minca and Kowalski, 2011; Lopez-Mosqueda et al., 
2010), we next studied how these drugs affect fork speed.  We measured fork 
rate in the combing data as the length of the green track (second analog) 
continuing from a red track (first analog), divided by the length of the chase time 
(10 minutes).  The average fork rate in our untreated samples was 0.91±0.02 
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kb/minute, which is within the range of previous estimates (Conti et al., 2007; 
Conti et al., 2010; Técher et al., 2013; Petermann et al., 2008; Petermann et al., 
2010). 
In MMS, the fork rate decreases to 76% of the untreated control (p=6.13x10-
38) (Figure 3.5A and Table 3.2).  The reduction in fork rate was expected since 
the lesions are so frequent that every fork encounters about ten of lesions during 
the 10 minutes pulse.  In case of 4NQO, the lesions are significantly less 
common, so only about half of the forks should encounter a lesion during the 
second pulse.  Consistent with the low density of lesions, fork rates in 4NQO 
treated cells were similar to untreated cells (Figure 3.5A).  In fact, the fork rate 
showed a 27% increase in the presence of 4NQO as compared to untreated cells 
(p=5.75x10-4).  The dose of bleomycin used should create only 5 breaks per 
haploid yeast genome and therefore should not affect fork rates.  Consistently we 
do not see any statistically significant reduction in fork rate for bleomycin treated 
sample as compared to untreated sample (p=0.3138) (Figure 3.5A).  
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Figure 3.5 Fork rate decreases in response to MMS and fork stall rate 
increases in response to damage 
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Figure 3.5 Fork rate decreases in response to MMS and fork stall rate 
increases in response to damage (A) Fork rate decreases in response to 
MMS, but not in response to 4NQO or bleomycin.  (B) Fork stalls per kb 
increases in response to MMS, but not in response to 4NQO or bleomycin (C) 
Fork stall rate increases in response to MMS, 4NQO and bleomycin.  For 
calculations of fork rate, fork stalls per kb and fork stall rate refer to Chapter II. All 
error bars represent SD.   
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Table 3.2 Summary of all the combing datasets with the fork rate for each 
sample.
 
  
Fork rate pH of 
Strain no. Expt Dataset No. Drug kb/min combing buffer
yFS940 WT WT1-N Untreated 0.67 6.35
yFS940 WT WT1-N 4NQO 0.75 6.35
yFS940 WT WT2-M Untreated 0.67 6.35
yFS940 WT WT2-M MMS 0.53 6.35
yFS940 WT WT3-M Untreated 0.60 6.35
yFS940 WT WT3-M MMS 0.43 6.35
yFS940 WT WT4-M Untreated 0.92 6.25
yFS940 WT WT4-M MMS 0.66 6.25
yFS940 WT WT5-M Untreated 0.91 6.25
yFS940 WT WT5-M MMS 0.6 6.25
yFS940 WT WT6-M Untreated 0.89 6.25
yFS940 WT WT6-M MMS 0.57 6.25
yFS940 WT WT7-N Untreated 0.85 6.2
yFS940 WT WT7-N 4NQO 0.88 6.2
yFS940 WT WT8-B Untreated 0.65 6.2
yFS940 WT WT8-B Bleomycin 0.62 6.2
yFS940 WT WT9-B Untreated 0.48 6.2
yFS940 WT WT9-B Bleomycin 0.47 6.2
yFS941 cds1 cds1-1-N Untreated 0.42 6.35
yFS941 cds1 cds1-1-N 4NQO 0.48 6.35
yFS941 cds1 cds1-2-M Untreated 0.61 6.25
yFS941 cds1 cds1-2-M MMS 0.27 6.25
yFS941 cds1 cds1-3-M Untreated 0.76 6.25
yFS941 cds1 cds1-3-M MMS 0.43 6.25
yFS941 cds1 cds1-4-M Untreated 0.75 6.25
yFS941 cds1 cds1-4-M MMS 0.35 6.25
yFS941 cds1 cds1-5-N Untreated 0.61 6.2
yFS941 cds1 cds1-5-N 4NQO 0.58 6.2
yFS941 cds1 cds1-6-B Untreated 0.58 6.2
yFS941 cds1 cds1-6-B Bleomycin 0.51 6.2
yFS941 cds1 cds1-7-B Untreated 0.52 6.2
yFS941 cds1 cds1-7-B Bleomycin 0.52 6.2
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Fork stalling increases in response to MMS, 4NQO and bleomycin 
In case of MMS treated sample, we only see a modest reduction in fork density 
as compared to 4NQO and bleomycin (Figure 3.3C).  In particular, there is no 
statistically significant reduction in fork density in the MMS treated sample during 
the first analog (93%, p=0.1951) (Figure 3.4C).  However by bulk assay we see 
the same kinetics of slowing for all three damage treatments (Figure 3.2A and 
3.3A).  A possible explanation for this discrepancy is that forks stall during the 
first pulse in response to damage and thus are not observed during the second 
pulse (Chapter II, Figure 2.6).  We therefore interrogated our combing data for 
evidence of fork stalling. 
We first determined the absolute number of stalls per kb for each dataset 
(see Chapter II for details).  The absolute number of stalls per kb determines the 
contribution of stalled forks towards total replication slowing.  In MMS treated 
sample we see a 3.47-fold increase in the number of stalls as compared to 
untreated (p=6.23x10-27), while we see no significant increase in stalling in 
response to 4NQO (1.12, p=0.604) and bleomycin (0.99, p=0.346) (Figure 3.5B).  
Thus an increase in the total number of stalls per kb in response to MMS helps 
explain the slowing of total replication to similar levels as compared to 4NQO and 
bleomycin despite having a delayed effect on origin firing rate. 
Next we estimated the fork stall rate.  We define the fork stall rate as the total 
number of stall events per fiber during the first analog pulse divided by the total 
number of ongoing forks in that fiber during the first analog.  Although the 
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absolute number of stalls per kb in response to 4NQO and bleomycin treatment 
is similar to the wild-type untreated sample, the treated samples have far fewer 
origins firing as compared to untreated sample (Figure 3.3B and 3.5B).  
Therefore the rate of stalling normalized to the origin firing rate is higher in the 
treated sample (Figure 3.5C). The average stall rate per fiber in the untreated 
sample was 14%.  The fork stall rate showed 1.8-fold increase in response to 
4NQO (p=1.2x10-4) and a 1.9-fold increase in response to bleomycin (p=2.26x10-
7), whereas MMS caused a 3.8-fold increase relative to untreated cells 
(p=1.55x10-26) (Figure 3.5C).  Combining our stall-rate data with estimates of 
lesion density, we estimate that forks stall at 1.3% of 4NQO lesions and at 0.5% 
of MMS lesions, consistent with the fact that 4NQO creates a bulkier lesion than 
MMS.  The stall rate per lesion is more complicated to interpret for bleomycin.  
Since the stalls we detect are not at the ends for our fibers, they cannot be at the 
sites of bleomycin-induced double-strand breaks.  However, bleomycin creates 
about a 20-fold excess of single-strand nicks to double strand breaks, which, at 
the dose we used should produce one nick about every 150 kb (Chen and 
Stubbe, 2005).  In the absence of repair, forks would stall at 8.1% of bleomycin-
induced nicks.  If nicks are repaired, that rate of stalling at the remaining 
unrepaired nicks could be much higher.  Although the stall events seem to be 
infrequent relative to lesion density, approximately 53% of forks in MMS-treated 
cells and 25% of forks in 4NQO- and bleomycin-treated cells stalled, contributing 
significantly to slowing, and ensuring that all treated cells had many stalled forks. 
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Inhibition of origin firing is checkpoint dependent 
To determine the role of the intra-S checkpoint in the observed DNA-damage 
dependent changes in replication kinetics, we repeated our combing experiments 
in checkpoint-deficient cds1∆ cells.  In the presence of 4NQO, wild-type cells 
replicated 42% (p=5.55x10-16) as much as untreated cells, as assayed by flow 
cytometry at 60 minutes after release, whereas, in the absence of checkpoint, 
cds1Δ 4NQO treated cells replicated 77% as compared to untreated cells 
(p=5.82x10-8) (Figure 3.6A). 4NQO did not significantly reduce origin firing in 
cds1Δ cells (89%, p=0.206), as opposed to 47% in wild-type cells (p=5.17x10-12) 
(Figure 3.6B).   
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Figure 3.6 Reduction in origin firing rate is checkpoint dependent 
 
Figure 3.6 Reduction in origin firing rate is checkpoint dependent. cds1∆ 
cells (yFS941) were synchronized in G1 and released into S phase untreated, or 
treated with 3.5 mM MMS, or 1µM 4NQO, or 16.5 µM bleomycin.  Cells were 
labeled at mid-S phase with CldU followed by IdU for DNA combing.  All 
parameters from combing data of cds1Δ are represented as a ratio of treated v. 
untreated.  Wild-type dataset is plotted alongside cds1Δ for comparison.    (A) 
Total replication by FACS was calculated at 60 minutes after release, which is 
close to the mid-point of analog labeling.  (B) and (C) Reduction in origin firing 
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and fork density is checkpoint dependent for 4NQO, bleomycin and MMS. For 
calculations of origin firing rate and fork density refer to Chapter II.  For each 
sample of each experiment, about 25Mb of DNA was collected.  All error bars 
represent SD.   
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Thus, the inhibition of origin firing in response to 4NQO is checkpoint-dependent 
(Figures 3.3B and 3.6B).  Analog specific origin density and fork density followed 
similar trends as the total origin firing rate data (Figure 3.7A).  During both the 
analog pulses, cds1Δ cells had a higher origin firing rate and fork density than 
wild-type cells (Figure 3.7A). 
 Likewise, inhibition of origin firing in response to bleomycin and MMS is 
checkpoint-dependent (Figure 3.6B, 3.6C, 3.7B and 3.7C).  In wild-type cells, the 
overall origin firing rate was reduced to 58% by bleomycin (p=7.45x10-5) and 
72% by MMS (p=1.18x10-6) treatment (Figures 3.3B and 3.6B).  In contrast, 
cds1Δ cells showed no significant decrease in origin firing relative to untreated 
cells when treated with bleomycin (96%, p=0.389) or MMS (114%, p=0.011) 
(Figure 3.6B).  Analog specific estimation of fork density and origin firing rate in 
cds1Δ treated with bleomycin or MMS showed a similar trend (Figure 3.7B and 
3.7C).  cds1Δ cells had higher fork density and origin firing rate in response to 
bleomycin and MMS than wild-type cells for both analog pulses (Figure 3.7B and 
3.7C). 
Figure 3.7 Reduction in origin firing rate in response to damage during 
each analog is checkpoint dependent 
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Figure 3.7 Reduction in origin firing rate in response to damage during 
each analog is checkpoint dependent. (A, B, C) Analog specific estimations of 
origin firing rate and fork density for 4NQO, bleomycin and MMS respectively 
shows higher values in cds1Δ than wild-type.  For calculations of origin firing rate 
and fork density refer to Chapter II.  For each sample of each experiment, about 
25Mb of DNA was collected.  All error bars represent SD.   
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In the absence of DNA damage, the lack of Cds1 caused a 51% increase in 
the rate of origin firing (3.5±0.6 v. 2.3±0.6 origins firing/Mb/minute, Table 3.1), 
consistent with previous reports in other systems of checkpoint inhibition of origin 
firing in unperturbed S phase (Petermann et al., 2010; Shechter et al., 2004b).  
Nonetheless, loss of Cds1 increases origin firing in damaged cells to the same 
level as in undamaged cells, showing that there is no checkpoint independent 
inhibition of origin firing (Figure 3.8). 
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Figure 3.8 cds1Δ cells have a higher origin firing rate as compared to wild-
type in untreated as well as treated samples. 
 
Figure 3.8 cds1Δ cells have a higher origin firing rate as compared to wild-
type in untreated as well as treated samples. Origin firing rate from cds1Δ 
untreated and treated samples, and wild-type treated samples were normalized 
to wild-type untreated sample. 
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Reduction in fork rate is checkpoint independent 
In MMS-treated wild-type cells, fork rate was reduced to 76% of the untreated 
cells (p=6.14x10-38) (Figures 3.5A and 3.9A).  This effect was not checkpoint-
dependent.  In fact, at 61% (p=6.13x10-66), cds1Δ cells showed a greater 
reduction in fork rate than seen in wild-type cells in response to MMS (Figure 
3.9A).  Thus, the observed reduction in fork rate in response to MMS seems to 
be due to the physical presence of the lesions and the checkpoint activation may 
facilitate efficient by-pass of the lesions. 
 
 
 
 
 
 
Figure 3.9 Reduction in fork rate and increase in fork stalling is checkpoint 
independent. 
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Figure 3.9 Reduction in fork rate and increase in fork stalling is checkpoint 
independent. (A) Fork rate, (B) fork stalls per kb and (C) fork stall rate data for 
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cds1Δ (yFS941) treated with 4NQO, bleomycin and MMS.  Both parameters are 
represented as a ratio of treated v. untreated.  Wild-type dataset is plotted 
alongside cds1Δ for comparison.  See Chapter II for calculation of fork rate, fork 
stall per kb and fork stall rate. 
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Fork rates showed similar increase in cds1Δ cells treated with 4NQO (126%, 
p=1.17x10-5) as they did in wild-type cells (127%, p=5.75x10-4) (Figures 3.5A and 
3.9A).  Although the lack of Cds1 does not seem to have an effect on the relative 
fork rate between untreated and 4NQO-treated cells, it does have a significant 
effect on the absolute fork rate in untreated cells.  Forks moved significantly 
slower in untreated cds1∆ cells than in wild-type cells (0.72 v 0.91 kb/min, p < 10-
9, Table 3.2).  This difference may be an indirect effect of the higher origin firing 
rate and fork density in cds1∆ cells (Table 3.1).  Several groups working in 
different systems have made the similar observation that fork rate is inversely 
correlated to the number of active forks, perhaps due to constrains on a limiting 
factor required for replication, such as the dNTP pool (Herrick and Sclavi, 2007; 
Poli et al., 2012; Herrick and Bensimon, 2008). 
 
Fork stalling in response to damage is largely checkpoint independent 
Similar to wild-type cells, we see an increase in fork stalls per kb in response to 
MMS treatment in cds1∆ but not in case of 4NQO and bleomycin (Figure 3.5B 
and 3.9B).  The fork stalls per kb shows a 1.9-fold increase in response to MMS 
as compared to untreated (p=4.42x10-10) cds1∆ cells.  Fork stalls per kb does not 
change significantly between 4NQO (1.39, p=0.987) and bleomycin (1.05, 
p=0.839) treated cds1∆ cells as compared to untreated cds1∆ (Figure 3.9B).  
 In wild-type cells, the fork stalling rate was increased 1.8-fold by 4NQO 
(p=1.2x10-4), 1.9-fold by bleomycin (p=2.26x10-7) and 3.8-fold (p=1.55x10-26) by 
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MMS treatment, relative to untreated cells (Figures 3.5C and 3.9C).  In cds1Δ 
cells, we saw a 1.7-, 2.3- and 2.8-fold increase of the stall rate in 4NQO 
(p=2.59x10-4), bleomycin (p=7.96x10-13) and MMS (p=2.93x10-15) treated cells 
respectively as compared to untreated cells (Figure 3.9C).  This increase in stall 
rate is slightly lower in MMS-treated cds1Δ cells than in wild-type cells (2.8 fold v 
3.8 fold, p=9.86x10-5), showing that there are checkpoint-dependent and -
independent contributions to stalling in response to MMS, however the difference 
in stall rates for cds1Δ treated with 4NQO (1.7 fold v 1.8 fold, p=0.746) and 
bleomycin (2.3 fold v 1.89 fold, p=0.01) as compared to wild-type are not as 
significant.  Therefore the bulk of fork stalling events appears to be checkpoint-
independent (Figure 3.9C). 
 
Delayed Inhibition of Origin Firing by MMS Correlates with Delayed 
Checkpoint Kinase Activation 
To test the possibility that the later inhibition of origin firing seen in response to 
MMS (Figure 3.3C and 3.4C) is due to delayed checkpoint activation, and to 
confirm that the doses of the various damaging agents we use cause comparable 
checkpoint activation, we assayed activation of the Cds1 S-phase checkpoint 
kinase in response to MMS, 4NQO and bleomycin.  Cells with an HA-tagged 
Cds1 were synchronized in G1 and released into DNA damage (Figure 3.10).   
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Figure 3.10 S phase progression of time-courses used for kinase activity 
measurement 
 
Figure 3.10 S phase progression of time-courses used for kinase activity 
measurement. cds1-HA (yFS988) cells were synchronized in G1 phase using 
cdc10-M17 temperature sensitive allele followed by elutriation. Elutriated G1 cells 
were released into permissive temperature untreated or treated with 3.5 mM 
MMS or 1 µM 4NQO or 16.5 µM Bleomycin. S phase progression was followed 
by taking samples for FACS. 
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Cells were harvested throughout S phase and Cds1 was immunopurified and 
split into two portions. One-half was used to estimate the amount of Cds1 pulled 
down by western blot and the second half was used to perform in vitro kinase 
assays. Kinase assay reactions were run on SDS-PAGE gel normalized to the 
amount of pull down in each lane (Figure 3.11). Average kinetics of kinase 
activity from all time courses is shown in Fig 3.11A and results from individual 
time courses are shown in Fig 3.11B (Figure 3.11A and 3.11B). We observe a 
significant and reproducible delay of Cds1 activation in response to MMS, 
relative to both 4NQO and bleomycin (Figure 3.11A).  These results are 
consistent with MMS taking longer to disrupt a sufficient number of replication 
forks to trigger a robust checkpoint response. 
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Figure 3.11: Delayed Inhibition of Origin Firing by MMS Correlates with 
Delayed Checkpoint Kinase Activation. 
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Figure 3.11: Delayed Inhibition of Origin Firing by MMS Correlates with 
Delayed Checkpoint Kinase Activation. (A) Wild-type cells with an HA-tagged 
Cds1 (yFS988) were G1 synchronized, released into S phase is the presence of 
1µM 4NQO, 16.5 µM bleomycin or 3.5 mM MMS, harvested at the indicated 
times and processed for Cds1 IP kinase assays.  Average signal normalized to 
the 4NQO 90-minute time point is plotted ± standard error of the mean. (B) 
Kinase assay to measure Cds1 activation in 5 time courses. For each time 
course, Cds1 western was done to estimate the amount of Cds1 pulled down in 
each condition. Kinase assay reactions were run normalized to the amount of 
Cds1 pull down. Signal from each lane of the kinase assay gel was normalized to 
the asynchronous MMS sample to get the normalized kinase activity. 
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Accumulation of RPA foci in response to 4NQO and MMS 
To investigate the relationship between the fork stalling that we measured by 
DNA combing and the fate of forks in living cells, we visualized replication protein 
A (RPA)-GFP foci, which mark the accumulation of single-stranded DNA 
(ssDNA), in cells treated with MMS or 4NQO.  Because RPA-coated single-
stranded DNA is a trigger for the activation of the intra-S checkpoint (Zou and 
Elledge, 2003; Cimprich and Cortez, 2008; Byun et al., 2005; Xu et al., 2008; Wu 
et al., 2005), we hypothesized that stalls that accumulate substantial amounts of 
RPA are likely to correlate with checkpoint activation, but that stalls that lead to 
less RPA accumulation may be checkpoint silent. 
We analyzed 100 cells for each sample and sorted them into three 
categories based on the intensity and number of foci: strong foci, weak foci or no 
foci (see Methods for details).  21% of untreated wild-type cells have some foci, 
consistent with previous reports (Sabatinos and Forsburg, 2015), but the majority 
of these are weak foci, consistent with the hypothesis that weak foci do not 
activate the checkpoint (Figure 3.12A).  In the presence of damage, we saw 
distinctly different responses to MMS and 4NQO.  In the presence of MMS, 36% 
of cells had strong foci (Figure 3.12A).  Since all MMS-treated cells have stalled 
forks (Table 3.3), we conclude that only a minority of MMS-induced stalls 
accumulate substantial ssDNA.  On the contrary, essentially all 4NQO-treated 
cells had strong foci, suggesting a qualitatively different nature of 4NQO-induced 
fork stalls, in which the majority of 4NQO-induced lesions accumulated 
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substantial ssDNA (Figure 3.12A).  As previously reported (Sabatinos et al., 
2012), RPA did not accumulate at HU-stalled forks in checkpoint-proficient cells. 
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Figure 3.12: Accumulation of RPA foci in response to 4NQO and MMS. 
 
Figure 3.12: Accumulation of RPA foci in response to 4NQO and MMS. (A) 
Percentage of cells with RPA foci in each sample with the numbers on the bars 
indicating the percentage of cells with strong foci.  Wild-type (yFS956) and cds1Δ 
(yFS957) cells were synchronized and released into S phase in the presence of 
3.5 mM MMS,1 µM 4NQO or 12 mM HU or left untreated.  Samples were 
collected for microscopy at 100 minutes after release.  Cells were fixed and 
stained with DAPI and imaged in the DIC, GFP and DAPI channels.  For each 
sample 100 cells were blinded and scored independently by two individuals.  (B) 
Representative images for all samples quantified in (A). 
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Table 3.3 Summary of all the combing datasets with the fork stall rate for 
each sample.
 
  
Stalling Stalls per Mb
Strain no. Expt. Dataset No. Drug Rate of total DNA
yFS940 WT WT1-N Untreated 0.16 2.451
yFS940 WT WT1-N 4NQO 0.28 2.988
yFS940 WT WT2-M Untreated 0.13 2.239
yFS940 WT WT2-M MMS 0.41 9.165
yFS940 WT WT3-M Untreated 0.09 3.099
yFS940 WT WT3-M MMS 0.25 6.762
yFS940 WT WT4-M Untreated 0.14 3.308
yFS940 WT WT4-M MMS 0.24 6.027
yFS940 WT WT5-M Untreated 0.15 3.254
yFS940 WT WT5-M MMS 0.30 9.959
yFS940 WT WT6-M Untreated 0.12 3.079
yFS940 WT WT6-M MMS 0.34 8.543
yFS940 WT WT7-N Untreated 0.26 6.209
yFS940 WT WT7-N 4NQO 0.30 4.282
yFS940 WT WT8-B Untreated 0.26 5.92
yFS940 WT WT8-B Bleomycin 0.31 6.529
yFS940 WT WT9-B Untreated 0.23 10.75
yFS940 WT WT9-B Bleomycin 0.33 8.471
yFS941 cds1 cds1-1-N Untreated 0.12 3.795
yFS941 cds1 cds1-1-N 4NQO 0.23 5.916
yFS941 cds1 cds1-2-M Untreated 0.07 2.821
yFS941 cds1 cds1-2-M MMS 0.23 8.482
yFS941 cds1 cds1-3-M Untreated 0.11 3.571
yFS941 cds1 cds1-3-M MMS 0.15 6.564
yFS941 cds1 cds1-4-M Untreated 0.14 4.27
yFS941 cds1 cds1-4-M MMS 0.17 6.644
yFS941 cds1 cds1-5-N Untreated 0.25 11.443
yFS941 cds1 cds1-5-N 4NQO 0.26 7.638
yFS941 cds1 cds1-6-B Untreated 0.23 13.266
yFS941 cds1 cds1-6-B Bleomycin 0.38 18.358
yFS941 cds1 cds1-7-B Untreated 0.32 15.906
yFS941 cds1 cds1-7-B Bleomycin 0.31 11.707
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In the absence of checkpoint all treated samples displayed strong foci in 
about 90% of cells.  In particular, in MMS and HU treated cells we saw a large 
increase in the number of cells with strong foci in cds1Δ as compared to wild-
type, suggesting that in response to MMS treatment the checkpoint plays a role 
in preventing accumulation of excess ssDNA at stalled forks, as it does in HU 
(Sogo et al., 2002; Sabatinos et al., 2012) (Figure 3.12A). 
 
Discussion 
The regulation of DNA replication in response to DNA damage involves both 
inhibition of origin firing and reduction of fork speed, but relative contributions of 
the two effects have been unclear.  Furthermore, although genetic evidence has 
suggested that the checkpoint regulation of fork progression is critical for 
genomic stability, it has been unclear if the checkpoint regulates fork speed, per 
se, and, if so, whether the regulation is at a global or local level (Seiler et al., 
2007; Unsal-Kaçmaz et al., 2007; Wang et al., 2004; Szyjka et al., 2008; Iyer and 
Rhind, 2013).  One of the reasons that these questions have persisted is that 
bulk methods, such as gel- or sequence-based approaches, provide an average 
profile of checkpoint regulation of origins and forks in response to damage and 
often convolve origin and fork dynamics.  We have used DNA combing in fission 
yeast to systematically look at the effect of the checkpoint on individual origins 
and forks at a global scale and hence to capture the heterogeneity in response to 
damage.  To understand the behavior of the checkpoint at a global and local 
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scale we have used three different types of lesion inducing agents at vastly 
differing concentrations—3.5mM (0.03%) for MMS, 1µM for 4NQO and 16.5 µM 
bleomycin—which thus produce very different densities of lesions—1000 per Mb 
for MMS, 40 per Mb for 4NQO and 0.35 per Mb for bleomycin (Lundin et al., 
2005; Snyderwine and Bohr, 1992; Ma et al., 2008; Asaithamby and Chen, 
2009)—but nonetheless have very similar effects on bulk replication kinetics 
(Figures 3.2A and 3.16).  We find that the inhibition of origin firing is a 
checkpoint-dependent response, but one that develops more slowly in response 
to the many fork encounters with MMS than the less frequent but more severe 
fork interactions with 4NQO lesions or in response to repair of bleomycin-induced 
double-strand breaks.  The slowing of fork progression, in contrast, is checkpoint-
independent and therefore a local effect in which forks only slow when they 
encounter DNA damage (Figure 3.13).  Finally, we discover that fork stalling, an 
event in which a fork stops and does not resume for the duration of the 
experiment, plays a significant role, with as many as 50% of forks stalling in 
response to DNA damage caused by MMS. 
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Figure 3.13 Summary of results 
 
Figure 3.13 Summary of results. 4NQO causes 1 lesion every ~25 kb and 
bleomycin causes 1 DSB every ~3000 kb. Although the lesions are rare, 4NQO- 
and bleomycin-induced lesions are severe and thus lead to rapid activation of the 
checkpoint and a strong reduction in origin firing rate. MMS causes 1 lesion 
every ~ 1kb. Since the MMS-induced lesions are minor as compared to 4NQO or 
bleomycin the checkpoint activation is delayed and correspondingly there is a 
modest reduction in origin firing rate. However, since MMS-induced lesions are 
more frequent than those caused by 4NQO or bleomycin there is a reduction in 
fork rate only in response to MMS. Thus reduction in origin firing is checkpoint-
dependent while reduction in fork rate is checkpoint-independent and simply due 
to the physical presence of the lesions. 
  
4NQO - lesion every ~25 kb
Bleomycin - DSB every ~3000kb
MMS - lesion every ~ kb
checkpoint 
activity
Time --------->
origin firing fork rate
+
-
-
4NQO-induced lesion
MMS-induced lesion
reduction
  
137 
Inhibition of origin firing is a global, checkpoint-dependent response to 
interactions of forks with DNA damage 
Consistent with previous studies from S. cerevisiae (Santocanale and Diffley, 
1998) and human cells (Falck et al., 2002; Sørensen et al., 2003; Merrick et al., 
2004) reduction in origin firing in response to 4NQO, bleomycin and MMS is 
checkpoint-dependent.  By flow cytometry, 4NQO, bleomycin and MMS lead to 
similar extent of slowing, however the combing data reveals important 
differences in the regulation of origin firing in response to the two drugs.  In case 
of 4NQO reduction in origin firing is robust and immediate.  The fork density 
during the first analog, which is a proxy for origin firing occurring prior to analog 
labeling, decreases to 64% (p=1.28x10-6) in case of 4NQO and 77% (p=7.65x10-
4) in case of bleomycin, as compared to untreated cells (Figure 3.4A and 3.4B).  
Therefore, origin firing inhibition starts early in S phase in response to 4NQO 
bleomycin.  On the contrary, in the case of MMS, fork density in the first analog is 
not significantly reduced (93%, p=0.074) suggesting no significant reduction in 
origin firing during early S phase (Figure 3.4C).  Furthermore, even during the 
second analog, the fork density is 40% higher in MMS than in 4NQO (62% v. 
44%, Figure 3.4A and C).  Therefore reduction of origin firing in MMS is delayed 
and modest as compared to 4NQO. 
The disparity in origin firing inhibition response can be explained by the 
observation that a certain threshold of damage has to be met for the activation of 
the intra-S checkpoint.  A certain number of arrested forks are necessary for 
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checkpoint activation during S phase (Shimada et al., 2002).  Therefore robust 
reduction in origin firing in response to 4NQO in early S phase suggests that 
4NQO lesions, although less frequent than MMS lesion at the concentrations 
used in our studies, have more severe effects on forks and hence are more 
efficient at activating the checkpoint than MMS.  Consistent with this 
interpretation, 4NQO lesions lead to a 2.6- fold higher rate of fork stalls per lesion 
than MMS (1.3% v. 0.5%) as detected by combing.  The low density of stalls per 
lesion in response to MMS suggests that MMS takes longer to induce sufficient 
fork stalls to activate a checkpoint signal, and explains why the checkpoint mainly 
inhibits origin firing later in S phase.  Our analysis of RPA accumulation is also 
consistent with this interpretation, showing that 4NQO-induced lesions 
accumulate RPA to a much greater extent than MMS-induced lesions (Figure 
3.12). 
 
Reduction in fork rate is a local checkpoint-independent response to 
interactions of forks with DNA damage 
The fork rate in wild-type cells is reduced in response to MMS to 76% 
(p=6.14x10-38) (Figure 3.5A).  The fork rate is also reduced to 61% in cds1Δ cells 
treated with MMS (p=6.13x10-66) (Figure 3.9A) consistent with previous reports 
(Tercero and Diffley, 2001).  Thus, reduction in fork rate is checkpoint-
independent and seems to be simply due to the physical presence of the lesions.  
In fact, by combing we see a slower fork rate in response to MMS in cds1Δ cells 
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than in wild-type cells as compared to untreated (61% v. 76%, Figure 3.9A).  The 
previously discussed correlation between fork rate and fork density in 
undamaged cells notwithstanding (Herrick and Bensimon, 2008), we do not 
believe this effect in MMS-treated cds1∆ cells is an indirect consequence of the 
increased origin firing, because we do not see a similar decrease in fork rate in 
the 4NQO-treated cells, which show much greater increase in origin firing and 
fork density in cds1∆ cells relative to wild-type cells (Figures 3.9A, 3.7A and 
3.7C).  Instead, we prefer the interpretation that the checkpoint facilitates fork 
progression across a damaged template.  Recent work shows that even in the 
absence of the checkpoint, the replisome is intact at stalled forks (De Piccoli et 
al., 2012).  Therefore, it has been speculated that the checkpoint does not affect 
the stability of the replisome per se, but instead helps maintain the replisome in a 
replication competent state at sites of DNA damage (Segurado and Diffley, 
2008), a possibility supported by our data.  In contrast, previous studies have 
reported similar extent of slowing in both wild-type and the checkpoint mutants in 
response to MMS (Tercero and Diffley, 2001; Szyjka et al., 2008).  One 
explanation for the discrepancy could be that the previous methods—density 
transfer approach and BrdU-IP-seq—offer an average profile at lower resolution 
and mask the difference between wild-type and checkpoint-deficient cells. 
Reduction of fork rate in response to MMS but not to 4NQO supports the 
model that slowing of forks is simply due to a transient physical slowing of forks 
at each lesion encountered and is not due to a global checkpoint-dependent 
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effect on fork progression rates.  Consistent with this model, we do not see a 
reduction in fork rate in response to bleomycin treatment (1.06, p=0.31), which 
activates the checkpoint robustly (Figure 3.5A and 3.11).  This result is consistent 
with our previous observations that slowing is dependent on MMS dose (Willis 
and Rhind, 2009) and occurs in response to frequent UV-induced lesions, but not 
rare IR-induced double-strand breaks (Rhind and Russell, 1998).  Since the 
lesions induced by 4NQO and bleomycin are 25 and 3000 times rarer than those 
caused by MMS, the forks are less likely to encounter damage and slow down in 
4NQO-treated cells.  The corollary to this conclusion is that activation of the 
checkpoint does not slow replication forks, as demonstrated by the fact that forks 
in 4NQO- and bleomycin-treated cells fail to slow despite the strong Cds1 
activation and checkpoint-dependent inhibition of origin function. 
 
Fork stalling is a qualitatively different response to damage than fork 
slowing 
The interaction of a fork with a DNA lesion is a first step towards recognition of 
damaged template during S phase and is a critical mechanism for checkpoint 
activation (Zou and Elledge, 2003).  Activation of the intra-S checkpoint by stalled 
forks allows the cell to activate repair pathways, tolerate damage and prevent 
genomic instability (Cimprich and Cortez, 2008).  Although it is believed that forks 
can pass polymerase-blocking lesions on the leading strand using translesion 
polymerases, leading-strand repriming or recombinational lesion bypass, the role 
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of the checkpoint in such responses is unclear (Branzei and Foiani, 2009; 
Branzei and Foiani, 2005; Ulrich, 2012; Daigaku et al., 2010; Sale, 2012; Lee and 
Myung, 2008). 
Here we show that forks can bypass both MMS- and 4NQO-induced lesions 
and that the checkpoint is not required for that bypass.  However, in the case of 
MMS-induced lesion, the checkpoint seems to facilitate bypass, since forks move 
past lesions more slowly in cds1∆ cells as compared to wild-type (0.61% v. 
0.76%, Figure 3.9A).  We also show that, whereas forks can bypass most lesions 
efficiently, at a small fraction of lesions—0.5% of MMS-induced lesions, 1.3% of 
4NQO-induces lesions and 8.1% of bleomycin-induced breaks—forks stall for the 
duration of the experiment.  Given the large number of lesions throughout the 
genome, even these small numbers lead to a large number of stalled forks: 50% 
in MMS-treated cells and 25% in 4NQO- and bleomycin-treated cells. 
Fork stalling does not appear to be simply an extreme example of the 
transient fork pausing that leads to observed fork slowing.  If it were, we would 
expect to see a continuum of fork pause lengths from very short pauses to full 
stalls.  Such heterogeneity would lead to a greater variation in apparent fork 
speeds and, in particular an increase in the asymmetry of rates in fork pairs, 
neither of which we see (Figure 3.14, 3.15).   
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Figure 3.14 Fork rate distribution in MMS treated samples does not show 
wider range as compared to untreated samples. 
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Figure 3.14 Fork rate distribution in MMS treated samples does not show 
wider range as compared to untreated samples.  Fork rate distribution in wild-
type and cds1Δ cells untreated or treated with MMS from a single experiment at 
time points 1 and 3, respectively (A and C) and from two experiments at time 
points 2 and 4, respectively (B and D).  For the exact timings refer to Table 3.4.  
Each distribution of fork rate was fit to a Gaussian curve.  Mean fork rate was 
obtained from the fit. 
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Figure 3.15 Comparing fork rates of left and right fork pairs in wild-type 
(yFS940)  
 
Figure 3.15 Comparing fork rates of left and right fork pairs in wild-type (yFS940) 
does not show a greater asymmetry in treated samples as compared to an 
untreated sample. 
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Therefore, we conclude that there are two distinct possible fate for a fork that 
encounters damage.  It can pause briefly as it bypasses the lesion or it can stall 
permanently.  A permanent stall does not appear to be a catastrophic event, as a 
majority of MMS-treated cells, which all have many stalls (Table 3.3), do not have 
strong RPA foci (Figure 3.12A).  However, such stalls do appear to require the 
checkpoint to restrain ssDNA accumulation.  4NQO-induced lesions appear to 
cause more severe stalls, since 4NQO-treated cells have many more strong RPA 
foci, even though they have fewer stalls (Table 3.3 and Figure 3.12A). 
The replication fork dynamics that we observe in response to MMS- and 
4NQO-induced DNA damage demonstrate that forks interact with DNA damage 
largely in a checkpoint-independent manner.  Forks are able to bypass lesions 
that stall the replicative polymerases with only a modest reduction in speed 
(Figure 3.9A) and are no more prone to stall at lesions in the absence of 
checkpoint (Figure 3.9B and 3.9C).  However, stalled forks do appear to 
accumulate more ssDNA in the absence of the checkpoint (Figure 3.12).  These 
results suggest that the major role of the checkpoint is not to regulate the 
interaction of replication forks with DNA damage, per se, but to mitigate the 
consequences of fork stalling when forks are unable to successfully navigate 
DNA damage on their own. 
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Material and Methods 
General methods 
The following strains used in this study were created by standard methods and 
grown in YES at 25°C (Forsburg and Rhind, 2006): yFS940 (h+ leu-32 ura4-D18 
his7-366 cdc10-M17 leu1::pFS181 (leu1 adh1:hENT1) pJL218 (his7 adh1:tk)), 
yFS941 (h- leu-32 his7-366 cdc10-M17 cds1::kanMX leu1::pFS181(leu1 
adh1:hENT1) pJL218 (his7 adh1:tk)), yFS956 (h+ leu1-32 ura4-D18 cdc10-M17 
rpa1-GFP::hph-MX6), yFS957 (h+ leu1-32 ura4-D18 cdc10-M17 cds1::ura4 rpa1-
GFP::hph-MX6), yFS988 (h- leu1-32 ura4-D18 ade-? cdc10-M17 cds1-
6his2HA(int))  
S phase progression assay by flow cytometry 
Cells were synchronized in G1 phase using cdc10-M17 temperature sensitive 
allele combined with centrifugal elutriation, which selects cells that have been 
arrested in G1 for as little time as possible (Willis and Rhind, 2011).  Cells were 
grown to mid log phase at 25°C and arrested at 35°C for 2 hours followed by 
centrifugal-elutriation-based size selection at 35°C to collect cells that had most 
recently arrested in G1.  The cells were then immediately released into S phase 
by shifting them to 25°C, untreated or treated with 3.5mM MMS or 1 µM 4NQO or 
16.5 µM bleomycin.  S-phase progression was followed by flow cytometry using a 
nuclei isolation protocol, as previously described (Willis and Rhind, 2011) with 
some minor modifications (Chapter II). In case of MMS, 3.5mM or 0.03% 
concentration was used, which is the standard dose used in DNA damage field. 
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The concentration of 4NQO and bleomycin was titrated to get similar levels of 
bulk slowing as seen in case of MMS (Figure 3.16A and 3.16B). 
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Figure 3.16 Titration of 4NQO and Bleomycin   
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Figure 3.16 Titration of 4NQO and Bleomycin.  (A) Titration of 4NQO. Wild-
type (yFS940) and cds1Δ (yFS941) cells were synchronized and released into S 
phase with 3.5 mM MMS, 0.5 µM, 1 µM, 2 µM 4NQO or left untreated (B) 
Titration of Bleomycin. Wild-type (yFS940) and cds1Δ (yFS941) cells were 
synchronized and released into S phase with different concentrations of 
bleomycin 16.5 µM, 23.79 µM, 47.9 µM or left untreated. S phase progression 
was monitored by taking samples every 20 minutes for flow cytometry.  
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We have used three different drugs (3.5mM MMS, 1 µM 4NQO and 16.5 µM 
bleomycin) to create significantly differing lesion densities (of 1 every 1 kb, 25 kb 
or 3000 kb, respectively) in order to differentiate between global v. local 
regulation of forks.  Conceivably, variable lesion density could be achieved by 
just titrating one of the drugs.  However, we cannot achieve a 25-fold difference 
in lesion density (let alone a 3000-fold difference) by just titrating either drug 
alone.  In case of 4NQO, increasing dose concentration to even 2 µM 4NQO 
almost inhibits replication, while decreasing MMS dose below 3.5mM to 
0.875mM greatly reduces the effect of damage on replication kinetics (Figure 
3.16A) (Willis and Rhind, 2009). 
 
DNA Combing 
Cell labeling and plug preparation 
Cells were pulse labeled with 2 µM CldU for 5 minutes and chased with 20 µM 
IdU for 10 minutes.  For the second replicate of 4NQO dataset in wild-type and 
cds1Δ cells and all the bleomycin datasets, cells were labeled with 5 µM CldU for 
5 minutes and chased with 20 µM IdU for 10 minutes.  For MMS, experiments 
were done 5 times in wild-type cells and 3 times in cds1Δ cells; 4NQO and 
bleomycin experiments were done twice in each wild-type and cds1Δ cells.  Cells 
were pulse labeled at different time points across S phase for both wild-type and 
cds1Δ, however they gave similar results and hence have been combined and 
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represented together in the figures for simplicity.  Refer to Table 3.4 for the exact 
timing of analog labeling during S phase for the various replicates.  
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Table 3.4 Summary of all the combing datasets with the time at which 
analog was added, temperature at which Proteinase K treatment was done, 
and the pH of MES buffer used for combing. 
 
  
Time point # Time of analog pH of Proteinase K
Strain no. Expt Dataset No. Drug (see Methods) addition combing buffer  temperature
yFS940 WT WT1-N Untreated Time point 1 50 min. 6.35 50°C
yFS940 WT WT1-N 4NQO Time point 1 50 min. 6.35 50°C
yFS940 WT WT2-M Untreated Time point 1 50 min. 6.35 50°C
yFS940 WT WT2-M MMS Time point 1 50 min. 6.35 50°C
yFS940 WT WT3-M Untreated Time point 1 50 min. 6.35 37°C
yFS940 WT WT3-M MMS Time point 1 50 min. 6.35 37°C
yFS940 WT WT4-M Untreated Time point 1 50 min. 6.25 37°C
yFS940 WT WT4-M MMS Time point 1 50 min. 6.25 37°C
yFS940 WT WT5-M Untreated Time point 2 55 min. 6.25 37°C
yFS940 WT WT5-M MMS Time point 2 55 min. 6.25 37°C
yFS940 WT WT6-M Untreated Time point 2 55 min. 6.25 37°C
yFS940 WT WT6-M MMS Time point 2 55 min. 6.25 37°C
yFS940 WT WT7-N Untreated Time point 1 50 min. 6.2 50°C
yFS940 WT WT7-N 4NQO Time point 1 50 min. 6.2 50°C
yFS940 WT WT8-B Untreated Time point 1 50 min. 6.2 50°C
yFS940 WT WT8-B Bleomycin Time point 1 50 min. 6.2 50°C
yFS940 WT WT9-B Untreated Time point 1 50 min. 6.2 50°C
yFS940 WT WT9-B Bleomycin Time point 1 50 min. 6.2 50°C
yFS941 cds1 cds1-1-N Untreated Time point 1 50 min. 6.35 50°C
yFS941 cds1 cds1-1-N 4NQO Time point 1 50 min. 6.35 50°C
yFS941 cds1 cds1-2-M Untreated Time point 3 45 min. 6.25 37°C
yFS941 cds1 cds1-2-M MMS Time point 3 45 min. 6.25 37°C
yFS941 cds1 cds1-3-M Untreated Time point 4 50 min. 6.25 37°C
yFS941 cds1 cds1-3-M MMS Time point 4 55 min. 6.25 37°C
yFS941 cds1 cds1-4-M Untreated Time point 4 50 min. 6.25 37°C
yFS941 cds1 cds1-4-M MMS Time point 4 55 min. 6.25 37°C
yFS941 cds1 cds1-5-N Untreated Time point 1 50 min. 6.2 50°C
yFS941 cds1 cds1-5-N 4NQO Time point 1 50 min. 6.2 50°C
yFS941 cds1 cds1-6-B Untreated Time point 1 50 min. 6.2 50°C
yFS941 cds1 cds1-6-B Bleomycin Time point 1 50 min. 6.2 50°C
yFS941 cds1 cds1-7-B Untreated Time point 1 50 min. 6.2 50°C
yFS941 cds1 cds1-7-B Bleomycin Time point 1 50 min. 6.2 50°C
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Analog labeling was stopped by adding sodium azide to a final concentration of 
0.1% and cooling the cells on ice.  10 O.D. of cells were pelleted for combing, 
frozen in liquid N2 and stored at -80°C.  Cells were processed as previously 
described with minor modifications (Chapter II) (Iyer et al., in press).  For MMS 
experiments the plugs were digested with proteinase K at 37°C instead of 50°C 
to facilitate isolation of longer fibers based on the observation that MMS creates 
heat-labile DNA damage (Table 3.4)(Lundin et al., 2005).  Higher pH of MES 
(6.25 or 6.35) was used for combing instead of pH 5.4 to isolate longer fibers 
(Table 3.4) (Kaykov and Nurse, 2015).  Combing and immuno-staining of 
samples were done as previously described (Chapter II) (Iyer et al., in press).  
For the second replicate of 4NQO dataset in wild-type and cds1Δ cells, and for 
all the bleomycin datasets, data collection was done in collaboration with 
Genomic Vision, France. Data collection and analysis was done as described in 
detail in Chapter II. For distribution of fiber lengths refer to Figure 3.17 and Table 
3.5. 
 
Figure 3.17 Fiber length distribution 
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Figure 3.17 Fiber length distribution.  Length of fibers from wild-type 4NQO 
(A) and MMS (B) samples from a single experiment.  Approximately 25 Mb of 
total DNA was collected for each sample (Table 3.5). 
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Table 3.5 Summary of all combing datasets with total DNA measured, 
maximum, minimum, median, and standard deviation of fiber lengths for 
each dataset. 
 
 
  
Total Fiber Max. fiber Min. fiber Median fiber Standard
Strain no. Expt Dataset No. Drug Length (Mb) Length (kb) Length (kb) Length (kb) Dev. (kb)
yFS940 WT WT1-N Untreated 25.11 744.59 234.61 375.21 97.02
yFS940 WT WT1-N 4NQO 25.27 710.73 197.34 355.49 100.15
yFS940 WT WT2-M Untreated 25.53 958.11 292.80 504.67 148.24
yFS940 WT WT2-M MMS 25.23 490.24 186.47 239.17 52.55
yFS940 WT WT3-M Untreated 9.81 1220.10 295.16 383.56 198.90
yFS940 WT WT3-M MMS 9.34 686.20 342.61 426.18 112.81
yFS940 WT WT4-M Untreated 25.09 1002.70 391.83 578.93 140.03
yFS940 WT WT4-M MMS 25.24 709.70 320.85 409.88 108.80
yFS940 WT WT5-M Untreated 25.43 1041.07 362.80 543.91 156.67
yFS940 WT WT5-M MMS 12.03 489.21 171.04 262.82 69.55
yFS940 WT WT6-M Untreated 25.27 1161.17 335.90 463.26 141.31
yFS940 WT WT6-M MMS 24.94 656.86 251.81 339.72 85.47
yFS940 WT WT7-N Untreated 24.84 1293.50 416.02 636.30 186.11
yFS940 WT WT7-N 4NQO 24.73 1288.80 165.90 485.87 231.67
yFS940 WT WT8-B Untreated 24.58 1360.30 363.55 580.56 201.69
yFS940 WT WT8-B Bleomycin 25.08 828.12 206.87 437.54 120.18
yFS940 WT WT9-B Untreated 25.23 1521.10 429.79 658.65 257.08
yFS940 WT WT9-B Bleomycin 24.42 1004.30 291.86 435.38 147.10
yFS941 cds1 cds1-1-N Untreated 25.03 585.50 203.60 308.20 76.09
yFS941 cds1 cds1-1-N 4NQO 25.27 469.64 170.98 261.11 63.08
yFS941 cds1 cds1-2-M Untreated 25.08 1426.07 403.80 588.80 210.95
yFS941 cds1 cds1-2-M MMS 24.99 715.53 248.00 354.10 101.79
yFS941 cds1 cds1-3-M Untreated 25.18 1474.83 300.62 478.76 172.51
yFS941 cds1 cds1-3-M MMS 23.47 450.52 176.62 230.62 54.79
yFS941 cds1 cds1-4-M Untreated 25.35 1607.26 413.59 497.38 189.87
yFS941 cds1 cds1-4-M MMS 23.42 509.38 208.27 287.28 66.72
yFS941 cds1 cds1-5-N Untreated 24.72 1027.80 330.62 549.59 160.81
yFS941 cds1 cds1-5-N 4NQO 24.3 1225.40 308.95 510.19 225.41
yFS941 cds1 cds1-6-B Untreated 24.73 2139.40 393.45 720.47 401.47
yFS941 cds1 cds1-6-B Bleomycin 24.08 839.32 124.53 331.86 147.39
yFS941 cds1 cds1-7-B Untreated 25.25 1983.1 237.1 578.69 337.99
yFS941 cds1 cds1-7-B Bleomycin 22.94 588.37 138.17 327.4 100.25
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Variation in absolute fork rate values 
We note that the fork rate for wild-type untreated samples varies across different 
replicates (0.65±0.4 kb/min for the first three replicates v. 0.91±0.2 kb/min for the 
last three replicates, Table 3.2).  We ascribe this variation to the pH of MES 
(6.35) used for combing the first three replicates, which we used to facilitate 
isolation of longer fibers.  We have concluded that the stretching factor estimated 
from lambda DNA at 6.35 is not reliable.  Hence we switched to a lower pH of 
6.25 for further combing experiments.  We believe that the values obtained at pH 
6.25 are more reliable, since we have obtained 0.9 kb/min fork rate value from 
wild-type untreated samples stretched at pH 5.4, which is close to the standard 
pH used in most combing experiments (Figure 3.18) (Michalet et al., 1997; 
Allemand et al., 1997; Herrick and Bensimon, 1999b; Bianco et al., 2012).  
Despite the variation in the absolute fork rate values the relative trend observed 
between treated and untreated sample holds true across both pH.  For example 
consider experiments WT3-M and WT4-M, which are similar except for the pH of 
the combing solution used (Table 3.2).  The absolute value of wild-type untreated 
fork rate differs between the experiments (0.60 kb/min v. 0.92 kb/min, Table 3.2).  
However the change in fork rate in treated v. untreated sample is 0.72 for both 
the experiments. 
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Figure 3.18 Wild-type fork rate distribution in untreated sample combed 
using MES buffer pH 5.4 
 
 
Figure 3.18 Fork rate distribution in wild-type untreated sample combed 
using MES buffer pH 5.4.  Fork rate value was estimated from the second 
analog track continuing from the first analog as explained in Chapter II. 
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High fork stall rate in untreated sample 
The fork stall rate in untreated wild-type and cds1Δ cells is about 15% (Table 
3.3).  This result reveals an unexpectedly high rate of spontaneous fork stalling.  
To exclude the possibility that the high stall rate is a result of previously identified 
combing artifacts (Demczuk and Norio, 2009), we re-analyzed our dataset, 
excluding the labeled events occurring at the ends of the fibers, where such 
artifacts can occur.  However the stall rate estimations remain unchanged after 
re-analysis (Figure 3.19).  We cannot rule out the possibility that the observed 
fork stall rate is increased by the thymidine analogs used to label the DNA.  
Nonetheless, since we normalize our quantitation of fork-stalling to an untreated 
sample, our results are internally controlled.  Furthermore, double-labeled 
combing studies done in mammalian cells show similar rate of fork stalling in the 
untreated sample (Merav Socolovsky, personal communication).  
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Figure 3.19 Re-estimation of stall rate accounting for potential artifacts 
yields minimal variation 
 
 
Figure 3.19 Re-estimation of stall rate accounting for potential artifacts 
yields minimal variation.  We re-analyzed the fibers considering stretching 
artifacts, which may lead to incorrect interpretation of analog incorporation 
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patterns (Demczuk and Norio, 2009).  Ends of the fiber are most susceptible to 
such stretching artifacts and hence we ignored the labeled events occurring at 
the ends of the fiber and re-calculated the stall rate.  However we do not see a 
significant change between the stall rate calculated from the whole fiber or after 
ignoring the labeled events occurring at the ends of the fiber.  
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Cds1 kinase assay 
To estimate the Cds1 kinase activity S phase progression assay was done in 
triplicate as described earlier in response to 3.5 mM MMS, 1 µM 4NQO, and 16.5 
µM bleomycin in yFS988 strain.  Approximately 10 OD of cells were pelleted at 
10, 20, 30, 40, 50, and 90 minutes in S phase for measuring Cds1 activity.  Cells 
were lysed by bead beating in 400µl ice-cold lysis buffer (150 mM NaCl, 50 mM 
Tris pH 8.0, 5 mM EDTA pH 8.0, 10% Glycerol, 1%IGEPAL CA630, 50 mM NaF, 
freshly added 1 mM Na3VO4 and protease inhibitor cocktail (Sigma 
11836170001)) for 15 minutes at 4°C.  Lysate was cleared by centrifuging at 
1000g, 5 minutes and combined with anti-HA Ab conjugated agarose beads 
(Pierce 26181) and incubated with constant mixing at 4°C for 4 hours.  Beads 
were washed twice with lysis buffer and twice with kinase buffer (5 mM HEPES 
pH 7.5, 37.5 mM KCl, 2.5 mM MgCl2, 1 mM DTT).  The sample was then split 
into two portions, one was used to estimate the amount of Cds1 pulled down by 
western blot and the other was processed to estimate the kinase activity.  For 
western, the Cds1 was eluted off the beads by boiling in 2x SDS PAGE gel 
loading dye.  Cds1 was detected by using rabbit anti-Cds1 Ab at 1:1000 and anti-
rabbit HRP conjugated secondary Ab at 1:10000.  For kinase assay, the beads 
were re-suspended in 10 µl 2x kinase buffer, 0.5 µl 10 µCi/µl γP32-ATP, 2 µl 1 
mM ATP, 5 µl 1 mg/ml myelin basic protein and incubated at 30°C for 15 
minutes.  The reaction was quenched by adding SDS PAGE gel loading buffer 
and boiling at 95°C for 5 minutes.  Kinase reactions were run on a 15% gel 
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normalized to the amount of Cds1 pulled down in each lane.  The gel was dried 
under vacuum and exposed to phosphorimager screen for 48 hours.  The screen 
was scanned on Typhoon FLA-9000 and quantitated using ImageJ (Schneider et 
al., 2012).  Asynchronous culture of yFS988 treated with 3.5 mM MMS for 4 
hours was used as a control to normalize across gels and blots.  
 
RPA foci estimation 
In order to estimate RPA foci formation due to damage, S-phase progression 
assays were performed as described above with strains expressing GFP-tagged 
Rpa1 (yFS956 and yFS957).  Cells were collected at 100 minutes after release 
from untreated, 3.5 mM MMS, 1 µM 4NQO and 12 mM HU treated cultures and 
fixed in ice-cold 100% methanol and stored at -20°C for at least 20 minutes.  
Fixed cells were washed thrice with 1x PBS and re-suspended in 10 µl 
Vectashield mounting medium with DAPI at 2 µg/ml.  Cells were visualized using 
a Zeiss Axioskop 2 Plus epifluorescence microscope with 100X Plan-
NEOFLUAR oil objective and imaged using SPOT monochrome cooled-CCD 
camera.  Images were analyzed using ImageJ and Microsoft Excel.  Image of 
each nuclei in the GFP channel was cut and pasted into cells in an excel file.  
The nuclei were then blinded, randomly sorted and scored independently by two 
individuals.  100 nuclei were analyzed for each sample.  The nuclei were scored 
into three categories: uncertain, foci negative, and foci positive.  Foci positive 
cells were further characterized into nuclei with few weak foci (1 or 2) or 
containing many weak foci, strong foci or a combination of strong and weak foci. 
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Chapter IV  
Aneuploidy causes replication defects 
 
(This work was done in collaboration with Angelika Amon’s lab at MIT. The 
experiments were designed by AA, SS and DI. The cells were prepared by SS. 
Sample processing, combing and analysis was performed by DI. This work is 
published as part of a larger study(Santaguida et al., 2017))  
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Introduction 
What is aneuploidy? 
The term ‘ploidy’ refers to the chromosomal content of a cell. Most mammalian 
cells tend to have two copies of each set of chromosome, a condition referred to 
as diploidy (Orr et al., 2015). Although diploid is the preferred state in mammals, 
other species such as plants and amphibians tend to have more than two sets of 
chromosomes (polyploidy) with stable genomes (Comai, 2005). In fact, being 
polyploid confers adaptive advantages to the species (Paquin and Adams, 1983; 
Zerulla and Soppa, 2014; Selmecki et al., 2015). Thus having multiple (more than 
2) sets of chromosomes is well tolerated, so long as all the genes on different 
chromosomes are equally represented. This condition of having an exact multiple 
of the haploid chromosomal content is called euploidy (Comai, 2005; Orr et al., 
2015; Siegel and Amon, 2012). In contrast, aneuploidy is a condition of having an 
unbalanced karyotype involving loss or gain of whole chromosomes or parts of a 
chromosome. In humans, having one chromosome less (monosomy) or extra 
(trisomy) is mostly lethal. In the few cases where trisomy is tolerated (trisomy 13, 
18, 21) the individuals tend to have severe developmental abnormalities. Thus 
having a balanced number of chromosomes is essential for the survival and 
fitness of the organism (Hassold and Hunt, 2001; Nagaoka et al., 2012; Potapova 
et al., 2013; Orr et al., 2015). Consistently, aneuploidy is rare amongst somatic 
tissues (Knouse et al., 2014). 
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Aneuploidy and cancer 
Although aneuploidy is mostly detrimental for cell survival, oddly it is also a 
hallmark of a disease involving unrestrained growth - cancer, with 90% of solid 
tumors and 50% of blood cancers being aneuploid (Holland and Cleveland, 2012; 
Mitelman et al., 2017). Chromosomal instability associated with aneuploidy 
promotes genomic instability and thus leads to heterogeneity amongst the 
population of tumor cells, which in turn provides genetic diversity, from which 
cells refractory to treatment can be selected. Aneuploidy in tumors is linked to 
metastasis and poor prognosis (Gordon et al., 2012; McGranahan et al., 2012; 
Gerlinger and Swanton, 2010; Lee et al., 2011; Walther et al., 2008). Thus to 
understand the effects of aneuploidy on cell behavior, we looked at the 
immediate consequences of mis-segregation of chromosomes. The goal of this 
project is to understand how mis-segregation and the resulting aneuploidy affect 
the progression of cells through the subsequent phases of cell cycle. 
 
Generation of aneuploid cells 
A common method used to generate aneuploid cells involves destabilizing the 
mitotic spindle with small molecule spindle poisons such as colchicine, taxol, 
nocodazole or monastrol, which is an inhibitor of Eg5, a kinesin required for bi-
polar spindle establishment (Lampson and Kapoor, 2006). Destabilization of the 
spindle leads to activation of the spindle assembly checkpoint (SAC), which 
leads to mitotic arrest. The SAC is a quality control mechanism, which ensures 
that each kinetochore from a pair of sister chromatids are attached to microtubule 
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spindles originating from the opposite poles, a phenomenon called as bi-
orientation. Bi-orientation of sister chromatids ensures that during cell division, 
each daughter cell receives an equal complement set of chromosomes 
(Musacchio and Salmon, 2007). Perturbation of the mitotic spindle with poisons 
and subsequent mitotic delay favor merotelic kinetochore attachment, wherein a 
single kinetochore is attached to microtubules originating from both the poles 
(Cimini et al., 1999; Cimini et al., 2001; Knowlton et al., 2006). Mis-attachment of 
kinetochores hampers the fidelity of chromosome segregation leading to lagging 
chromosomes during anaphase culminating in generation of aneuploid daughter 
cells (Thompson and Compton, 2008).  
Recently, studies have found that aneuploidy induced by using spindle 
poisons leads to p53 activation and subsequent arrest in G1 phase and thus 
making it difficult to study cell cycle progression in aneuploid cells (Thompson 
and Compton, 2010; Hinchcliffe et al., 2016; Li et al., 2010). Interestingly, Uetake 
and Sluder found that the p53-dependent arrest is linked to the duration spent in 
pro-metaphase rather than mis-segregation of chromosomes. If cells spent more 
than 1.5 hours in pro-metaphase then they arrested in the subsequent G1 phase 
regardless of whether chromosomes mis-segregated or not (Uetake and Sluder, 
2010). Thus aneuploidy itself does not activate p53, but rather prolonged 
duration of arrest in pro-metaphase does (Uetake and Sluder, 2010; Orth et al., 
2012; Hayashi et al., 2012).  
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With this result in mind Santaguida et al., generated aneuploid cells by using 
the exact opposite approach, that is by inhibiting SAC rather than activating it 
(Santaguida et al., 2010; Santaguida et al., 2015; Hewitt et al., 2010; Colombo et 
al., 2010). Since SAC ensures bi-orientation and proper segregation of 
chromosomes, its inhibition allows for mitosis to occur even when the 
chromosomes are mis-attached thus generating aneuploid daughter cells. 
Aneuploid cells are generated by faster progression through mitosis in the 
presence of mis-attached chromosomes rather than a delay and thus avoid G1 
arrest. By generating aneuploid cells by inhibiting SAC, we could look at how 
aneuploidy affects the subsequent progression through cell cycle. Specifically we 
studied how subsequent S phase progression is affected by DNA combing 
(Santaguida et al., 2017). 
 
Results 
Examining S phase by DNA combing in human aneuploid cells 
To study the effect of aneuploidy on S phase progression we induced mis-
segregation in non-transformed human retinal pigment epithelial cells 
immortalized with human telomerase reverse transcriptase  (RPE-1 hTERT).  
The cells were treated for 24 hours with vehicle control or 2 µM AZ3146, an 
inhibitor of Mps1, to generate aneuploidy (Hewitt et al., 2010). Mps1 is a kinase 
that localizes to the kinetochores and is necessary for activation and 
maintenance of the SAC (Liu and Winey, 2012). Inhibition of Mps1 leads to mis-
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segregation of a few chromosomes in a majority of cells (Santaguida et al., 
2015). Each chromosome was found to be mis-segregated in 6-8% of mitoses 
(Santaguida et al., 2015; Santaguida et al., 2017). Following mis-segregation the 
cells were synchronized in G1 phase using mimosine and released into S phase. 
3 hours into S phase the cells were pulsed with 25 µM IdU for 1 hr. followed by 
200 µM CldU for 1 hr. The cells were processed for combing as before except 
the cell wall digestion step was skipped. IdU was visualized using green antibody 
and CldU was visualized using red antibody. Figure 4.1 shows a representative 
fiber from each sample with an interpretation for each labeled track below it. The 
combing experiment was done twice. The second replicate was done in 
collaboration with Genomic Vision, France. For euploid cells we collected a total 
of 47 and 54 Mb of DNA and for the aneuploid cells we collected 33 and 38 Mb of 
DNA in the first and the second replicate respectively. 
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Figure 4.1 Representative fibers from euploid and aneuploid cells. 
 
 
 
Figure 4.1 Representative fibers from euploid and aneuploid cells. RPE-1 
hTERT cells were treated with Mps1 inhibitor to induce aneuploidy. Following 
mis-segregation cells were synchronized in G1 phase and pulsed with IdU and 
CldU in the subsequent S phase. Figure 4.1 shows a fiber from each euploid and 
aneuploid cells with IdU labeled in green and CldU in red.   
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Aneuploidy causes an increase in origin firing rate 
We first examined the effect of aneuploidy on origin firing. As explained in greater 
detail in Chapter II we calculated origin firing rate and fork density for both 
analogs combined as well as separately for each analog per fiber per kb. We 
normalized the values obtained from the aneuploid cells to that from the euploid 
cells. We find that the total origin firing rate is higher by 2-fold (p=1.5x10-34) in the 
aneuploid cells as compared to euploid cells (Figure 4.2A). Analog specific origin 
firing estimations also show 2- and 1.5- fold higher origin firing during first 
(p=2.27x10-36) and second (p=0.03) analog in aneuploid cells as compared to 
euploid cells (Figure 4.2A). It should be noted that the increase in origin density 
seen in the second analog in aneuploid cells as compared to euploid cells is not 
reflected in the total origin density because, there were far fewer second analog 
origins than the first analog origins in the majority of fibers. Fork density also 
shows a similar pattern. We see a 1.7-fold increase in total (p=7.46x10-13) as well 
as first (p=1.22x10-19) and second (p=4.71x10-11) analog specific fork densities in 
aneuploid cells as compared to euploid cells (Figure 4.2A). 
 
 
 
Figure 4.2 Aneuploidy causes replication defects. 
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Figure 4.2 Aneuploidy causes replication defects. (A) Aneuploidy causes an 
increase in origin firing rate. Total and analog specific origin firing rate and fork 
densities were estimated for aneuploid cells from 2 replicates and normalized to 
that from the euploid cells. (B) Aneuploidy causes reduction in fork rate and an 
increase in fork stalls and fork stalling rate. Fork rate from all forks, or IdU forks, 
or CldU forks, fork stalls, and fork stall rate were estimated for aneuploid cells 
from 2 replicates and normalized to that from the euploid cells. See Chapter II for 
calculations. 
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Aneuploidy causes reduction in fork rate and an increase in fork stalls 
We calculated fork rate values from both IdU (green [G]) and CldU (red [R]) 
tracks. For IdU, fork rate values were obtained from RG and GR elongating forks 
as well as GRG termination events. For CldU, fork rates were obtained from RG, 
GR, and RGR (origins). Overall we see a reduction of 29% in fork rates 
(p=2.21x10-16) from aneuploid cells as compared to euploid cells (Figure 4.2B). 
Fork rate during IdU (p=4.46x10-10) and CldU (p=2.89x10-8) also show 29 and 
28% reduction respectively in aneuploid as compared to euploid cells (Figure 
4.2B). 
Next, we calculated fork stalls as well as fork stall rate per fiber per kb. We 
see a 2.35-fold increase (p=2.93x10-33) in absolute number of fork stalls per kb in 
aneuploid cells as compared to euploid cells (Figure 4.2B). Since the origin firing 
rate is higher in aneuploid cells as compared to euploid population, we 
normalized the absolute number of stalls to the number of ongoing forks to get 
the fork stall rate. We see a 1.4-fold increase (p=7.71x10-23) in fork stall rate in 
aneuploid cells as compared to euploid cells (Figure 4.2B). 
 
Discussion 
In this study we have looked at the immediate consequences of aneuploidy on S 
phase progression. Although aneuploidy is frequently associated with genomic 
instability and poor outcomes in tumor therapy, the exact mechanism by which 
aneuploidy induces genomic instability or whether it is merely a consequence of 
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genomic instability has been difficult to tease apart (Storchova and Pellman, 
2004; Santaguida and Amon, 2015; Gordon et al., 2012; Weaver and Cleveland, 
2006; Siegel and Amon, 2012). To understand the immediate consequences of 
aneuploidy on cell cycle progression we took a novel approach to generate 
aneuploid cells. Briefly, we used an SAC inhibitor rather than an activator to 
generate aneuploid cells, which usually triggers a mitotic delay. The absence of 
mitotic delay prevents p53 dependent G1 arrest, allowing us to study the 
immediate consequences of aneuploidy on cell cycle progression.  
By DNA combing we find that there is a discernable effect on the subsequent 
S phase progression following mis-segregation in mitosis. Fork progression is 
slowed and origin firing rate increased in aneuploid cells as compared to euploid 
cells. The reduced fork progression may prevent passive replication of less 
efficient origins and thus increase the probability of them firing leading to 
increased origin firing rate in aneuploid cells (Yekezare et al., 2013; Rhind et al., 
2010). Reduction in fork rate and increase in origin firing in response to 
aneuploidy was recently also reported in human pluripotent stem cells (Lamm et 
al., 2016). Thus it appears to be a conserved response to aneuploidy across cell 
types. Finally we also see an increase in fork stalling events in aneuploid cells as 
compared to euploid cells.  
 
What is the source of replication defects in aneuploid cells? 
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A recent study has found evidence that addition of even a single extra 
chromosome causes a reduction in the levels of MCM2, 3, 7 subunits. 
Specifically, less MCM complexes were loaded on the chromatin in aneuploid 
cells as compared to euploid cells (Passerini et al., 2016). Several studies have 
shown that reduced MCM levels causes replication defects (Ge and Blow, 2010; 
Ge et al., 2007; Woodward et al., 2006). Decrease in MCM levels was found to 
be consistent, regardless of which extra copy of chromosome was added 
(chromosome 3, 5, 8, 12 or 21) to HCT116 or RPE-1 cells. Finally Passerini et 
al., were able to mitigate the accumulation of DNA damage markers such as 
53BP1 foci by over-expressing MCM7 subunit in aneuploid cells (Passerini et al., 
2016). Thus, perturbations of replication components could be a source of 
replication stress in aneuploid cells. 
Based on the combing results Santaguida et al. carried out further 
investigation of immediate effects of aneuploidy on cell cycle progression 
(Santaguida et al., 2017). They found that replication defects during S phase 
furthers genomic instability as assessed by accumulation of 53BP1 and γ-H2AX 
foci, and DNA bridges during the subsequent anaphase. Mitosis of such 
aneuploid cells further exacerbates the genome imbalance with a larger 
percentage of cells harboring complex karyotypes during the second round of cell 
division.  Thus mis-segregation and generation of aneuploidy during one round of 
mitosis leads to replication stress and exacerbates the chromosomal imbalance 
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during the second round of mitosis leading to generation of cells with complex 
karyotypes. 
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Chapter V 
 
Discussion 
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Discussion 
 
The intra-S checkpoint plays a critical role in protecting the integrity of genome. 
ATR deletion is lethal and hypomorphic mutations lead to severe developmental 
abnormalities, resulting in Seckel Syndrome in humans (Brown and Baltimore, 
2000; O'Driscoll et al., 2003). Depletion of ATR in adult mice leads to replication 
stress, genomic instability and premature onset of age-related degeneration of 
tissues, emphasizing the importance of the intra-S checkpoint (Ruzankina et al., 
2007; Murga et al., 2009). Thus, understanding the role of intra-S checkpoint is 
critical.  
The overall goal of this project is to understand the regulation of forks by the 
checkpoint in response to DNA damage. Several studies have hinted that 
regulation of forks is the most crucial function of intra-S checkpoint in response to 
damage (Chapter I). However the role of the checkpoint at replication forks 
encountering damage has remained largely elusive. A major hurdle to studying 
fork progression has been lack of techniques to measure fork rates at single-
molecule resolution on a global scale. To address this issue we implemented 
sequential analog labeling in fission yeast to measure replication fork rates by 
DNA combing (Chapter II). We also developed a detailed analysis of every 
permutation of labeled track found in a tri-color combing dataset. This analysis 
has helped us rigorously identify and measure fork stall rates as a distinct 
response from fork slowing in response to DNA damage (Chapter III). Further, by 
combing we also saw a distinct response to DNA damage caused by different 
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kinds of lesions at different densities. To summarize, inhibition of origin firing is 
checkpoint dependent, while reduction in fork rate is checkpoint independent. 
However the checkpoint may facilitate progression of forks through a damaged 
template. 
Finally we also looked at how aneuploidy affects S phase progression in 
collaboration with Angelika Amon’s lab at MIT. We find that aneuploidy leads to 
decrease in fork rate, increase in origin firing and fork stall rate. 
In this chapter, I’ll discuss the implications of our results (Chapter III) and 
avenues for future research.  
 
Fork slowing is checkpoint independent 
Although several different groups have reported slowing of forks in response to 
DNA damage, whether the response is checkpoint dependent or not has been 
controversial (Tercero and Diffley, 2001; Szyjka et al., 2008; Unsal-Kaçmaz et 
al., 2007; Seiler et al., 2007; Conti et al., 2007). Therefore, we addressed this 
issue by using three different DNA damaging drugs – 4NQO, MMS and 
bleomycin at very different lesions densities. We find that fork rate reduces only 
in response to MMS, which causes the highest lesion density at the 
concentrations used in our study as compared to 4NQO and bleomycin. Even 
though 4NQO and bleomycin activate the checkpoint we don’t see any reduction 
in fork rate. Consistently, we see reduction in fork rate only in cds1Δ cells treated 
with MMS. Thus we have conclusively shown that reduction in fork rate is 
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checkpoint independent and depends on the physical presence of the lesions at 
a sufficiently high frequency (Chapter III). 
 
How does the checkpoint facilitate fork progression across a damaged 
template? 
We see a greater reduction in fork rate in cds1Δ cells as compared to wild-type 
cells treated with MMS (Chapter III). This result indicates that the checkpoint may 
facilitate replication through a damaged template. It would be interesting to 
identify the factors at the replication fork that facilitate replication across a 
damaged template in a checkpoint dependent manner. One approach could be 
using isolation of proteins on nascent DNA (iPOND), which involves labeling cells 
with 5-ethynyl-2’-deoxyuridine (EdU), conjugating biotin to EdU using click 
chemistry, and purifying nascent replicated regions using biotin-streptavidin 
affinity purification (Sirbu et al., 2012; Dungrawala and Cortez, 2015; Sirbu et al., 
2013; Dungrawala et al., 2015). When combined with mass-spectrometry, iPOND 
allows identification of proteins at nascent replication forks (Sirbu et al., 2012). 
Comparing the proteins or the post-translational modification they harbor in the 
presence and absence of checkpoint in response to damage may shed light on 
the role of checkpoint in facilitating replication across a damaged template. 
Further it would be interesting to quantitatively identify the modifications on 
PCNA in the presence and absence of the checkpoint. Such an approach may 
shed light on the regulation of mono-, poly-ubiquitination, and sumoylation of 
PCNA by the checkpoint in response to damage. 
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Another approach could be to try combing with mutants implicated in fork 
restart to see whether we can recapitulate the phenotype of cds1Δ. Candidates 
of interest could be Mus81 and Dna2 (Chapter I).  
 
Fate of stalled forks 
A major finding from our combing data is that fork slowing and fork stalling are 
two distinct responses to DNA damage with different contribution towards bulk 
slowing (Chapter III). This finding opens a lot of questions regarding fork 
progression through a damaged template. What is the kinetics of fork 
progression across a damaged template? What is the kinetics of fork stalling? Do 
forks stall only at complex lesions or is stalling a stochastic response to lesions? 
Are the fork stalls different between 4NQO and MMS? What is the fate of the 
forks that stall (at least throughout the duration of our experiment)? Further, we 
see a high percentage (15%) of forks stalling even in unperturbed conditions 
(Chapter III). What is the source of stalling under unperturbed conditions? Is it 
sequence specific?  
A major limitation of combing is that it provides a snapshot rather than a 
dynamic picture of replication. The questions listed above can be addressed by 
monitoring real-time fork progression through a damaged template as discussed 
below.  
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Real-time analysis of forks 
Several tools recently developed in the field of replication offer great promise for 
elucidation of fork regulation. The three main advances are – the first - 
development of in vitro purified system for regulated eukaryotic replication, the 
second - ‘DNA curtains’ to look at protein-DNA interaction at single–molecule 
level in a high-throughput manner, and the third - a novel approach termed 
‘PhADE’ to look at single molecules of labeled protein in action (Yeeles et al., 
2017; Yeeles et al., 2015; Kurat et al., 2017; Yardimci et al., 2012; Loveland et 
al., 2012; Greene et al., 2010; Duzdevich et al., 2014).  
The Diffley lab has made great advances in the field of replication by 
purifying and defining the minimal components necessary for eukaryotic 
chromosomal replication (Yeeles et al., 2017; Yeeles et al., 2015; Kurat et al., 
2017). This system could potentially be used to understand the roles of individual 
proteins in fork regulation identified from iPOND as well as other studies 
(Chapter I).  
Although the reconstituted system will allow us to identify the role of new 
factors at the fork, ensemble studies mask heterogeneity and short-lived 
interactions. DNA curtains, is a powerful approach to study protein-DNA 
interactions at single-molecule level in a high-throughput fashion (Greene et al., 
2010; Collins et al., 2014). Briefly, flow cells with slides containing nanobarriers 
are created manually or using nanofabrication techniques. The slide is coated 
with lipid bilayer and one end of the λ-DNA is conjugated to the lipid bilayer using 
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biotin-streptavidin interaction. The DNA molecules are aligned, by flowing buffer 
into the flow cell. The lipid molecules flow in the direction of buffer until they hit a 
nanobarrier, which is designed to be perpendicular to the direction of the flow. 
This approach leads to alignment of thousands of DNA molecules parallel to one 
another. The slide can be modified so that the second end of the DNA is also 
tethered. By flowing in a fluorescently labeled protein of interest we can study the 
dynamics of protein-DNA interaction at several molecules of DNA simultaneously 
using total internal reflection fluorescence (TIRF) microscopy (Sternberg et al., 
2014; Redding et al., 2015; Wang et al., 2013; Qi et al., 2015; Gorman et al., 
2012; Finkelstein et al., 2010; Collins et al., 2014).  
A major obstacle to studying protein function at single-molecule level in real-
time is the ability to image fluorescently labeled protein at physiological 
concentrations. This obstacle was overcome by the development of a novel 
approach termed ‘PhADE’ (PhotoActivation, Diffusion, Excitation) by Loveland 
from the Walter lab (Loveland et al., 2012).  Briefly, replication is visualized on λ-
DNA immobilized in a flow cell supplemented with Xenopus egg extract (Yardimci 
et al., 2012). In the egg extract, a protein of interest is tagged with a photo-
activatable fluorescent protein and allowed to flow in and bind to the immobilized 
DNA. The labeled molecules of the protein of interest close to the surface are 
converted by using TIRF illumination, so that they fluoresce at a different 
wavelength than the protein molecules that are not illuminated. The converted 
molecules of protein bound on the DNA can be easily visualized by TIRF 
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excitation. The converted protein molecules that are not bound to DNA but are 
close to the surface are in constant equilibrium with the non-illuminated protein 
molecules in the extract, which are in far greater excess. Thus the unbound 
converted protein molecules easily diffuse away minimizing the noise in this TIRF 
imaging system (Loveland et al., 2012).  
DNA curtains could be potentially combined with the purified reconstituted 
system developed by the Diffley lab to study the role of individual factors in action 
at the replication forks in real-time at single-molecule resolution. The PhADE 
approach could be implemented with DNA curtains if a protein of interest must be 
used at high concentration for optimal activity. While combing only gives us static 
information regarding fork stalling, using real-time monitoring will allow us to 
detect the kinetics of fork stalling. We will be able to address whether fork stalling 
is programmed or stochastic. We could potentially create λ-DNA molecules 
harboring different kinds of MMS-induced lesions, to characterize which lesions 
predominantly cause fork stalling. Further it will also allow us to clarify whether 
reduction of forks observed by combing is due to uniform slowing or frequent 
stalls leading to less replication in response to damage.  
 
Why does 4NQO activate the checkpoint faster than MMS? 
We estimate that the lesions caused by 4NQO are 25-fold rarer than those 
caused by MMS at the concentrations used in our study (Snyderwine and Bohr, 
1992; Lundin et al., 2005). Yet 4NQO appears to activate the checkpoint faster 
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than MMS and leads to similar levels of bulk slowing as assessed by flow 
cytometry (Chapter III). Lesions caused by 4NQO are repaired by NER and 
MMS-induced lesions are repaired by BER (Wyatt and Pittman, 2006; Jones et 
al., 1989; Fujiwara, 1989; Edwards et al., 1987; Ikenaga et al., 1977). The 
kinetics of repair of the lesions caused by the two drugs could be different. It 
would be interesting to ascertain how their repair efficiencies affect the 
checkpoint response. One approach could be to use radioactive 4NQO and MMS 
to estimate the lesion densities achieved in the S phase time course, although 
such reagents are not commercially available. It may be interesting to see 
whether the checkpoint activation occurs faster or slower in NER and BER repair 
deficient mutants as opposed to wild-type. Finally a quantitative detection of 
formation of ssDNA in response to 4NQO and MMS as described below may 
help us understand why 4NQO is better at activating the checkpoint.  
 
Bypass of lesions in cds1Δ cells 
cds1Δ cells show greater reduction in fork rate than wild-type in response to 
MMS, yet they manage to complete replication by 100 minutes as seen by flow 
cytometry (Chapter III). We wanted to understand how forks are able to bypass 
lesions and complete replication in cds1Δ cells treated with MMS. As mentioned 
in Chapter I, restart of forks encountering lesions is thought to rely on repriming, 
translesion-polymerase-based synthesis and/or recombination-mediated 
template switching. To see which of the above mechansims are used in cds1Δ 
cells to bypass lesions, we deleted all the translesion polymerases as well 
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recombination factors swi5 and rad51 (Chapter VI, Appendix). Surprisingly even 
in the absence of translesion polymerases as well as recombination factors, 
cds1Δ cells still manage to replicate in the presence of MMS nearly to the levels 
seen in wild-type (Figure 6.2B). Perhaps lesion bypass in the absence of 
translesion polymerase as well as recombination occurs via repriming. Repriming 
of forks on the leading strand should leave ssDNA gaps (Figure 6.2B). One 
approach could be to look for ssDNA gaps by electron microscopy (Lopes et al., 
2006). Another approach to detect ssDNA could be, to do a pull-down for ssDNA 
regions in the genome using an antibody against ssDNA binding protein followed 
by strand-specific sequencing (Zhou et al., 2013). 
 
Conclusion 
In summary, we have studied the regulation of replication in response to damage 
using a single-molecule approach in S pombe. Using three different damaging 
drugs at different densities we find that reduction in forks in response to damage 
is checkpoint independent. However the checkpoint may facilitate fork 
progression through a damaged template. Using a novel approach we have 
rigorously quantified fork stall events in a tri-color combing dataset and find that 
they contribute significantly towards bulk slowing.  
For future work, it would be interesting to look at the kinetics of fork stalling 
using real-time monitoring of fork progression as well identifying factors that 
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mediate checkpoint-dependent progression of forks through a damaged 
template. 
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Chapter VI 
Appendix 
 
Bypass of lesions in cds1Δ cells 
 
 
 
 
Unpublished results 
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Bypass of lesions in cds1Δ cells  
cds1Δ cells fail to suppress origin firing and show a greater reduction in fork rate 
than wild-type in response to MMS. By bulk assay, cds1Δ cells complete 
replication in the presence of MMS by 100 minutes. We were interested in 
understanding the mechanism by which cds1Δ cells bypass lesions and 
complete replication in the presence of MMS. As mentioned in Chapter I the 
mechanisms by which forks restart include repriming, translesion-polymerase-
based synthesis, and template switching. We were interested in understanding 
which of the above three pathways are employed in cds1Δ cells to bypass MMS-
induced lesions. To this end, we deleted all the four translesion polymerases as 
well as recombination factors swi5 and rad51 in a cds1Δ background in S. 
pombe. We performed the S phase progression assay in response to MMS and 
4NQO. 
 
Results 
To examine the progression of S phase in cds1Δ cells lacking translesion-
polymerase-based synthesis and recombination-mediated template switching we 
built cds1Δswi5Δrad51Δrev3Δrev1Δmug40Δeso1-D147N (yDI157) strain. The 
eso1 gene in fission yeast encodes a fusion protein of two domains with one 
domain coding for DNA polymerase η and the other domain coding for an 
essential sister chromatid cohesion protein, Eco1/Ctf7 (Tanaka et al., 2000). The 
point mutant (147 aspartate to asparagine) of Eso1 abolishes the catalytic activity 
of the polymerase domain (Callegari et al., 2010). We performed the S phase 
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progression assay as mentioned before. We found that in yDI157 replication in 
the untreated sample itself is slightly slower than in the cds1Δ cells. In the 
presence of MMS or 4NQO, yDI157 cells replicate slower and do not complete 
replication even by 180 minutes (Figure 6.1 A). The extent of slowing in yDI157 is 
quite similar to what we observe in wild-type in response to 4NQO or MMS, albeit 
a little less (Figure 6.1 B).  
We also looked at S phase slowing in cds1Δswi5Δrev3Δrev1Δmug40Δeso1-
D147N (yDI132) or cds1Δswi5Δrev3Δrev1Δmug40Δrad30Δnmt41::eso1 
(yDI131). rad30Δnmt41::eso1 is an allele in which the polymerase domain of 
eso1 is deleted and the eso1 is overexpressed under the nmt41 promoter. In 
yDI131 and yDI132, the TLS pathway is completely compromised however the 
rad51-dependent recombination pathway is only partially compromised. In S. 
pombe the Rad51-dependent recombination depends on two sets of mediators, 
Swi5/Sfr1 and Rhp55/57 (Akamatsu et al., 2003; Akamatsu et al., 2007). 
Therefore deletion of swi5 only compromises the recombination pathway 
partially. In yDI131 or yDI132 the phenotype in response to MMS is very similar 
to that of cds1Δ (Figure 6.1C). Only at 120 minutes we see slightly less 
replication in yDI131 or yDI132 as compared to cds1Δ treated with MMS (Figure 
6.1C). Thus recombination may play a bigger role than TLS pathway in bypass of 
lesions in the absence of cds1 (Figure 6.1).  
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Figure 6.1 Replication of damaged DNA in cds1Δ is partially dependent on 
translesion polymerases and recombination. 
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Figure 6.1 Replication of damaged DNA in cds1Δ is partially dependent on 
translesion polymerases and recombination. (A) yDI157 cells were 
synchronized in G1 phase using cdc10-M17 temperature sensitive allele followed 
by elutriation. Elutriated G1 cells were released into permissive temperature 
untreated or treated with 3.5 mM MMS or 1 µM 4NQO or 12mM HU. S phase 
progression was followed by taking samples for FACS. (B) S phase progression 
in yDI157 is overlayed with wild-type for comparison. (C) Average S phase 
progression of yDI131 and132 overlayed with cds1Δ. Error bars represent 
standard deviation. TLSΔ = rev3Δrev1Δmug40Δeso1-D147N or 
rev3Δrev1Δmug40Δrad30Δnmt41::eso1.   
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Discussion 
 
The goal of this experiment was to understand how forks bypass damage-
induced lesions to complete replication in cds1Δ cells. To address this question 
we deleted all the translesion polymerases and recombination factors in cds1Δ 
cells. We find that the bypass of lesion and continued progression of fork relies 
on translesion-polymerase-based synthesis as well as recombination-mediated 
template switching. Recombination may contribute more to bypass of lesions 
than the translesion polymerases in the absence of cds1. Despite the lack of 
translesion polymerases and recombination, the yDI157 cells still manage to 
replicate nearly as much as seen in wild-type cells in response to MMS. We 
hypothesize that some forks may still bypass lesions using downstream 
repriming as a mechanism (Figure 6.2). It would be interesting to test this 
hypothesis by looking for ssDNA gaps. 
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Figure 6.2 Schematic representation of ssDNA gaps left behind by 
repriming on the leading strand. 
 
Figure 6.2 Schematic representation of ssDNA gaps left behind by 
repriming on the leading strand. 
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Materials and Methods  
Strains 
yDI157 (h- leu1-32 ura4-D18 cdc10-M17 cds1::ura4+ rad51::natR swi5::his3 
rev3::kanMX6 rev1::ura4 mug40::hyg eso1-D147N-kanMX rad11-GFP::hph-MX6) 
yDI131 (h- leu1-32 ura4-D18 cdc10-M17 cds1::ura4+ swi5::his3 rev3::kanMX6 
rev1::ura4 mug40::hyg rad30::kanMX::nmt41:eso1) 
yDI132 (h- leu1-32 ura4-D18 cdc10-M17 cds1::ura4+ swi5::his3 rev3::kanMX6 
rev1::ura4 mug40::kanMX eso1-D147N-kanMX) 
 
S phase progression by flow cytometry. 
yDI157, 131, and 132 were grown to mid log phase at 25°C and arrested at 35°C 
for 2 hours followed by centrifugal-elutriation-based size selection at 35°C to 
collect cells that had most recently arrested in G1.  The cells were then 
immediately released into S phase by shifting them to 25°C, untreated or treated 
with 3.5mM MMS or 1 µM 4NQO or 12mM HU. S-phase progression was 
followed by flow cytometry using a nuclei isolation protocol, as previously 
described (Willis and Rhind, 2011) with some minor modifications (Chapter II). 
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